Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,29561,-0.103818239055096,0.00206489840006223,-0.107865439919218,-0.0997710381909737,0
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,29438,-0.115354025981561,0.00197423441911402,-0.119223525443024,-0.111484526520097,0
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,29495,-0.130306960160368,0.00337089242725672,-0.136913909317791,-0.123700011002945,1.1125369292846e-308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,24840,-0.0804847814852665,0.00235960503197124,-0.0851096073479301,-0.0758599556226029,3.01446941111171e-249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,29430,-0.0659081914009682,0.00204036375139213,-0.0699073043536968,-0.0619090784482397,5.59418910125908e-225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29781,-0.0441295767878012,0.0016867921645215,-0.0474356894302633,-0.040823464145339,3.5229909322761e-149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,29561,-0.0617574012200942,0.00260749800198011,-0.0668680973039752,-0.0566467051362132,7.28207930733338e-123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,24788,0.0802596464477596,0.00360585164979455,0.0731921772141623,0.0873271156813569,1.09407518308583e-108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,29502,-0.0276090462689069,0.00128796901920936,-0.0301334655465573,-0.0250846269912566,3.64767747172953e-101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,29029,-0.0729340279521302,0.0034899075952497,-0.0797742468388197,-0.0660938090654408,2.83009050075227e-96
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9,Complement component C9,24946,-0.0678687927741289,0.00346153038771159,-0.0746533923340436,-0.0610841932142142,5.93444724494379e-85
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,24402,-0.0391797008885392,0.00201051904868852,-0.0431203182239687,-0.0352390835531097,6.11863081629441e-84
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFP,Properdin,24961,-0.0291670578029122,0.00149903039966304,-0.0321051573862518,-0.0262289582195727,1.05598831828897e-83
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,29720,-0.074350402426532,0.00382484585271382,-0.0818471002978511,-0.0668537045552129,1.20118712420808e-83
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,24721,-0.0436099794426555,0.00225793470970118,-0.0480355314736698,-0.0391844274116412,1.66022641241729e-82
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,29448,-0.0398062088877387,0.00207829232214867,-0.0438796618391501,-0.0357327559363273,2.83860728591866e-81
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,29756,-0.150678779427727,0.00793797573026885,-0.166237211859054,-0.1351203469964,7.13401840639204e-80
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29815,-0.0359542373845436,0.00189897066324366,-0.0396762198845012,-0.0322322548845861,1.7695050753585e-79
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,29815,-0.0293773146347141,0.0016069524181404,-0.0325269413742693,-0.026227687895159,2.9676801098629e-74
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,29213,0.0702698409178391,0.00384744416764508,0.0627288503492548,0.0778108314864235,4.14274215035027e-74
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,29720,-0.0411855771775032,0.00232302353798789,-0.0457387033119595,-0.0366324510430469,5.71855686858851e-70
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,24887,-0.0838712206054387,0.00477600185373476,-0.0932321842387589,-0.0745102569721186,1.27314622084517e-68
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,29438,-0.0327261856978878,0.00187009839179606,-0.036391578545808,-0.0290607928499675,3.19342679665563e-68
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,24946,-0.0281955813797263,0.00163133730571582,-0.0313930024989293,-0.0249981602605233,1.52482710738902e-66
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24961,-0.0290431069452738,0.0016878362454383,-0.0323512659863328,-0.0257349479042147,5.62990981864033e-66
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,24376,-0.0474396118352574,0.00279578004229167,-0.0529193407181491,-0.0419598829523657,3.29803441197914e-64
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29781,-0.031387895515792,0.00186938207293954,-0.0350518843787535,-0.0277239066528305,5.58457194618903e-63
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,29473,-0.0286724243631784,0.00172029052564361,-0.0320441937934398,-0.0253006549329169,4.37193994193319e-62
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,29697,0.038882288981834,0.00234045659337883,0.0342949940588115,0.0434695839048565,1.06443894165357e-61
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,29473,-0.0359570901299883,0.00223912746340766,-0.0403457799582674,-0.0315684003017093,8.76995751077721e-58
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,24618,-0.043772064538732,0.00272982217100439,-0.0491225159939006,-0.0384216130835634,1.43092132991234e-57
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29438,-0.0374888092536354,0.00234842440296804,-0.0420917210834527,-0.032885897423818,3.99636266980535e-57
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,29187,-0.0295154949569464,0.00185042959104257,-0.0331423369553898,-0.0258886529585029,4.91803706326228e-57
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,29342,0.0426887359300823,0.00267687537191665,0.0374420602011257,0.047935411659039,5.17495149160774e-57
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,29344,-0.0425965043234119,0.002673220374569,-0.0478360162575672,-0.0373569923892567,6.3297111583422e-57
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FST,Follistatin,29531,-0.0524743853524513,0.00329956251062981,-0.0589415278732857,-0.0460072428316169,1.03235080025138e-56
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,29815,-0.016434070012317,0.00103577219115027,-0.0184641835069716,-0.0144039565176625,1.84217273386103e-56
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,29656,-0.0443345367619908,0.00280575437394344,-0.04983381533492,-0.0388352581890617,5.16328876639881e-56
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,29438,-0.0283302172620488,0.00179946916837305,-0.03185717683206,-0.0248032576920376,1.28135830508725e-55
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,29815,-0.0269903521155197,0.00172131978628581,-0.0303641388966399,-0.0236165653343996,3.44415603870774e-55
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,24917,0.0847556107491077,0.00540370336547843,0.07416435215277,0.0953468693454455,3.53549586299481e-55
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,29781,-0.0427035033306958,0.00273341008675027,-0.0480609871007263,-0.0373460195606653,8.40998247151439e-55
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,29164,-0.0520058170474967,0.00337286261956641,-0.0586166277818469,-0.0453950063131466,1.98668793986373e-53
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,29378,-0.0299999664038201,0.00195112307582834,-0.0338241676324436,-0.0261757651751965,3.8374995984665e-53
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,29369,-0.0328729467418004,0.00214422826514784,-0.0370756341414901,-0.0286702593421106,7.62061080203959e-53
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYY,Peptide YY,24106,0.0971390032932799,0.00634520923599764,0.0847023931907246,0.109575613395835,1.17809137093179e-52
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29689,-0.0453371265037067,0.00297505648730772,-0.0511682372188298,-0.0395060157885835,3.06973938831615e-52
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,29720,-0.0458908942106912,0.00301546618635456,-0.0518012079359462,-0.0399805804854363,4.19264739987467e-52
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,24376,-0.11416188548786,0.00756687310063697,-0.128992956765109,-0.0993308142106118,3.35740021959374e-51
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,29473,-0.0447459496672862,0.00297147924331851,-0.0505700489841905,-0.0389218503503819,4.70606343006225e-51
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,24878,-0.0145588386544605,0.000967262077431985,-0.0164546723262272,-0.0126630049826938,5.6541391042269e-51
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,29531,-0.0309704366393007,0.002060004251631,-0.0350080449724974,-0.0269328283061039,6.77099586765748e-51
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),24479,-0.175139755532763,0.0116591944987714,-0.197991776750355,-0.152287734315171,8.93211515308254e-51
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,29438,-0.0332116048899896,0.00221571931218307,-0.0375544147418684,-0.0288687950381108,1.33097636386263e-50
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,29468,-0.0381815397292629,0.00255410100562943,-0.0431875777002966,-0.0331755017582293,2.41562293869773e-50
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASN,Vasorin,29060,-0.02677901267918,0.00179988222368678,-0.0303067818376061,-0.0232512435207539,6.97301228623057e-50
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,29720,-0.0317687562380431,0.00214425311938914,-0.0359714923520458,-0.0275660201240403,1.74086480347002e-49
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,24235,0.0491355083275642,0.00333687741959535,0.0425952285851573,0.0556757880699711,7.24878409940898e-49
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29589,-0.0406856696581772,0.00277779876484165,-0.0461301552372668,-0.0352411840790875,2.08938904573156e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,29429,-0.0317795909459247,0.00217217339914891,-0.0360370508082566,-0.0275221310835928,2.66068381407451e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,29689,-0.0357006304489066,0.00244261920414477,-0.0404881640890303,-0.0309130968087828,3.28105177781919e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,24224,0.11679394570096,0.00803667455637327,0.101042063570469,0.132545827831452,1.19525972243272e-47
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,29720,-0.0311251399242146,0.00215124878194902,-0.0353415875368347,-0.0269086923115945,2.77932503125682e-47
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,24946,-0.0245426640325986,0.00170424076483386,-0.0278829759316729,-0.0212023521335242,7.87093848165682e-47
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,29429,-0.0318624553353301,0.00222247547995274,-0.0362185072760375,-0.0275064033946227,1.85735839129134e-46
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,29452,0.0906725474019791,0.00633979387387107,0.0782465514091918,0.103098543394766,3.03311849287227e-46
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,29576,-0.038778885377109,0.00271502231550124,-0.0441003291154915,-0.0334574416387266,3.97400169944658e-46
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,29576,-0.0622337502207392,0.00436449938204324,-0.070788169009544,-0.0536793314319345,5.59346609528767e-46
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,24917,-0.0254376721556879,0.00179801170253943,-0.0289617750926652,-0.0219135692187106,2.89168472774709e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24235,-0.0240033673111992,0.00170309643613112,-0.0273414363260162,-0.0206652982963822,6.22853277370694e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29438,-0.0463902388893147,0.00331611305622835,-0.0528898204795223,-0.0398906572991072,2.51191987754171e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,29689,0.126994593237122,0.00908146071037694,0.109194930244784,0.144794256229461,2.70132349217036e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,29213,-0.0309272049579927,0.00222406633468736,-0.0352863749739799,-0.0265680349420055,8.07113313883719e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,29815,-0.0177553536422658,0.0012797644270257,-0.0202636919192362,-0.0152470153652954,1.24613789660801e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELL,L-selectin,24961,-0.0210039124640564,0.00151587633296597,-0.0239750300766697,-0.0180327948514431,1.69739755910781e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,29637,-0.036888758525344,0.00266538440744211,-0.0421129119639305,-0.0316646050867574,1.99813419007626e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,28949,-0.0373520352474812,0.00271158622813151,-0.042666744254619,-0.0320373262403435,4.92991483774958e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,29561,-0.0269223971767325,0.00195703898339206,-0.030758193584181,-0.0230866007692841,6.2975475505485e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29492,-0.0304729857297406,0.00221674413410077,-0.0348178042325782,-0.0261281672269031,7.22676238222904e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,29344,-0.0266230554873909,0.0019399820102269,-0.0304254202274356,-0.0228206907473461,9.97479736326488e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,29296,-0.0676666917236756,0.00493584379590945,-0.0773409455636581,-0.0579924378836931,1.21075212275167e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,23400,0.0990757810275112,0.00723416796892554,0.0848968118084171,0.113254750246605,1.57574827525354e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,28863,-0.0339914714489797,0.00250321807502454,-0.0388977788760278,-0.0290851640219316,7.16612831187501e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,28792,0.110164513261165,0.00813241022989959,0.094224989210562,0.126104037311768,1.11773219111973e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,29561,0.0354836208888229,0.00262424132368552,0.0303401078943992,0.0406271338832465,1.5528368051979e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29589,-0.0386610402377824,0.00285973622555104,-0.0442661232398624,-0.0330559572357024,1.60324995927961e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,29213,-0.0319711765708944,0.00237101136436376,-0.0366183588450474,-0.0273239942967414,2.57666168304108e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFH,Complement factor H,23688,-0.0205927049808068,0.00152880485749377,-0.0235891625014946,-0.017596247460119,3.34056387991619e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,29473,-0.0354417507794733,0.00263274418382673,-0.0406019293797737,-0.0302815721791729,3.4697444335121e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,29689,-0.0260922400154609,0.00195786878572547,-0.0299296628354828,-0.022254817195439,2.11142415711618e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,29486,-0.0345041356684699,0.00260057924740801,-0.0396012709933896,-0.0294070003435502,4.63358741350503e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,24800,-0.0258069747195927,0.00195629340378208,-0.0296413097910056,-0.0219726396481798,1.33092810657582e-39
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,29561,-0.0238553732316182,0.00182730122561832,-0.0274368836338301,-0.0202738628294062,7.62609398722873e-39
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28926,-0.0362947052791727,0.00278239803716556,-0.0417482054320172,-0.0308412051263282,8.80244597981329e-39
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,29386,-0.0246122704461491,0.00188685768436378,-0.0283105115075021,-0.020914029384796,8.80739823934599e-39
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,29473,-0.0331524468029186,0.00254456507011209,-0.0381397943403383,-0.0281650992654989,1.07471665575317e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,24961,0.0233965447254909,0.00179617232407824,0.0198760469702975,0.0269170424806842,1.16743371581863e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29213,-0.0354386199533073,0.00273435680542172,-0.0407979592919339,-0.0300792806146807,2.61420265315e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24863,-0.077185989152473,0.00597876977417033,-0.0889043779098469,-0.0654676003950992,5.23770521525602e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,29420,-0.0188324917498833,0.00145920638799544,-0.0216925362703544,-0.0159724472294122,5.28272921661742e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRN,Agrin,29576,-0.0289879533532871,0.00225032645426508,-0.0333985932036467,-0.0245773135029275,7.21978044094663e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29438,-0.0204618201502161,0.00158903064722038,-0.023576320218768,-0.0173473200816641,7.68343536008867e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,29689,-0.0511488347820289,0.00397357561437605,-0.0589370429862059,-0.0433606265778518,8.14417716078107e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,24961,-0.0175819692454914,0.0013668834259004,-0.0202610607602562,-0.0149028777307266,9.60755284341463e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,29344,-0.0235319445763704,0.00184464052630066,-0.0271474400079197,-0.0199164491448211,3.58158285373786e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,29308,-0.0322760931179814,0.0025327412870319,-0.0372402660405639,-0.0273119201953988,4.24968416103039e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,29438,-0.0238959170497558,0.00187643380295749,-0.0275737273035525,-0.0202181067959591,4.74879566928984e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,29815,-0.0185116597561973,0.00145651207825814,-0.0213664234295832,-0.0156568960828113,6.52386281923732e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,24376,-0.0431760514913573,0.00339614990972314,-0.0498325053144146,-0.0365195976682999,6.54130931759213e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,24946,-0.023554439177862,0.00185304602476042,-0.0271864093863924,-0.0199224689693316,6.67147740475687e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",24800,-0.0723870297309003,0.00572705971748347,-0.0836120667771679,-0.0611619926846327,1.65804852556811e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,28926,-0.032475894133285,0.00257371059304205,-0.0375203668956474,-0.0274314213709225,2.0878512036939e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29344,-0.0261696249011314,0.00208039620002304,-0.0302472014531765,-0.0220920483490862,3.41024126509687e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,24920,-0.0160145845905002,0.00127463446814276,-0.01851286814806,-0.0135163010329403,4.28280322545582e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,29525,-0.0232272875773555,0.00185551959301481,-0.0268641059796645,-0.0195904691750464,7.34707294819274e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29589,-0.0311806909700458,0.00249363606648147,-0.0360682176603495,-0.0262931642797421,8.73315620690327e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,29561,-0.022469932909102,0.00180077341619391,-0.0259994488048421,-0.0189404170133619,1.21166273496296e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,29781,-0.0334816237317184,0.00270282511630508,-0.0387791609596763,-0.0281840865037604,3.72259348669358e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2,Complement C2,29540,-0.0188144488048138,0.0015286485719518,-0.0218106000058394,-0.0158182976037883,9.99391553541281e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,29344,-0.0314265888978795,0.00255700085902974,-0.0364383105815778,-0.0264148672141812,1.24118075767202e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,29461,-0.0321546144804475,0.00261826021146634,-0.0372864044949215,-0.0270228244659735,1.39400366745439e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,29473,-0.0257210471790497,0.00209851245456033,-0.0298341315899879,-0.0216079627681114,1.87444756957368e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,24933,-0.0211252815545308,0.00172919619951016,-0.0245145061055707,-0.0177360570034909,3.16736749669484e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24235,-0.0729899564193111,0.00597882362721067,-0.084708450728644,-0.0612714621099782,3.54728289290189e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,24376,-0.0296097656897008,0.00242609674879035,-0.0343649153173299,-0.0248546160620717,3.6921618974644e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,29385,-0.0225339489222991,0.0018492554831182,-0.0261584896692108,-0.0189094081753874,4.49332561226778e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,29438,-0.0231276443076137,0.00190367637037708,-0.0268588499935528,-0.0193964386216746,7.00645253625478e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,28272,-0.0183039653729008,0.00150837281026065,-0.0212603760810117,-0.0153475546647899,8.37380469375449e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24235,-0.036402254622249,0.00300013713055283,-0.0422825233981325,-0.0305219858463654,8.79341985840597e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,29531,-0.0356696675336887,0.00295641807330773,-0.0414642469573719,-0.0298750881100055,1.93419439593362e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,29815,-0.0227322132050549,0.00188989605914401,-0.0264364094809771,-0.0190280169291326,3.01336101472024e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,24898,-0.0282558887604608,0.00235103418579346,-0.0328639157646159,-0.0236478617563056,3.51086420600083e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,29161,-0.0551982932798859,0.00459811919554101,-0.0642106069031463,-0.0461859796566256,4.02671470759658e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,24840,-0.0597665203601804,0.004978553636332,-0.0695244854873911,-0.0500085552329696,4.14147323293723e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24376,-0.0320605514261594,0.00268355953054221,-0.0373203281060221,-0.0268007747462966,8.31121427488635e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,29429,-0.0458179998075844,0.00383771122850365,-0.0533399138154515,-0.0382960857997172,8.83602808270414e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,29689,-0.0228771145172874,0.00191655504903695,-0.0266335624133999,-0.019120666621175,9.06932017916549e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,29344,0.0705521048688466,0.00591348404139847,0.0589616761477056,0.0821425335899876,9.74784576656211e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,29344,0.0539828119995085,0.00452591628172998,0.0451120160873177,0.0628536079116992,1.01314662266428e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,24961,0.0278730983260617,0.00233878175728816,0.0232890860817769,0.0324571105703465,1.17281583786081e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,29344,-0.0228866738009839,0.00192085529386748,-0.0266515501769641,-0.0191217974250036,1.17846655273038e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29505,-0.0177534657720948,0.00149260798372862,-0.0206789774202029,-0.0148279541239867,1.50492500861262e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,29561,-0.0287584635994614,0.00241801093111135,-0.0334977650244397,-0.0240191621744832,1.51922637100638e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,24933,-0.0187587119576439,0.00157775511938654,-0.0218511119916415,-0.0156663119236463,1.64347856140869e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,29473,-0.0360534305353626,0.00303352280234364,-0.0419991352279562,-0.0301077258427691,1.68069079486408e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,29328,0.0488280141530692,0.00412454908234208,0.0407438979516787,0.0569121303544597,2.92766161774433e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,29344,-0.0252318337401625,0.00213409616389373,-0.0294146622213942,-0.0210490052589308,3.50530131384444e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,29673,-0.02102644113673,0.00177996152278148,-0.0245151657213817,-0.0175377165520783,3.95428412867582e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,29461,-0.0410296421897499,0.00347546554514096,-0.0478415546582262,-0.0342177297212737,4.31900838129016e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,29449,0.0421249562118905,0.00357141332747063,0.0351249860900481,0.049124926333733,4.88881817813889e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,28748,-0.0356964485274072,0.00302699372550628,-0.0416293562293995,-0.0297635408254148,5.04578350718641e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,24510,-0.0105010133640549,0.000890703011844769,-0.0122467912672706,-0.00875523546083915,5.39141120395433e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,29213,-0.019848190661754,0.00168536435642331,-0.0231515048003437,-0.0165448765231643,6.07268809250031e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,29438,-0.0192043036851947,0.00163639427591843,-0.0224116364659948,-0.0159969709043946,9.83860870047138e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,29589,-0.0211860311187284,0.00180903651736642,-0.0247317426927666,-0.0176403195446903,1.31138347162607e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29344,-0.0343020552776057,0.00292934699175016,-0.040043575381436,-0.0285605351737754,1.33533615872567e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28911,-0.0421231965442318,0.00359978967925265,-0.049178784315567,-0.0350676087728966,1.47419228603607e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,29678,-0.0263218624215632,0.0022499788607934,-0.0307318209887183,-0.0219119038544082,1.5179863111309e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,29689,-0.0205799666943052,0.00176263495406362,-0.0240347312042699,-0.0171252021843405,1.98816601413715e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,29344,-0.0216865535484487,0.00186115902501272,-0.0253344252374737,-0.0180386818594238,2.62205129980373e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29589,-0.0327204971639029,0.00281130755332561,-0.0382306599684211,-0.0272103343593847,3.0581053017077e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,29576,-0.0205343313134088,0.00176819516477702,-0.0239999938363718,-0.0170686687904458,4.12809586315615e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,29576,-0.0322049922546552,0.00278054701433357,-0.037654864402749,-0.0267551201065614,5.91370374213301e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,29689,-0.0347542384791876,0.00300399546268911,-0.0406420695860583,-0.028866407372317,6.86602255465638e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,29475,-0.0397177905127256,0.00343430311123374,-0.0464490246107437,-0.0329865564147075,7.22650559313366e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29755,-0.0288063515378789,0.00249395888181399,-0.0336945109462343,-0.0239181921295235,8.54371461117388e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,29376,-0.0310018400368385,0.00268566959909829,-0.0362657524510712,-0.0257379276226059,9.28545092176182e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",29720,-0.0551930282290456,0.00479910894954355,-0.064599281770151,-0.0457867746879403,1.51905637442241e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,29781,-0.0191121721877771,0.00166727634780841,-0.0223800338294816,-0.0158443105460726,2.34080756285046e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29356,-0.0201977983846549,0.00176719987230266,-0.0236615101343681,-0.0167340866349417,3.45966743858548e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,29647,-0.0277058683508191,0.00243724639991989,-0.0324828712946621,-0.0229288654069761,6.98533534114605e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,29111,-0.02186375796348,0.0019297718582512,-0.0256461108056524,-0.0180814051213077,1.07925537731608e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,24376,-0.0208799938428931,0.00184614750072689,-0.0244984429443178,-0.0172615447414684,1.38721676285993e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,29540,-0.0217724185379064,0.00192639564401384,-0.0255481540001736,-0.0179966830756393,1.47267765986071e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24800,-0.0758614887675016,0.0067154786158727,-0.0890238268546121,-0.0626991506803911,1.61227174567546e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_E,,29429,-0.0213456418659485,0.00189900399536373,-0.0250676896968614,-0.0176235940350356,2.96111158910376e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,29689,-0.0165917247237239,0.00147786173821399,-0.0194883337306233,-0.0136951157168245,3.44744443015151e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,29599,-0.0438788163065883,0.00390898187180593,-0.0515404207753279,-0.0362172118378486,3.51628184688719e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,24840,-0.0269236015644744,0.00239973293683789,-0.0316270781206767,-0.0222201250082722,3.84829927987351e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,29561,-0.0246539442073652,0.0021982953288704,-0.0289626030519511,-0.0203452853627792,3.94040787389796e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,29540,-0.018944683859309,0.00169267226639267,-0.0222623215014387,-0.0156270462171794,5.09539671401641e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,29218,-0.0296260050156185,0.00264806127172143,-0.0348162051081925,-0.0244358049230445,5.35932960420108e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,24417,-0.0280964860877394,0.00251109220694791,-0.0330182268133573,-0.0231747453621215,5.43401538298469e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,24764,-0.0639166786752281,0.00571880345989907,-0.0751255334566303,-0.052707823893826,6.22829021876641e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,28930,0.0575552436591937,0.0051583653902349,0.0474448474943333,0.0676656398240541,7.52576332156499e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,28985,-0.0219045033099103,0.00196383454197917,-0.0257536190121895,-0.0180553876076311,7.84258868684738e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,24800,-0.0501384312282742,0.00449697558664641,-0.0589525033781012,-0.0413243590784473,8.44475163326817e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,29473,-0.0177695627830177,0.00159493188303301,-0.0208956292737624,-0.014643496292273,9.0176448959529e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,29383,-0.0350644823169086,0.00315034906007656,-0.0412391664746587,-0.0288897981591586,1.01922976145621e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,24840,-0.0222028823875691,0.00199500146560246,-0.0261130852601499,-0.0182926795149882,1.05694391887396e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,24800,0.052389438491498,0.0047073565653744,0.0431630196233642,0.0616158573596318,1.05705615447905e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29429,-0.0247437728211592,0.00222470971605956,-0.0291042038646359,-0.0203833417776825,1.11550249973916e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29815,-0.0199106732433552,0.00179689826179687,-0.0234325938364771,-0.0163887526502333,1.7717351013791e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,28769,-0.0338498726906259,0.00305775530012986,-0.0398430730788805,-0.0278566723023714,1.99834173605884e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,29781,-0.0303563896541548,0.00274705815395334,-0.0357406236359034,-0.0249721556724063,2.47478177606402e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,24933,0.0294697999526367,0.00266770781787953,0.0242410926295928,0.0346985072756806,2.6410714584448e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,29473,-0.0442726573775997,0.00401160103404912,-0.052135395404336,-0.0364099193508634,2.90545246849265e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPN,Asporin,24917,-0.0198630175227597,0.00180122024066642,-0.0233934091944659,-0.0163326258510535,3.27161567106517e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,28979,-0.0245972789272731,0.00223138164774616,-0.0289707869568556,-0.0202237708976906,3.35573006268024e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,29473,-0.0206254534534052,0.00187809937026634,-0.0243065282191273,-0.0169443786876832,5.28148024468306e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,29356,-0.0243670907697881,0.00222036983930775,-0.0287190156548313,-0.0200151658847449,5.75532745946796e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,24961,-0.0186266097983065,0.001703764420593,-0.0219659880626688,-0.0152872315339442,9.30572968870818e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPS,Colipase,29395,-0.050684807015246,0.00464185797707663,-0.0597828486503162,-0.0415867653801758,1.05632226636315e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C3,Complement C3,23774,-0.0332245256044738,0.00304797824855128,-0.0391985629716343,-0.0272504882373133,1.33229870102454e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,29323,-0.0305431525530795,0.00280440098638295,-0.03603977848639,-0.0250465266197689,1.43465153461211e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,24800,-0.0682122598652932,0.00626218096603995,-0.0804861345587315,-0.0559383851718549,1.44162448411183e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,29213,-0.0243916118292263,0.00224188229269393,-0.0287857011229064,-0.0199975225355462,1.62190008315016e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,24224,-0.0230792326424368,0.00212102821633201,-0.0272364479464476,-0.0189220173384261,1.64160038764387e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29344,-0.0271126787197817,0.00249534705047273,-0.0320035589387083,-0.0222217985008552,1.90276196287688e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,24376,-0.0213377223785969,0.00196475159329553,-0.0251886355014562,-0.0174868092557377,2.05981292727881e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24800,-0.0733363183352897,0.00675650827171588,-0.0865790745478528,-0.0600935621227265,2.19571740809888e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,29623,-0.0334438145566611,0.00308830547389058,-0.0394968932854867,-0.0273907358278356,2.81686507352697e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,24909,-0.0160112208329535,0.00147844163485183,-0.0189089664372631,-0.0131134752286439,2.86097059929828e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,24235,-0.0223961668577491,0.00206877677583176,-0.0264509693383794,-0.0183413643771189,2.9995003492543e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,29589,-0.0218812540442536,0.00202304320501135,-0.0258464187260759,-0.0179160893624314,3.25088246176258e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29344,-0.0170999265341985,0.0015849379356028,-0.02020640488798,-0.013993448180417,4.36122009336898e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,29815,-0.0184269570809996,0.00170867408075294,-0.0217759582792754,-0.0150779558827239,4.57858773693646e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",28769,-0.0372970552074628,0.00346007371366864,-0.0440787996862534,-0.0305153107286723,4.85852310389127e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24225,-0.0274326894149692,0.00254798086079948,-0.0324267319021362,-0.0224386469278022,5.70682935928511e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29556,-0.0220566751995258,0.00204968015272174,-0.0260740482988604,-0.0180393021001912,5.89931907878873e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,29689,-0.0553898639621828,0.00515338049998017,-0.065490489742144,-0.0452892381822217,6.76889857574098e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,24811,-0.0453019809973839,0.0042221052036863,-0.053577307196609,-0.0370266547981587,8.4538749737363e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,29689,-0.0368441092020716,0.00343592762666913,-0.0435785273503431,-0.0301096910538001,8.87018035663752e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,29344,-0.0254670171824795,0.00237548714987418,-0.0301229719962329,-0.0208110623687261,9.11806002244962e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,29473,0.0477557060719981,0.0044546480694967,0.0390245958557845,0.0564868162882116,9.14633949923177e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,29344,-0.0599803518199686,0.00560282041421148,-0.0709618798318231,-0.0489988238081141,1.07583541911805e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29668,-0.0242212073570234,0.0022638192502922,-0.0286582930875961,-0.0197841216264506,1.14756788774382e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,29720,-0.0421151144017142,0.00395206039023738,-0.0498611527665795,-0.0343690760368489,1.81545595063823e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,29561,-0.0391494472784071,0.0036750379311238,-0.0463525216234097,-0.0319463729334045,1.88982364259757e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,29755,-0.035810514051706,0.00336365597093482,-0.0424032797547382,-0.0292177483486737,2.02436362864717e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,29014,-0.0155916595737495,0.00146594212880297,-0.0184649061462033,-0.0127184130012957,2.26819536018978e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,28792,-0.0374265825521351,0.00352115745758286,-0.0443280511689975,-0.0305251139352727,2.4431420217191e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29720,-0.043529135330529,0.00410084121746455,-0.0515667841167595,-0.0354914865442985,2.8382476807182e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28926,-0.0500916507674487,0.00471975186407501,-0.0593423644210357,-0.0408409371138617,2.892245903472e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,29781,-0.0187909729829339,0.00177183564241992,-0.022263770842077,-0.0153181751237909,3.13389324454366e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,29365,-0.0140458758618061,0.00132441609518704,-0.0166417314083727,-0.0114500203152395,3.13986705245697e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,29561,-0.0168501254772619,0.00159236725330224,-0.0199711652937343,-0.0137290856607895,4.0305902868015e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29344,-0.0238160507090268,0.00226724605728337,-0.0282598529813022,-0.0193722484367514,9.16124314402491e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,29781,-0.0307549338212897,0.00293392382180161,-0.0365054245120209,-0.0250044431305586,1.15204349824939e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,29492,-0.0164072830034683,0.00156624846349007,-0.0194771299919089,-0.0133374360150278,1.2413997088877e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29492,-0.0209442323331446,0.00199982133672858,-0.0248638821531326,-0.0170245825131566,1.27422032204566e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,29164,-0.0170495516551071,0.00163060372082029,-0.0202455349479149,-0.0138535683622993,1.52672724984813e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,28757,-0.0217166005140815,0.00207980836768001,-0.0257930249147343,-0.0176401761134286,1.77749502068311e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29438,-0.0248950804587887,0.00239275318105624,-0.0295848766936589,-0.0202052842239184,2.62034651051136e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,29815,-0.0216725204262169,0.00208415400213962,-0.0257574622704105,-0.0175875785820232,2.77637544368139e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,29576,-0.0293043562847583,0.00282554158698051,-0.0348424177952401,-0.0237662947742765,3.70196684104685e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,24933,-0.0400281172436457,0.00386840015441707,-0.0476101815463031,-0.0324460529409882,4.82984450865454e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,29370,-0.0250899534879596,0.00242569201554011,-0.0298443098384182,-0.020335597137501,4.94917377243584e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,24376,-0.0389128612043665,0.00376676421249279,-0.0462957190608524,-0.0315300033478806,5.77092094041607e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,29438,-0.0512511320600723,0.00496321377678843,-0.0609790310625776,-0.0415232330575669,5.91780964834307e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,29438,0.0295989383806878,0.00286712927791872,0.0239793649959671,0.0352185117654085,6.08312165718073e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,29554,-0.0157079584169257,0.00153139278965567,-0.0187094882846508,-0.0127064285492006,1.20693104652949e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,29689,-0.0231864488080563,0.00226423322305173,-0.0276243459252377,-0.0187485516908749,1.43736357048676e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOST,Sclerostin,29428,-0.0258725413227547,0.00253434057821255,-0.0308398488560513,-0.0209052337894581,1.989390910776e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,28792,-0.0244077256232469,0.00239138954424974,-0.0290948491299764,-0.0197206021165174,2.04078574686284e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,29395,0.0676750671275759,0.00666461654513511,0.0546124186991111,0.0807377155560407,3.47337472670036e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,24840,-0.0204589546768033,0.00201511332849273,-0.024408576800649,-0.0165093325529575,3.59147016242294e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24235,-0.0350946052989392,0.00346203783420039,-0.041880199453972,-0.0283090111439064,4.22986959429476e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPTC,Opticin,29344,-0.0300158412977349,0.00296225090499516,-0.0358218530715254,-0.0242098295239444,4.3306439278464e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,29213,-0.0271461710168192,0.00267983936754585,-0.032398656177209,-0.0218936858564293,4.4672115513473e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,24900,-0.0228110350767015,0.00225460947685434,-0.027230069651336,-0.018392000502067,5.14205003519656e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24235,-0.0510532783193648,0.00505083161653421,-0.0609529082877719,-0.0411536483509578,5.68673093146254e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,29428,0.0319817666713879,0.00316760075214204,0.0257732691971895,0.0381902641455863,6.26132358372446e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,24224,-0.0263159396601521,0.00261078757905573,-0.0314330833151013,-0.0211987960052028,7.57144191541623e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,29429,0.0350702851575218,0.00348965304176308,0.0282305651956661,0.0419100051193774,1.00551218343705e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,29326,-0.0188501108680463,0.00187654289530785,-0.0225281349428497,-0.0151720867932429,1.05439723334755e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29720,-0.0224759616411706,0.00223918095444589,-0.0268647563118846,-0.0180871669704567,1.13659796012118e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,29115,-0.0284612564629188,0.00283783144838303,-0.0340234061017495,-0.022899106824088,1.23885882678282e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2,Brorin,29109,-0.0261872795508805,0.00261109849917705,-0.0313050326092675,-0.0210695264924935,1.23898021331275e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,29367,0.0414683920253424,0.00413784729489767,0.033358211327343,0.0495785727233418,1.33517483366138e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,29449,-0.0173004292487139,0.00172738621194871,-0.0206861062241333,-0.0139147522732944,1.42311743757743e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,24376,-0.0340172413986724,0.00339731396751657,-0.0406759767750049,-0.02735850602234,1.48447828136434e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,24800,-0.0359111160198329,0.00358721814738163,-0.0429420635887009,-0.0288801684509649,1.51391236092286e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29503,-0.0322805601283553,0.00322814778323271,-0.0386077297834915,-0.0259533904732192,1.66604268176513e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29473,0.0221797618276211,0.00222260429731208,0.0178234574048895,0.0265360662503528,2.04833190801157e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,28792,-0.0330875414501935,0.00331773204593905,-0.039590296260234,-0.0265847866401529,2.1851171621615e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,29438,-0.0229592210337127,0.00230371663964249,-0.027474505647412,-0.0184439364200135,2.33433443847495e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,29720,-0.0184832045521587,0.00185858154550848,-0.0221260243813553,-0.0148403847229621,2.88956080387861e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,29782,-0.0280605890205002,0.00282402389964745,-0.0335956758638092,-0.0225255021771912,3.1425588864317e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,28911,-0.0325347492481213,0.00328128943711897,-0.0389660765448745,-0.0261034219513681,3.89177237063834e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29635,-0.0188193493043269,0.00189917726286296,-0.0225417367395383,-0.0150969618691155,4.12419439976013e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28926,-0.0284327229971371,0.00287472114532725,-0.0340671764419785,-0.0227982695522956,4.97459597380195e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,29781,-0.0341986650174733,0.00346066776904266,-0.0409815738447969,-0.0274157561901497,5.40081373655226e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,29286,-0.0197387676239426,0.00199808759698725,-0.0236550193140376,-0.0158225159338476,5.58704915622729e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,29531,-0.0193892284598266,0.00196341861110885,-0.0232375289376,-0.0155409279820533,5.78616520521739e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,28926,-0.0259224159484986,0.00262690123465575,-0.0310711423684239,-0.0207736895285733,6.22477211739301e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29627,-0.022250729102766,0.00225682955440245,-0.0266741150293948,-0.0178273431761371,6.77797438036841e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24235,-0.029280832760419,0.00297004007328057,-0.0351021113040489,-0.0234595542167891,6.93929493252656e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,29781,-0.0302756049529481,0.00307395519614513,-0.0363005571373926,-0.0242506527685036,7.4977529524811e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,29213,0.0335735921918657,0.00341147604829955,0.0268870991371985,0.0402600852465328,8.10531658047671e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRN,Progranulin,29308,-0.0158685345867043,0.00161513226496093,-0.0190341938260277,-0.0127028753473809,9.53683545851745e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,24376,-0.0696398127406476,0.00709569380348911,-0.0835473725954863,-0.055732252885809,1.07576634703506e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,28581,-0.0246895573591111,0.00252027672534603,-0.0296292997407893,-0.0197498149774329,1.26691753603525e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,29448,-0.060300851967112,0.00615826263921316,-0.0723710467399698,-0.0482306571942542,1.32130305335964e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,29576,-0.0131231290645624,0.00134130248888862,-0.0157520819427841,-0.0104941761863407,1.4290869171348e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,29116,-0.0366557971654295,0.00375078229226203,-0.044007330458263,-0.0293042638725959,1.59500773686117e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,24933,-0.0137487188763985,0.00140956516702625,-0.01651146660377,-0.0109859711490271,1.94765543242702e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,29815,-0.0262456305199765,0.00269483012114468,-0.03152749755742,-0.0209637634825329,2.21448107206969e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29344,-0.0212240609479256,0.00218109237902475,-0.0254990020108141,-0.0169491198850371,2.40566502572173e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,29438,-0.0247885058086564,0.00254771361657248,-0.0297820244971384,-0.0197949871201743,2.43411708700572e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,29473,-0.0216916611099655,0.0022332266255281,-0.0260687852960006,-0.0173145369239305,2.86226085579182e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,29518,-0.0351413829612866,0.00362355781073484,-0.0422435562703269,-0.0280392096522463,3.31763150561454e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",24235,-0.0551320221008395,0.00569359124308946,-0.0662914609372948,-0.0439725832643841,3.89939546241738e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,24917,-0.0619401052684435,0.00640254881239857,-0.0744891009407447,-0.0493911095961424,4.2412054300214e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,29344,-0.0152020683471453,0.0015732005215347,-0.0182855413693533,-0.0121185953249372,4.6639390234702e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,29669,-0.0178852994957921,0.00185253834497874,-0.0215162746519504,-0.0142543243396337,5.06996873870164e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,29720,-0.0697486710738694,0.00723125243262895,-0.0839219258418221,-0.0555754163059166,5.53466578999493e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,24841,-0.0126108478027538,0.00130908062543411,-0.0151766458286047,-0.0100450497769029,6.31468216115946e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,29331,-0.0289639067615166,0.00301076447080321,-0.0348650051242909,-0.0230628083987423,7.08387708805652e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,29118,-0.016225245895793,0.00168731260401089,-0.0195323785996543,-0.0129181131919316,7.37415307246877e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24800,-0.0741218197830176,0.00771041145407437,-0.0892342262330033,-0.0590094133330318,7.67720702185728e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,24800,-0.0713626750987931,0.00743929046354084,-0.0859436844073332,-0.0567816657902531,9.36382249678649e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,24224,-0.0165731333567257,0.00173052280900886,-0.0199649580623831,-0.0131813086510684,1.09203504086179e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,24863,-0.0223377784456861,0.00233809230349547,-0.0269204393605372,-0.017755117530835,1.3611280838467e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24917,-0.0453061721946356,0.00474285490289955,-0.0546021678043187,-0.0360101765849525,1.37849770902366e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24235,-0.0435371528962367,0.00456653544170236,-0.0524875623619734,-0.0345867434305001,1.65149696058717e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,24946,-0.0453034398376121,0.00475341440661488,-0.0546201320745773,-0.0359867476006469,1.69949215820974e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,29815,-0.010231853997017,0.0010739600908502,-0.0123368157750834,-0.00812689221895058,1.73349888874039e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29344,-0.0433058169422119,0.00454705260228374,-0.052218040042688,-0.0343935938417357,1.79111320349615e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,29526,-0.017515802544071,0.00183993510995363,-0.0211220753595801,-0.0139095297285619,1.8628352043773e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,29531,-0.0324010864998151,0.00340419335917332,-0.0390733054837948,-0.0257288675158354,1.89527822309003e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,24652,-0.0186114799528251,0.001955940514143,-0.0224451233605454,-0.0147778365451048,1.97109851881189e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,24933,-0.0141481284593794,0.00149050986179635,-0.0170695277885003,-0.0112267291302586,2.45937677751013e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,29531,-0.0514625163973294,0.00542448168363424,-0.0620945004972525,-0.0408305322974063,2.54809787416065e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,29492,-0.0149672563591513,0.00157888408460414,-0.0180618691649754,-0.0118726435533272,2.73619507691971e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,24828,-0.0293568592436654,0.00309666660268666,-0.0354263257849313,-0.0232873927023996,2.75890720773905e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24917,-0.0382445420775194,0.00403457350123558,-0.0461523061399412,-0.0303367780150977,2.78309853422173e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29429,-0.0511582851011737,0.00539923486567669,-0.0617407854379001,-0.0405757847644474,2.85797264415963e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,23386,-0.0151508460616867,0.00160197224236885,-0.0182907116567297,-0.0120109804666438,3.43754536767238e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,29576,-0.0803723739644421,0.00850246911225129,-0.0970372134244547,-0.0637075345044296,3.5331941406879e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,24631,-0.0614315778450258,0.0064995407767794,-0.0741706777675134,-0.0486924779225381,3.62167124160507e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,29344,-0.0463777237231272,0.00491049275423492,-0.0560022895214276,-0.0367531579248268,3.82262247702811e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24376,-0.0392895772095489,0.00416032525104631,-0.0474438147015997,-0.0311353397174981,3.90440481589734e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,29576,-0.0410910531851927,0.00435422331969864,-0.0496253308918021,-0.0325567754785834,4.10553489581272e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,29473,0.0380828993337241,0.0040371415165202,0.0301701019613445,0.0459956967061037,4.26258643897805e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,29752,-0.0382605076459394,0.00407154038828702,-0.046240726806982,-0.0302802884848969,5.99911986634253e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,24235,-0.0397853759504416,0.00423342032252578,-0.0480828797825921,-0.031487872118291,6.04118660236737e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,29213,-0.0312515350004051,0.00332687141303008,-0.037772202969944,-0.0247308670308661,6.20242029642336e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,29815,-0.0195371598376365,0.00208244241042531,-0.0236187469620701,-0.0154555727132029,6.9271723735599e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,24917,-0.0209703464944455,0.00223816067958284,-0.0253571414264279,-0.0165835515624631,7.88959280098226e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,29640,-0.0302718673294954,0.00323168971951543,-0.0366059791797457,-0.0239377554792452,7.95925192970089e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,29561,-0.0155604472629408,0.00166191822867444,-0.0188178069911427,-0.0123030875347389,8.28665806295206e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,24961,-0.0189628911201793,0.00203654644607683,-0.0229545221544899,-0.0149712600858687,1.36370752848443e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,29429,-0.0368508103529129,0.00396020807600544,-0.0446128181818836,-0.0290888025239422,1.42634994593373e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,29429,-0.0542801167978372,0.00583688945905103,-0.0657204201375772,-0.0428398134580972,1.50578088997819e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,28769,-0.0272987574328574,0.00293584063511356,-0.0330530050776799,-0.0215445097880348,1.52289892654896e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,24961,-0.0324614328210728,0.00349145629134969,-0.0393046871521182,-0.0256181784900274,1.55366583513461e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,29689,-0.0412191277637139,0.00443648889957635,-0.0499146460068836,-0.0325236095205443,1.63063709787004e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,29449,-0.0169159519436385,0.00182157959441717,-0.0204862479486962,-0.0133456559385809,1.70196563909515e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,29576,-0.0127971031785078,0.00137878688574338,-0.0154995254745648,-0.0100946808824507,1.78298764081059e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29492,-0.0206337956148077,0.00222698804811471,-0.0249986921891126,-0.0162688990405029,2.07277953599371e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,29429,-0.0224683882088382,0.00242546567932588,-0.0272223009403169,-0.0177144754773595,2.10825038263276e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,29127,-0.0182473084449322,0.00197001093555843,-0.0221085298786267,-0.0143860870112377,2.12932763567445e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,29634,0.0350514022560326,0.00378483893822314,0.0276331179371153,0.04246968657495,2.15778376788181e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,29344,-0.0471101769132595,0.00509113602736485,-0.0570888035268946,-0.0371315502996244,2.3185412657518e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,28867,-0.0341222506440148,0.00369220392907878,-0.0413589703450092,-0.0268855309430204,2.58782639880764e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,29409,-0.0549566801485461,0.00595168140817166,-0.0666219757085626,-0.0432913845885297,2.78204392533648e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFI,Complement factor I,24961,-0.012029279776161,0.00130362772782526,-0.0145843901226985,-0.00947416942962349,2.98236805303249e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,29781,0.0171201232766066,0.0018568526973861,0.0134806919897298,0.0207595545634833,3.16194475084191e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,29576,-0.0159775152291199,0.00173318431036534,-0.019374556477436,-0.0125804739808038,3.20411420996945e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,24376,-0.0186661413146905,0.00202572639124802,-0.0226365650415367,-0.0146957175878444,3.37138760259947e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,24800,-0.0204083228108,0.00221524573418623,-0.024750204449805,-0.016066441171795,3.42617790597172e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,29344,-0.0440175816873706,0.00477874830362815,-0.0533839283624817,-0.0346512350122594,3.4364377039532e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,24840,-0.0558650995434496,0.00606665086712832,-0.0677557352430212,-0.0439744638438781,3.55905526075158e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,29429,0.0197801596716807,0.00214900826169341,0.0155681034787616,0.0239922158645998,3.65949402085586e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,24788,-0.02535354233064,0.00275438759776364,-0.0307521420222568,-0.0199549426390233,3.68646605105013e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,29513,-0.0214005264087022,0.0023328824982175,-0.0259729761052085,-0.0168280767121959,4.87192853835213e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,24917,-0.0392021668434005,0.00427349153858195,-0.0475782102590211,-0.0308261234277799,4.931455758675e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,24883,-0.0293566166394966,0.00320234515601341,-0.0356332131452829,-0.0230800201337103,5.21857167966037e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,29678,-0.0362264955873165,0.0039608170375595,-0.0439896969809332,-0.0284632941936999,6.26243392728299e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,29669,-0.0310759521040563,0.00339833817366193,-0.0377366949244337,-0.024415209283679,6.36521132441407e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,29344,-0.018288532276216,0.00200233356161795,-0.0222131060569872,-0.0143639584954448,7.03933024197496e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,29429,-0.0239474187224129,0.00262635177500772,-0.029095068201428,-0.0187997692433978,8.11607991311534e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,24933,0.0300753006071721,0.0033011365650668,0.0236050729396411,0.036545528274703,8.79308424344828e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,24863,-0.067942016043948,0.00745863972319764,-0.0825609499014154,-0.0533230821864806,8.91029168926451e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB2,Calretinin,28769,-0.0182363569294007,0.00200313730282759,-0.0221625060429427,-0.0143102078158586,9.26319724409159e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,29781,-0.0331332832743725,0.00363995246218815,-0.0402675901002613,-0.0259989764484837,9.34891954082346e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,29689,-0.0137907407782,0.0015164736474489,-0.0167630291271999,-0.0108184524292002,1.01295283192253e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,24204,-0.0337963548274278,0.00372058166324278,-0.0410886948873836,-0.0265040147674719,1.12849853015849e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,28857,-0.0312345756860289,0.00343935784740256,-0.037975717066938,-0.0244934343051199,1.13726324244823e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24235,-0.0577391598897616,0.00635774821165305,-0.0702003463846016,-0.0452779733949216,1.14843065547621e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,29473,-0.016148911005058,0.0017789007903081,-0.0196355565540619,-0.0126622654560542,1.17269393804775e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,24840,-0.0160167831533376,0.00176896210714503,-0.0194839488833419,-0.0125496174233334,1.4723725380077e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,24863,-0.0458846084597356,0.00507431771824788,-0.0558302711875015,-0.0359389457319698,1.64000254566706e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,29473,0.0221013419421258,0.00244588558799785,0.01730740618965,0.0268952776946016,1.71982478369505e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,29623,-0.0119909635256271,0.00132726958346922,-0.0145924119092268,-0.00938951514202746,1.74812004862685e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,24800,-0.0535713368991795,0.00593018655137547,-0.0651945025398754,-0.0419481712584835,1.77810417603803e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,24961,-0.0109420489207803,0.0012126847126125,-0.0133189109575008,-0.0085651868840598,1.9587305016528e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,24224,-0.0178849032652649,0.00198233671025802,-0.0217702832173706,-0.0139995233131592,1.97826373952158e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,24840,-0.0165233133342513,0.00183170051657014,-0.0201134463467287,-0.0129331803217738,1.99982296269246e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29095,-0.0279528588008127,0.00310252757514768,-0.0340338128481021,-0.0218719047535232,2.18932989649821e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29647,-0.0165821810828694,0.00184179304842233,-0.0201920954577771,-0.0129722667079616,2.31847830591837e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,29512,-0.015847575392748,0.00176266193802939,-0.0193023927912856,-0.0123927579942104,2.59961099398322e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,29321,-0.0167851610897869,0.00186733168449502,-0.0204451311913971,-0.0131251909881767,2.64477839338526e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,29429,-0.0156203365266877,0.00173845442689378,-0.0190277072033995,-0.0122129658499759,2.73353855881568e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,29576,-0.0196446729413206,0.00218980928105371,-0.0239366991321859,-0.0153526467504554,3.109030694863e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",24862,-0.0133145700605779,0.00148410408366018,-0.0162234140645519,-0.010405726056604,3.12795091177374e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,28926,-0.0222175184507897,0.00248078341420984,-0.027079853942641,-0.0173551829589384,3.56875071936175e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,29322,-0.0259176179203947,0.0028945549808505,-0.0315909456828616,-0.0202442901579277,3.62864746611716e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,29720,0.0216593494675207,0.00241936176736171,0.0169174004034918,0.0264012985315497,3.67262716704994e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,28926,-0.0169502911783382,0.00189375888655181,-0.0206620585959797,-0.0132385237606967,3.74184503062216e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,29429,-0.0273779084852563,0.0030605136817931,-0.0333765153015708,-0.0213793016689418,3.91373248638847e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNLY,Granulysin,29438,-0.030470741092501,0.00341857387814447,-0.0371711458936642,-0.0237703362913379,5.23344208114132e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,27934,-0.0233052785906387,0.00262047224915527,-0.028441404198983,-0.0181691529822944,6.26834376991391e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,24933,-0.0275938721434583,0.00310297685100606,-0.0336757067714301,-0.0215120375154864,6.35896512741746e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,29561,-0.0242379822997363,0.00272807952215914,-0.0295850181631683,-0.0188909464363044,6.7688015251036e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,29781,-0.0269777585143955,0.00303945663986531,-0.0329350935285316,-0.0210204235002595,7.32047941682888e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAX,Protein max,28769,-0.0611325059278697,0.00689443018835026,-0.0746455890970362,-0.0476194227587032,7.94337821510469e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,29344,0.0783124764944514,0.00885741461834137,0.0609519438425023,0.0956730091464005,9.96497653818759e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,24324,-0.0177254328186087,0.00200671865228741,-0.021658601377092,-0.0137922642601254,1.08604850885507e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29492,-0.0195178831277273,0.00221089674471189,-0.0238512407473625,-0.015184525508092,1.12294922093947e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29561,0.0201347627494168,0.0022863501720009,0.015653516412295,0.0246160090865386,1.36009384561913e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24917,-0.0306860856155339,0.00349368197871909,-0.0375337022938233,-0.0238384689372445,1.68747053982582e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSN,Gelsolin,24840,-0.0109727144810381,0.00124947479311754,-0.0134216850755484,-0.00852374388652769,1.70957947954148e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,29688,-0.0185043346132794,0.00211063086296088,-0.0226411711046827,-0.0143674981218761,1.9273357915753e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,24909,-0.0107872162931757,0.00123065277718152,-0.0131992957364515,-0.00837513684989992,1.9768537739141e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFD,Complement factor D,24961,-0.0112194437472352,0.00128123724353266,-0.0137306687445592,-0.00870821874991119,2.135025776086e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,29158,-0.0182905147287685,0.00208983875262486,-0.0223865986839133,-0.0141944307736238,2.20462434950446e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,29537,-0.0176962228750304,0.00202725892702375,-0.021669650371997,-0.0137227953780639,2.69876131796198e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,24224,-0.050434407556642,0.00577706384827097,-0.061757452699253,-0.0391113624140309,2.70539525987307e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,29619,-0.0388368392749063,0.00445017297287155,-0.0475591783017345,-0.030114500248078,2.74875559226192e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,29539,-0.0170271529716632,0.00195108343542485,-0.0208512765050959,-0.0132030294382305,2.74951345878503e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,29513,-0.0216886494189993,0.00248624155598758,-0.026561682868735,-0.0168156159692637,2.837188552362e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,29589,0.0262192755739581,0.00301132068807985,0.0203170870253216,0.0321214641225946,3.28227881798838e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,24933,-0.0178914724527986,0.00205497731526432,-0.0219192279907167,-0.0138637169148805,3.32729503026528e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,28348,-0.0179637117968327,0.00206506469105636,-0.0220112385913031,-0.0139161850023622,3.53037978605751e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,24189,-0.0156939512858205,0.00180510818608149,-0.0192319633305403,-0.0121559392411008,3.71108327016988e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",29815,-0.0283958690338935,0.00327054234817492,-0.0348061320363164,-0.0219856060314707,4.072168391575e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,28911,-0.0197456399034975,0.00227568932051185,-0.0242059909717008,-0.0152852888352943,4.28136361997008e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,29429,-0.0378234761147883,0.00436143709700818,-0.0463718928249243,-0.0292750594046522,4.45053561194603e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29689,-0.0156479874874034,0.00180871699130547,-0.0191930727903621,-0.0121029021844446,5.33787070277202e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,24946,-0.0226879442198382,0.00262607720433599,-0.0278350555403367,-0.0175408328993396,5.97954270723825e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,29164,-0.0173951813557339,0.00201497760024295,-0.0213445374522101,-0.0134458252592577,6.27865013616576e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29109,-0.0188030305502546,0.00218126610642754,-0.0230783121188525,-0.0145277489816566,7.01454946010352e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,24224,-0.0245842638516933,0.00285385800792033,-0.0301778255472171,-0.0189907021561694,7.45298349776201e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29302,-0.0589881929593697,0.00686759936439756,-0.0724486877135889,-0.0455276982051504,9.17322060217625e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24800,-0.0785503485332789,0.0091485742866184,-0.0964815541350509,-0.0606191429315068,9.51913955590963e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24800,-0.0498806860038819,0.00582104955813345,-0.0612899431378235,-0.0384714288699404,1.10353391066482e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FN1,Fibronectin,24961,-0.0149914070825239,0.00175178990271537,-0.018424915291846,-0.0115578988732018,1.215948113278e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,28533,-0.0683719813577622,0.00800337280254939,-0.0840585920507591,-0.0526853706647654,1.37319240559956e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,29473,-0.0147137839864041,0.00172654359284512,-0.0180978094283805,-0.0113297585444277,1.64041878819107e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,29404,-0.0257548481227828,0.00302698092721262,-0.0316877307401195,-0.0198219655054461,1.84557495484911e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,29514,-0.017064075497014,0.00200695438839291,-0.020997706098264,-0.0131304448957639,1.94220454622322e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,29781,-0.0193025136820792,0.00227095100583321,-0.0237535776535123,-0.0148514497106461,1.98740260907655e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,29576,0.0359280080496423,0.00422737921760022,0.0276423447831459,0.0442136713161387,2.00284430216803e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,24604,-0.0176808987111069,0.00208643986386594,-0.0217703208442842,-0.0135914765779297,2.49788145754162e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,24800,-0.0633729197791312,0.00748243984465068,-0.0780385018746465,-0.0487073376836158,2.59806388756708e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,24933,-0.0336477712787119,0.00397313406577793,-0.0414351140476366,-0.0258604285097871,2.61359218988911e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,29752,-0.0255792938734671,0.00302147780909419,-0.0315013903792917,-0.0196571973676425,2.65875446100459e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24917,-0.0181290503181712,0.00214287421917606,-0.0223290837877562,-0.0139290168485861,2.81485022597118e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24800,-0.0152238870701592,0.00180081017752687,-0.0187534750181119,-0.0116942991222065,2.96995365852472e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,29189,-0.0542517235339086,0.00642504675670464,-0.0668448151770496,-0.0416586318907675,3.21264470183125e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29429,-0.0337246428383721,0.00399840364452913,-0.0415615139816492,-0.025887771695095,3.47554647482051e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",28911,-0.0513761017823376,0.00609148529110838,-0.06331541295291,-0.0394367906117652,3.49143976916979e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29127,-0.0226074121166358,0.00268133712511783,-0.0278628328818667,-0.0173519913514048,3.57125439646265e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,24376,-0.0138592021171244,0.00164449119697227,-0.0170824048631901,-0.0106359993710588,3.7190276618159e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,29389,-0.0165933789885657,0.00196935626915736,-0.0204533172761141,-0.0127334407010173,3.7445747065098e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,29473,-0.0444259314523175,0.00529480070994177,-0.0548037408438033,-0.0340481220608316,5.05515065071099e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,24917,-0.0375698703205305,0.00447769779976185,-0.0463461580080637,-0.0287935826329973,5.09684367764695e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RETN,Resistin,29357,-0.0231751438748307,0.00276324551845618,-0.0285911050910048,-0.0177591826586565,5.21075971139861e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,29328,-0.0143353275913216,0.00171002778424013,-0.0176869820484322,-0.0109836731342109,5.38314233734315e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",24235,-0.0351081468961876,0.00418813294130806,-0.0433168874611514,-0.0268994063312238,5.44735067997411e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,24376,-0.0198743268337168,0.0023719282607824,-0.0245233062248503,-0.0152253474425833,5.62356954938287e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,29589,-0.0165897092436485,0.00198125392077374,-0.020472966928365,-0.012706451558932,5.84498263864169e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29438,-0.0163682765837924,0.00195592302113288,-0.0202018857052129,-0.012534667462372,6.08717754244143e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,29169,-0.0319412173796453,0.00382279041014809,-0.0394338865835355,-0.024448548175755,6.80294595697449e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,28926,-0.0465870082393942,0.00557903987344054,-0.0575219263913376,-0.0356520900874507,7.10557662322772e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,28926,-0.0192684611280694,0.00230850280475442,-0.0237931266253881,-0.0147437956307508,7.32664528101065e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,28911,0.028275747316287,0.00338900821406221,0.021633291216725,0.0349182034158489,7.53795059791387e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,29429,-0.0206307573542137,0.00247580988286306,-0.0254833447246253,-0.0157781699838021,8.22538418906948e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,29429,-0.0233132480534674,0.00280127018402144,-0.0288037376141494,-0.0178227584927853,8.98978561613839e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,29781,-0.0478650276170058,0.00575149217776253,-0.0591379522854203,-0.0365921029485912,8.99985872093772e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,29364,-0.0106175055345895,0.00127690768902865,-0.0131202446050857,-0.00811476646409338,9.56595423827497e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,29438,0.0203787221453321,0.00245162271672204,0.0155735416205569,0.0251839026701073,9.78250626284835e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,28911,-0.0210030572469817,0.00253056907441688,-0.0259629726328388,-0.0160431418611246,1.08836578615505e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,29781,-0.0398702030525725,0.00480797975146779,-0.0492938433654494,-0.0304465627396957,1.15504351036853e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,29720,-0.0185100793972046,0.00223340518019676,-0.0228875535503902,-0.0141326052440189,1.20136642107608e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,24788,-0.021049948426085,0.00253966022478888,-0.0260276824666712,-0.0160722143854988,1.20444841632765e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,29025,-0.0230737483593627,0.00278481428610662,-0.0285319843601317,-0.0176155123585937,1.2256220399125e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",29397,-0.0301652431675564,0.00365065947030919,-0.0373205357293624,-0.0230099506057504,1.48018284479725e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,29462,-0.0512759194986198,0.0062057400227872,-0.0634391699432827,-0.0391126690539568,1.48373373114701e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,29599,-0.0177209833651643,0.00214564091065426,-0.0219264395500467,-0.013515527180282,1.52873718946036e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,29699,-0.0441853577424532,0.00535820224927051,-0.0546874341510234,-0.033683281333883,1.70041374643031e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLU,Clusterin,24961,-0.0170659736913716,0.00207975064984569,-0.0211422849650692,-0.0129896624176741,2.4005213377809e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,29731,-0.0148589026718876,0.00181210240739361,-0.018410623390379,-0.0113071819533961,2.50358767590092e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C5,Complement C5,24961,-0.00813394306578912,0.000992793398118195,-0.0100798181261008,-0.00618806800547745,2.66926711464536e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,24863,0.0283236663167732,0.00346339193797131,0.0215354181183494,0.035111914515197,3.02222265755708e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,29669,0.0633964711513035,0.00775813933605574,0.0481905180526342,0.0786024242499727,3.16298596526932e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,28792,-0.0251743817595248,0.00308386453645837,-0.0312187562509832,-0.0191300072680664,3.3930258451634e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,24605,-0.0577890628183916,0.00707927571361414,-0.0716644432170754,-0.0439136824197079,3.41953157444838e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,24224,-0.049711234958582,0.00609436899159305,-0.0616561981821044,-0.0377662717350597,3.60234027582288e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREH,Trehalase,24933,0.0399521764032691,0.0048999640300846,0.0303482469043033,0.0495561059022349,3.69829666015167e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,24376,-0.0670686223546124,0.00823288129106698,-0.0832050696851037,-0.0509321750241211,3.9264043032347e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29720,-0.0172056441315728,0.0021130527090605,-0.0213472274413314,-0.0130640608218142,4.02037218413984e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,29283,-0.0120156260868905,0.00147589207975301,-0.0149083745632063,-0.00912287761057456,4.06564985699038e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,29429,-0.0297693454196161,0.00365750392719267,-0.0369380531169138,-0.0226006377223185,4.13281853043977e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,29781,-0.0408333310987957,0.00503169126096116,-0.0506954459702796,-0.0309712162273119,5.0337861304853e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,29344,-0.0173867440318224,0.0021426164821325,-0.0215862723368021,-0.0131872157268427,5.05751824039504e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24933,-0.0192423163067965,0.00237178050034902,-0.0238910060874805,-0.0145936265261124,5.16316475979644e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,29438,-0.0142984276597425,0.00176550418917282,-0.0177588158705212,-0.0108380394489637,5.76409599799857e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,24756,-0.0150568723112062,0.00185999275503593,-0.0187024581110766,-0.0114112865113358,5.9816781709709e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,24933,-0.0133893317433216,0.00165680687987866,-0.0166366732278838,-0.0101419902587595,6.69044566452262e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,29213,-0.0274704421004466,0.00341017852518492,-0.034154392009809,-0.0207864921910841,8.21958689241264e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,29554,0.0171950452735521,0.00213606514786014,0.0130083575837463,0.021381732963358,8.59699146545707e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,24840,-0.0165329521334361,0.00205561425194006,-0.0205619560672387,-0.0125039481996336,9.16783373090941e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29428,-0.0600943089554421,0.00748378069980496,-0.0747625191270598,-0.0454260987838243,1.01132887822932e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,29344,-0.0120905704003926,0.00150619833106582,-0.0150427191292817,-0.00913842167150362,1.03413671659749e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,24224,-0.0448443532975443,0.00558837681486391,-0.0557975718546775,-0.033891134740411,1.06466648656838e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,24376,-0.023281437909637,0.00290363167603292,-0.0289725559946616,-0.0175903198246125,1.12238446494854e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,24376,0.0134183443789234,0.00167525224686419,0.0101348499750696,0.0167018387827772,1.20052794294415e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29689,-0.0273266492124223,0.00341641137750927,-0.0340228155123405,-0.0206304829125042,1.30346150053872e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29367,-0.0312035996249965,0.00390355963265241,-0.0388545765049952,-0.0235526227449978,1.35802027863992e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29438,-0.0621446146392784,0.00778499430401202,-0.077403203475142,-0.0468860258034149,1.48445752114579e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,28792,-0.0575450590778045,0.00721183344240017,-0.0716802526249089,-0.0434098655307002,1.52655178756474e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,24961,-0.0158846826916907,0.0019918720694569,-0.0197887519478263,-0.0119806134355552,1.59195002248191e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFB,Complement factor B,24533,-0.0170869961780509,0.00214866650114332,-0.0212983825202918,-0.01287560983581,1.90819270100059e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,29572,0.0339225300381863,0.00427298472102176,0.0255474799849837,0.0422975800913889,2.11271687072853e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24863,-0.0437103768116996,0.00550629428634329,-0.0545027136129324,-0.0329180400104668,2.13654539046752e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,29473,0.0221676572266085,0.00279367853867431,0.0166920472908068,0.0276432671624101,2.18032356063571e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSG,Basigin,29755,-0.0106811305526831,0.00134678830290268,-0.0133208356263723,-0.00804142547899383,2.25297459975417e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,24917,-0.0232796145882151,0.00293609499978956,-0.0290343607878027,-0.0175248683886276,2.30562288612846e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,24800,-0.0274883011232206,0.00346739197725779,-0.0342843893986459,-0.0206922128477954,2.32668637548553e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,29438,-0.041595451550465,0.0052545161705208,-0.0518943032446857,-0.0312965998562442,2.53578895868269e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,28926,-0.0177367180361695,0.00224105879967432,-0.0221291932835312,-0.0133442427888078,2.57209784354489e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24863,-0.024851812363791,0.00314555022036014,-0.0310170907956969,-0.0186865339318851,2.88943498419438e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,29473,-0.0182281087615644,0.00231020345282867,-0.0227561075291086,-0.0137001099940202,3.11950556842969e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNC,Tenascin,29589,-0.0246729626541341,0.00312890065216616,-0.0308056079323798,-0.0185403173758885,3.23996024761863e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,29731,-0.0105771747084543,0.00134182027232419,-0.0132071424422097,-0.00794720697469891,3.31271445461083e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDK,Midkine,29450,-0.026256942531217,0.00333122562694701,-0.0327861447600331,-0.0197277403024008,3.3307391322674e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,28740,-0.0291083237815387,0.00369677784973632,-0.0363540083670219,-0.0218626391960555,3.55607853281727e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,28792,-0.0276591358462152,0.00351396588673735,-0.0345465089842204,-0.02077176270821,3.63530322439548e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,28911,-0.0376398185604806,0.00478235633296288,-0.0470132369730879,-0.0282664001478734,3.65348007512713e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,24840,-0.0203536222624325,0.00258768872995341,-0.0254254921731412,-0.0152817523517238,3.82335418946677e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,24518,-0.0287143396744218,0.00365424014947102,-0.035876650367385,-0.0215520289814586,4.06880428674926e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,29589,-0.030043164401566,0.00382683922877419,-0.0375437692899634,-0.0225425595131686,4.27824626537229e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,24946,-0.0138282290867051,0.00176190780820993,-0.0172815683907965,-0.0103748897826136,4.38085996063641e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,24946,-0.0265070113795252,0.0033800452344891,-0.0331319000391239,-0.0198821227199266,4.60345169155678e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,28701,-0.0388078313197072,0.00496289428208651,-0.0485351041125968,-0.0290805585268177,5.4803347501981e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,24917,-0.051115846368229,0.00653664416294207,-0.0639276689275955,-0.0383040238088626,5.49549044339902e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,29429,-0.0199062592481613,0.00254595326394597,-0.0248963276454954,-0.0149161908508272,5.51116141078579e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,29576,-0.0144955593006572,0.0018565208755847,-0.0181343402168032,-0.0108567783845112,6.00564527845146e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,24224,-0.00867282584871617,0.00111259999964656,-0.0108535218480234,-0.00649212984940891,6.69387446436685e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29344,-0.0450998966112564,0.00578945682785316,-0.0564472319938486,-0.0337525612286642,6.92112524560964e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,24376,0.0168612112363193,0.00216832005339975,0.0126113039316558,0.0211111185409828,7.7706167781288e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,29213,-0.02863505502131,0.00368294371674227,-0.0358536247061248,-0.0214164853364951,7.78939359262712e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLC,Galectin-10,29421,-0.0338233962666942,0.00435209808057375,-0.0423535085046187,-0.0252932840287696,7.99286899852769e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,28548,0.0514254698394211,0.00661766586428114,0.0384548447454301,0.0643960949334122,8.0517297391452e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,24917,-0.0139911139575091,0.0018007877933754,-0.0175206580325249,-0.0104615698824933,8.18640782186006e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,29315,-0.0213409054539974,0.0027495830662689,-0.0267300882638844,-0.0159517226441103,8.66506321733724e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,28911,-0.0239612358820494,0.00308841606781975,-0.0300145313749761,-0.0179079403891227,8.88184785355628e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,29463,-0.0195949033097676,0.00253033160267751,-0.0245543532510155,-0.0146354533685196,9.94150380560869e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,29627,-0.0312206188290944,0.00403339953856998,-0.0391260819246916,-0.0233151557334973,1.02154120865517e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,29429,-0.0237798753483746,0.00307359204030952,-0.0298041157473813,-0.017755634949368,1.05175226790995e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,29429,-0.0285466561208173,0.00369036826250256,-0.0357797779153223,-0.0213135343263123,1.06325213236826e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,24376,-0.010827668927542,0.0014004661442995,-0.013572582570369,-0.00808275528471501,1.10405524457638e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",24106,-0.0285896001120173,0.00370149561668098,-0.035844531520712,-0.0213346687033226,1.17299536527953e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REN,Renin,29473,0.0385231879873693,0.00498944806361051,0.0287438697826927,0.0483025061920459,1.19132758529285e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,29130,-0.0173765596967789,0.00225236626959072,-0.0217911975851768,-0.0129619218083811,1.25033905798827e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23618,-0.0547163909968245,0.00709274849701988,-0.0686181780509834,-0.0408146039426655,1.26335947782616e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23716,-0.0250251808926032,0.0032442933133692,-0.0313839957868068,-0.0186663659983995,1.27121368968734e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,29368,-0.0336150635992575,0.00437149957462933,-0.042183202765531,-0.025046924432984,1.52208011797529e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,28485,-0.0132756681189887,0.0017271307223808,-0.0166608443348551,-0.00989049190312235,1.56020474877949e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,29689,-0.0151326371436588,0.00196972568209039,-0.018993299480556,-0.0112719748067616,1.60672467917237e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24376,-0.0145102192307006,0.00188973071974609,-0.0182140914414029,-0.0108063470199983,1.67052080517104e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,24917,0.0132822016082302,0.00173020666561219,0.00989099654363028,0.0166734066728301,1.69277673211161e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,24909,-0.00742500042468195,0.000968394935536787,-0.00932305449833405,-0.00552694635102985,1.82022950962479e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,29781,-0.0273542655875685,0.00356940337012111,-0.0343502961930058,-0.0203582349821311,1.86368308294988e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29689,-0.0229621849542178,0.00300146357916157,-0.0288450535693745,-0.0170793163390611,2.06528561208024e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,29344,-0.010560951512559,0.00138171382876919,-0.0132691106169467,-0.00785279240817143,2.18060222646565e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,24933,-0.025917050429945,0.00339130701631567,-0.0325640121819238,-0.0192700886779663,2.21218069540778e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,24933,-0.014059546880235,0.00184271005867148,-0.0176712585952311,-0.0104478351652389,2.43479749795413e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,29438,-0.0117338088799835,0.00153943335596413,-0.0147510982576731,-0.00871651950229375,2.56963057543573e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,29344,0.0228283399556137,0.00299815051863753,0.0169519649390842,0.0287047149721433,2.73423896839784e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24376,-0.0443516139178775,0.00583442209687275,-0.055787081227748,-0.0329161466080069,3.02758520642619e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,24106,-0.0294150375109843,0.00387092221417528,-0.0370020450507678,-0.0218280299712007,3.09346466277207e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGMN,Legumain,29576,-0.0178371065928681,0.0023487019813742,-0.0224405624763615,-0.0132336507093746,3.18210284278391e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,29781,-0.0117210649034122,0.00154351813689544,-0.0147463604517273,-0.00869576935509718,3.19916221014858e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29438,-0.0210351590116115,0.00277109748440622,-0.0264665100810477,-0.0156038079421753,3.27054333795182e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,29561,-0.0159187275890205,0.00209718013611314,-0.0200292006558023,-0.0118082545222388,3.27957398218939e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,24268,-0.0170532832031295,0.00225260821635397,-0.0214683953071833,-0.0126381710990757,3.85138616410793e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,29373,-0.0202118328020846,0.00267112918727746,-0.0254472460091484,-0.0149764195950207,3.93801795167399e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,24165,-0.0420210862291608,0.00555644346919706,-0.0529117154287871,-0.0311304570295346,4.09197508125388e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24800,-0.0148183252135835,0.00196140317710468,-0.0186626754407087,-0.0109739749864583,4.33453170950472e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,24847,-0.0320653541621306,0.00424721517019343,-0.0403898958957097,-0.0237408124285514,4.51131661874379e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,29338,-0.0537806693771494,0.00712640403540853,-0.0677484212865501,-0.0398129174677487,4.5944922997665e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,24235,-0.0187801055210347,0.00249141237067144,-0.0236632737675507,-0.0138969372745187,4.94198071777041e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,29561,-0.0135165619369505,0.00179381074895763,-0.0170324310049075,-0.0100006928689936,5.01874202127981e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,28926,-0.0455932735125139,0.00605583363023361,-0.0574627074277718,-0.033723839597256,5.26931254308827e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,29815,-0.0117328982347131,0.0015586174095492,-0.0147877883574295,-0.00867800811199662,5.30756425079665e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,29368,-0.0432700847843637,0.00574963638552536,-0.0545393720999934,-0.032000797468734,5.39372761508818e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,24376,-0.0266770872800796,0.00354564865240139,-0.0336265586387863,-0.0197276159213729,5.50061606191744e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRELP,Prolargin,29449,-0.0114690994803718,0.00152571874298124,-0.014459508216615,-0.00847869074412858,5.75626416830491e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,29469,-0.0107081776134784,0.00142497813198532,-0.0135011347521697,-0.00791522047478719,5.86934172296789e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,29344,-0.042740462480407,0.00569318654289161,-0.0538991081044745,-0.0315818168563394,6.20725099750929e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,24376,-0.0338840749053479,0.00452274557796151,-0.0427486562381525,-0.0250194935725434,7.01768934564021e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24185,-0.0175956083020387,0.00235042316038704,-0.0222024376963973,-0.0129887789076801,7.33484914146708e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,24800,0.0478916301939473,0.00639753594651196,0.0353524597387839,0.0604308006491108,7.33964349458328e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,29506,-0.0181688677025518,0.00242840397701395,-0.0229285394974991,-0.0134091959076044,7.53449633108627e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,24933,0.0113918373641162,0.00152538585545616,0.00840208108742216,0.0143815936408103,8.39861903475155e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,29278,-0.0188031379733916,0.0025186412423254,-0.0237396748083494,-0.0138666011384339,8.52361493051294e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,29429,-0.0229053128238883,0.0030695600364049,-0.0289216504952419,-0.0168889751525347,8.75182368438051e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,24788,-0.0269392232763402,0.00361154464619134,-0.0340178507828753,-0.0198605957698052,8.9909540841536e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,29203,-0.0222424549013015,0.00298637838763745,-0.0280957565410709,-0.0163891532615322,9.74076372481532e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,29731,-0.0159130351776542,0.00213742042217401,-0.0201023792051152,-0.0117236911501931,9.95926030582866e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,24376,-0.0417906368408924,0.00561857546873799,-0.0528030447596189,-0.030778228922166,1.05642886742999e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,29379,-0.0554338532461312,0.0074539582807859,-0.0700436114764715,-0.0408240950157908,1.05942916630537e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,28911,-0.0264016032557769,0.00355057139847836,-0.0333607231967944,-0.0194424833147593,1.06760211438476e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,29344,-0.0410831634100946,0.00553009404871827,-0.0519221477455825,-0.0302441790746068,1.12386417271384e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,29438,-0.0117745816880877,0.00158540817632967,-0.0148819817136939,-0.00866718166248158,1.14232911039546e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,29438,-0.0589074271340778,0.0079427409244845,-0.0744751993460674,-0.0433396549220882,1.23487229582471e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29473,-0.0154895473815861,0.00209041466835373,-0.0195867601315595,-0.0113923346316128,1.29886912991037e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,29473,-0.037058299933354,0.0050031531398483,-0.0468644800874567,-0.0272521197792514,1.32660196569518e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,24917,-0.0438396591443622,0.00592730227188951,-0.0554571715972656,-0.0322221466914588,1.44534855282097e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,29561,-0.0133567705923243,0.00180864719110913,-0.0169017190868982,-0.0098118220977504,1.56534790960351e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,29752,-0.0145134078477961,0.00196682604823476,-0.0183683869023363,-0.010658428793256,1.63527461652568e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,24961,-0.00937564456990118,0.00127114606508289,-0.0118670908574636,-0.00688419828233872,1.68527515772963e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,29344,-0.0398311090538889,0.00540274923153938,-0.0504204975477061,-0.0292417205600718,1.72037703785478e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",29781,-0.0326967861223062,0.0044482100330924,-0.0414152777871673,-0.0239782944574451,2.02469846873731e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,28926,0.0212765475554025,0.00289513581367691,0.0156020813605957,0.0269510137502092,2.04876344908016e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,24376,-0.0345259020774091,0.00469896720170785,-0.0437358777927565,-0.0253159263620617,2.08219176620086e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,24235,-0.0295476784675078,0.00402217038019729,-0.0374311324126945,-0.0216642245223211,2.10362901974928e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,29531,-0.0275728212979234,0.00375651336474829,-0.03493558749283,-0.0202100551030167,2.19095704787408e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,29077,-0.0226359446763808,0.00308414803909803,-0.028680874833013,-0.0165910145197487,2.20092373697123e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,28911,-0.0198963608447167,0.00271237206287492,-0.0252126100879515,-0.0145801116014818,2.2685288520802e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,24800,-0.0283969451437696,0.0038713204214333,-0.0359847331697789,-0.0208091571177604,2.2817054058955e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,29492,-0.0142878512589431,0.00195025454539097,-0.0181103501679094,-0.0104653523499768,2.42934202708813e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24106,0.0269843521081507,0.00368615028267495,0.0197594975541078,0.0342092066621936,2.54848254023815e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,29576,-0.0137049251191082,0.00187339906657194,-0.0173767872895892,-0.0100330629486272,2.62861948699677e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,29438,-0.0274396121425759,0.00375220519682295,-0.0347939343283489,-0.020085289956803,2.68042839630297e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,24863,-0.036530391884961,0.00500602103652654,-0.046342193116553,-0.026718590653369,3.02425189433022e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,29522,-0.0186089272670598,0.00255120801588185,-0.0236092949781882,-0.0136085595559314,3.08082042225614e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,29781,-0.0281456553292518,0.00386391218396588,-0.0357189232098249,-0.0205723874486786,3.31517439975169e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,29344,-0.0428772123356198,0.00588886134671694,-0.054419380575185,-0.0313350440960546,3.39506122789107e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,28792,-0.0264224787263221,0.00362986347790719,-0.0335370111430202,-0.019307946309624,3.4441680865087e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,24800,-0.0369472672442298,0.00507634774442781,-0.0468969088233083,-0.0269976256651513,3.48069022131307e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,28911,-0.0403209403283612,0.00554064807911863,-0.0511806105634338,-0.0294612700932887,3.49247061225391e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,29127,-0.0324070514392743,0.00445862594625643,-0.0411459582939369,-0.0236681445846117,3.72933998795343e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,29273,-0.0130998179355918,0.00180324072078867,-0.0166341697483376,-0.00956546612284605,3.83492961993459e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,24800,-0.0170324044549388,0.00234509237257296,-0.0216287855051818,-0.0124360234046958,3.89771605200932e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,29344,-0.0103612970047565,0.00142803272461609,-0.013160241145004,-0.00756235286450893,4.09663713406575e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,29689,-0.0206090485780958,0.00284544398794274,-0.0261861187944636,-0.015031978361728,4.50127205040325e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,29473,-0.0365003338621088,0.00504814844812439,-0.0463947048204326,-0.026605962903785,4.93148931015706e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,29689,-0.0273592028680201,0.00378789385953175,-0.0347834748327023,-0.0199349309033379,5.2152758107134e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,24751,-0.0277179691771735,0.00385314530830144,-0.0352701339814444,-0.0201658043729027,6.49028807127242e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,23857,-0.0380886082533977,0.00529774810974518,-0.0484721945484983,-0.0277050219582972,6.69042533235264e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,24840,-0.0311868290882106,0.00434004794720825,-0.0396933230647388,-0.0226803351116824,6.86881969845276e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,29815,-0.0290665283063002,0.00406051244376663,-0.0370251326960828,-0.0211079239165176,8.35475890100843e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,29689,0.017355790327334,0.00242613873562103,0.0126005584055168,0.0221110222491512,8.64458787167841e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",29344,-0.0283495064090401,0.00397161947312256,-0.0361338805763603,-0.0205651322417198,9.68829631966717e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24863,-0.0333475383667504,0.00467208643300534,-0.0425048277754409,-0.0241902489580599,9.75744961107937e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,24759,-0.0327844995869264,0.00459702473558282,-0.0417946680686687,-0.0237743311051841,1.01878218932788e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,29213,-0.0157557655911505,0.00221515292752464,-0.0200974653290988,-0.0114140658532022,1.16394514273481e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,24933,0.0153002932069401,0.00215151332019873,0.0110833270993506,0.0195172593145296,1.17963185657232e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,24224,-0.0143630893154916,0.00201975719372236,-0.0183218134151874,-0.0104043652157957,1.1815322103982e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,29492,-0.0154940734918876,0.00218223787090196,-0.0197712597188554,-0.0112168872649197,1.27501705592451e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,29589,-0.0160318860083832,0.00225838046538553,-0.0204583117205389,-0.0116054602962276,1.28641809826632e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24863,-0.0461485426267286,0.00650773275454858,-0.0589036988256438,-0.0333933864278134,1.36374451744316e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,24376,-0.0552140448705426,0.00779800442792345,-0.0704981335492725,-0.0399299561918126,1.47495731741383e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,24883,-0.0205938268238937,0.00291006683134675,-0.0262975578133333,-0.014890095834454,1.51484052520982e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,24096,-0.0219574228695015,0.003103860217344,-0.0280409888954957,-0.0158738568435072,1.54391911738218e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",24840,-0.0490812283782531,0.00694202867581835,-0.0626876045828571,-0.0354748521736492,1.58855640396883e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24800,-0.00991769240170569,0.0014049104698574,-0.0126713169226262,-0.00716406788078519,1.71746268784032e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,29344,-0.0341164415913364,0.00484132515332648,-0.0436054388918563,-0.0246274442908165,1.86956404358624e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,24863,-0.0348336830515565,0.00494847587584508,-0.0445326957682128,-0.0251346703349001,1.98264719626386e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29213,-0.0164029307547787,0.00233135274229055,-0.0209723821296681,-0.0118334793798892,2.02487319597721e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,29438,-0.0211603990203396,0.00300828194423644,-0.0270566316310431,-0.0152641664096362,2.05008902984501e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,28865,-0.0230529388709108,0.00327850920449142,-0.029478816911714,-0.0166270608301076,2.08824998044897e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,29415,-0.043805573507746,0.0062382101069968,-0.0560324653174597,-0.0315786816980322,2.23243012970454e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",29576,-0.0503573257280614,0.00720209981876005,-0.0644734413728311,-0.0362412100832917,2.76681708702789e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,29473,-0.0145823091447073,0.00208559133363271,-0.0186700681586274,-0.0104945501307871,2.76906120928352e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,29755,-0.0241194305557551,0.00344967396195078,-0.0308807915211787,-0.0173580695903316,2.77107547491877e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,28926,-0.0222170510863799,0.00317816816569386,-0.0284462606911399,-0.0159878414816199,2.79808919131665e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24800,-0.0671005806646,0.00959877037577819,-0.0859141706011252,-0.0482869907280747,2.80772594397922e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,28911,-0.0346359382106411,0.00496495260431635,-0.0443672453151011,-0.0249046311061811,3.1005059193285e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,24224,-0.0186032435520401,0.00266684540250589,-0.0238302605409517,-0.0133762265631285,3.12077197852631e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29429,-0.0330072052243303,0.00473855187826306,-0.0422947669057259,-0.0237196435429347,3.33706994077297e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,24917,-0.0129933694664407,0.00186548618039993,-0.0166497223800245,-0.00933701655285679,3.36238706902742e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,24863,-0.0287933319354796,0.00413579030733947,-0.036899480937865,-0.0206871829330942,3.43844127698271e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,29168,-0.0129622855560522,0.00186234571007169,-0.0166124831477928,-0.00931208796431174,3.46992326241558e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24376,-0.0275316745144268,0.00395996580630314,-0.035293207494781,-0.0197701415340727,3.67918880498843e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29473,-0.0223079293716985,0.00321558493102517,-0.0286104758365078,-0.0160053829068891,4.07514066846723e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,28769,-0.0173582299225194,0.00250840982619085,-0.0222747131818535,-0.0124417466631854,4.61064145549828e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,24840,-0.0488656767739737,0.00706397120198438,-0.0627110603298631,-0.0350202932180843,4.70533411980099e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,29668,-0.0191949330449962,0.00277759233838656,-0.0246390140282339,-0.0137508520617586,4.922304173508e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24863,-0.0118552157670479,0.00171701059388038,-0.0152205565310535,-0.00848987500304236,5.15686944206644e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,24840,-0.0208774215385669,0.00302495302829602,-0.0268063294740271,-0.0149485136031067,5.26072252378058e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,24899,-0.0216573530210299,0.00313840622033614,-0.0278086292128887,-0.015506076829171,5.29697540239079e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,28792,-0.0335867007195219,0.00486815409959327,-0.0431282827547247,-0.0240451186843191,5.33526703398261e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24840,-0.018074396729652,0.00261989652512176,-0.0232093939188907,-0.0129393995404134,5.36663681661104e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,29589,-0.0210387985143224,0.00305520212203411,-0.0270269946735093,-0.0150506023551356,5.84384128211387e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,29158,-0.0327747035334692,0.00476310738167627,-0.0421103940015547,-0.0234390130653837,6.06566350477486e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29449,-0.0175549682525928,0.00255342057960921,-0.0225596725886268,-0.0125502639165587,6.31912868164671e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,29579,0.015407934194308,0.00224332150712505,0.0110110240403429,0.0198048443482731,6.62299694587378e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,29213,-0.019321671245457,0.002813963946538,-0.0248370405806714,-0.0138063019102425,6.71815466348802e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,29429,-0.0217107088859498,0.00316630467620831,-0.0279166660513181,-0.0155047517205815,7.18123911204866e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,29403,-0.0159168049811193,0.00232211361276731,-0.0204681476621432,-0.0113654623000954,7.30021203598693e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24917,-0.0402056499579758,0.00586590311707892,-0.0517028200674505,-0.0287084798485011,7.34228086874001e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,24840,-0.0204286424746301,0.00298177451743699,-0.0262729205288066,-0.0145843644204536,7.49600232972438e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,24224,-0.0192836453252326,0.00281574484685205,-0.0248025052250626,-0.0137647854254026,7.64108066829701e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,29324,-0.0350200893220511,0.00513291150854327,-0.0450805958787959,-0.0249595827653062,9.11094333577409e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,29540,-0.0122271603439118,0.00179258452347028,-0.0157406260099135,-0.00871369467791005,9.21723410394034e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,29344,-0.0140109417807695,0.00205439227491827,-0.0180375506396093,-0.0099843329219297,9.28101588816619e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28792,-0.0354621464743156,0.00520206371381769,-0.0456581913533983,-0.0252661015952329,9.48363468635668e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,29344,-0.0187215090483947,0.00274703792588696,-0.0241057033831331,-0.0133373147136563,9.5978191431868e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,29344,-0.0239175621061592,0.00351246827266343,-0.0308019999205795,-0.0170331242917389,9.99427071179873e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,29336,-0.0321677482297602,0.00472423951632197,-0.0414272576817513,-0.0229082387777691,1.00114608192295e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,29689,-0.0264260674589018,0.00388288674602501,-0.0340365254811109,-0.0188156094366928,1.02414419502683e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,29429,0.0338428474147766,0.00497523509152631,0.024091386635385,0.0435943081941682,1.04960710780695e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,29344,-0.0303230866778975,0.00446077684595677,-0.0390662092959728,-0.0215799640598222,1.08326595473941e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,29781,-0.025063528424262,0.00369208599044307,-0.0323000169655304,-0.0178270398829935,1.15473434774328e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,29213,-0.0156042621115378,0.00229919945304151,-0.0201106930394991,-0.0110978311835764,1.16819102762396e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,24863,-0.026490257386797,0.00390744889699079,-0.0341488572248989,-0.018831657548695,1.23356231731472e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29576,-0.0530214096441379,0.0078236710812736,-0.0683558049634342,-0.0376870143248416,1.24955909104537e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFM,Afamin,24961,0.00864203222498069,0.00127578115339216,0.00614150116433206,0.0111425632856293,1.28130040144985e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,24190,-0.0186608153899496,0.00275624479646585,-0.0240630551910227,-0.0132585755888766,1.31388554270741e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,29164,-0.0227112975830395,0.00336116054773773,-0.0292991722566054,-0.0161234229094735,1.43546896237229e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29429,-0.0173227056302689,0.002564809184335,-0.0223497316315655,-0.0122956796289723,1.46505825988519e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,29451,-0.0282961544940402,0.00419041612217796,-0.036509370093509,-0.0200829388945714,1.47928563521086e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29781,-0.0121842876174983,0.00180501260627503,-0.0157221123257973,-0.00864646290919923,1.50297237657886e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,24224,-0.0128005661646473,0.00189636713728351,-0.016517445753723,-0.00908368657557159,1.51137130794051e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2,Prothrombin,24961,-0.00654605647458838,0.000970203262417897,-0.00844765486892745,-0.0046444580802493,1.5413184981936e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,29336,-0.0153948952723564,0.00228653771714578,-0.0198765091979621,-0.0109132813467507,1.69448943914366e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,28669,-0.0197717578732827,0.00294405050009876,-0.0255420968534762,-0.0140014188930891,1.90485152693349e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,29391,-0.0180491060166126,0.00268874256693454,-0.0233190414478043,-0.0127791705854209,1.94339830604435e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,24032,-0.0242199889762117,0.00360922337360912,-0.0312940667884856,-0.0171459111639379,1.98163618587877e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,24440,-0.0565944359082584,0.00843497848414977,-0.0731269937371919,-0.0400618780793248,1.99570745442818e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,28792,-0.0191834006271898,0.00287171903827591,-0.0248119699422106,-0.013554831312169,2.43110429523998e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,24701,-0.0315731628506999,0.00472741973479649,-0.0408389055309011,-0.0223074201704988,2.46140256144948e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,24823,-0.0134491798770052,0.00201459552090231,-0.0173977870979738,-0.0095005726560367,2.50953679263697e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29531,0.0283378076973483,0.00424513701173902,0.0200173391543398,0.0366582762403568,2.5099602667027e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,29344,-0.0241341152854063,0.00361610265817844,-0.0312216764954361,-0.0170465540753766,2.53237624440993e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29720,-0.0113312939842903,0.00169811439225358,-0.0146595981931073,-0.00800298977547331,2.55256991710657e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,24788,-0.0183342548095669,0.00274809234600101,-0.0237205158077289,-0.012947993811405,2.58310023939835e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,29344,-0.0228660526999169,0.00342772866199129,-0.0295844008774198,-0.016147704522414,2.58748116257255e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,24840,-0.0329701495668138,0.0049431278780308,-0.0426586802077542,-0.0232816189258734,2.6136291531149e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,28792,-0.0229304044237302,0.00343816393981165,-0.029669205745761,-0.0161916031016993,2.6154414958878e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29429,-0.0355908359864978,0.00535477425432666,-0.0460861935249781,-0.0250954784480176,3.05258818343258e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,29781,-0.00387564383468123,0.000583191319405569,-0.00501869882071615,-0.00273258884864632,3.07236668256522e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,28926,-0.0211876276381918,0.00318919432879938,-0.0274384485226385,-0.014936806753745,3.11611480099257e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,28926,-0.0207627040748268,0.00312797025455675,-0.026893525773758,-0.0146318823758956,3.24124151650857e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,24376,-0.0199025008736343,0.00300289210367527,-0.0257881693968378,-0.0140168323504307,3.47895619613291e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,28769,-0.0266893641174277,0.0040281856621501,-0.0345846080152419,-0.0187941202196135,3.51815162777797e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,29438,-0.0226220363782253,0.00341834209293838,-0.0293219868803845,-0.0159220858760661,3.7074419824042e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,24235,-0.0333059003939504,0.00503250044560383,-0.0431696012673339,-0.0234421995205668,3.71290348113634e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,28926,-0.0284807187731493,0.00430590075278796,-0.0369202842486137,-0.0200411532976849,3.79702973906266e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,29158,-0.0327949915390451,0.00495909521549006,-0.0425148181614057,-0.0230751649166846,3.82857967117607e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,24788,-0.0267311962021119,0.00404855040263284,-0.0346663549912722,-0.0187960374129515,4.12018129238534e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,24376,-0.0241667394141235,0.00366173309194361,-0.031343736274333,-0.0169897425539141,4.20143095636074e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,24808,-0.0321236409725156,0.00487483981044787,-0.0416783270009935,-0.0225689549440378,4.49611550643711e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPL,Periplakin,24224,-0.0141092446908865,0.00214376087623997,-0.0183110160083168,-0.00990747337345614,4.75123700686484e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29344,-0.0406311257959995,0.00617498127802784,-0.052734089100934,-0.0285281624910649,4.78497977745319e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24917,-0.031624552635306,0.00481737890955703,-0.0410666152980378,-0.0221824899725742,5.31702676083277e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29213,-0.0247525197339411,0.00377091973191456,-0.0321435224084937,-0.0173615170593886,5.32413238384012e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24440,-0.0156961278526935,0.00239226377119602,-0.0203849648442377,-0.0110072908611493,5.44437774652429e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,29561,-0.0239115635808195,0.00364551742244249,-0.0310567777288068,-0.0167663494328322,5.50014240344295e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,29781,-0.0140800433904088,0.00214957432855135,-0.0182932090743694,-0.00986687770644815,5.84139751335896e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,24961,-0.0109301174111412,0.00167127256079322,-0.0142058116302959,-0.00765442319198647,6.27101924671628e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,24172,-0.0187194930181268,0.00286243232051392,-0.024329860366334,-0.0131091256699195,6.28673786014698e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,28792,-0.024349294436803,0.00373057438141418,-0.0316612202243748,-0.0170373686492312,6.82352918512262e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,29377,-0.0109075114189445,0.00167258621451896,-0.0141857803994017,-0.00762924243848735,7.0810754250082e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,28911,-0.0143397592509873,0.00220009733451752,-0.0186519500266417,-0.010027568475333,7.25280360374798e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24917,-0.0418046634864445,0.00641907604681235,-0.0543860525381967,-0.0292232744346923,7.52853262898697e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,29531,0.0349274012516945,0.00537032830662981,0.0244015577707001,0.0454532447326889,7.95808804359732e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,28926,-0.0255821634671411,0.00393541032900467,-0.0332955677119903,-0.017868759222292,8.13527598694205e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,24863,-0.0287359613966503,0.00442049218920857,-0.0374001260874991,-0.0200717967058015,8.15039754925468e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,24917,-0.0301649634930234,0.00464057397671059,-0.0392604884873762,-0.0210694384986707,8.16951907556353e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,24917,-0.0223983025684979,0.00345253337557907,-0.0291652679846329,-0.0156313371523629,8.89119846137586e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,24788,-0.0337925703503135,0.00521191515558631,-0.0440079240552627,-0.0235772166453644,9.11763636870132e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28911,-0.0135285493482126,0.00208887970971879,-0.0176227535792614,-0.00943434511716378,9.54056795151891e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,29815,-0.0135045462610713,0.00208731179925734,-0.0175956773876157,-0.00941341513452689,9.96358273536508e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24788,0.0160741677819479,0.00248700525986924,0.0111996374726042,0.0209486980912916,1.04374697188347e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,29540,-0.0139767125791144,0.00216400380516905,-0.0182181600372458,-0.0097352651209831,1.07227156169814e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,28769,-0.0312853876863457,0.00484590549337357,-0.0407833624533579,-0.0217874129193335,1.09186388546708e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,24840,-0.0169836771130308,0.00263057338908066,-0.0221396009556288,-0.0118277532704327,1.09301952177888e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,24840,-0.0347569379917352,0.00538448609387453,-0.0453105307357293,-0.0242033452477411,1.10206005359017e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,29429,0.0147812199650335,0.00229135400688094,0.0102901661115468,0.0192722738185201,1.12938400879547e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28714,-0.0198706084590488,0.00308127476745025,-0.0259099070032513,-0.0138313099148463,1.14510399244549e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,24840,-0.0381240594920915,0.00591221646756539,-0.0497120037685197,-0.0265361152156633,1.1515113849265e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COCH,Cochlin,24917,-0.0195128985828701,0.00302885785172833,-0.0254494599722576,-0.0135763371934826,1.19802578513798e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,29429,-0.0472862902692111,0.00735104761867374,-0.0616943436018117,-0.0328782369366106,1.27371693328075e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,29109,-0.0440198609078741,0.00684406561115711,-0.0574342295057421,-0.0306054923100062,1.28033251399875e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,24863,-0.035911549092124,0.00558343312830723,-0.0468550780236061,-0.0249680201606418,1.28391107301393e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29429,-0.0510998183002377,0.00794812800559015,-0.0666781491911944,-0.0355214874092811,1.30273108597312e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29438,-0.0116617515626136,0.00181471401554818,-0.015218591033088,-0.00810491209213918,1.3281566434043e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,29213,-0.0256633620710603,0.0039965359561741,-0.0334965725451616,-0.0178301515969591,1.37099227300562e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,24788,-0.0297497085794849,0.0046344658473769,-0.0388332616403437,-0.0206661555186262,1.39443166355139e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,29213,-0.0280597217354623,0.00437722801497242,-0.0366390886448082,-0.0194803548261164,1.47365924419026e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24376,-0.03582688289077,0.00559612526713108,-0.0467952884143469,-0.0248584773671931,1.56058758533045e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,29344,-0.0249016853460195,0.0038922066358877,-0.0325304103523594,-0.0172729603396796,1.59973293700089e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,29815,-0.0177609536773727,0.00277658576380115,-0.023203061774423,-0.0123188455803225,1.61136185002342e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29429,-0.0503677507280903,0.00788097413013053,-0.0658144600231461,-0.0349210414330344,1.67208740227342e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,29344,-0.0275547142055745,0.00431371655737335,-0.0360095986580263,-0.0190998297531227,1.70924721466458e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,29589,-0.041871847465012,0.00657781002631045,-0.0547643551165805,-0.0289793398134435,1.97350410646933e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28792,-0.0324254865286728,0.00509946431440418,-0.042420436584905,-0.0224305364724406,2.06644981459558e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29269,-0.0109079858970277,0.00171597180624358,-0.0142712906372651,-0.00754468115679026,2.09116693099125e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,24800,-0.0318552541164818,0.0050149367127573,-0.0416845300734861,-0.0220259781594774,2.16116810871677e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,28657,-0.0239637719975492,0.00377502376048882,-0.0313628185681073,-0.0165647254269911,2.21426767751494e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,29473,0.0222276396684951,0.0035051790880837,0.0153574886558511,0.0290977906811392,2.31029696531167e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24863,-0.032853128403646,0.00518364314765711,-0.0430130689730539,-0.022693187834238,2.36998938506318e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,29689,-0.0124940135614109,0.00197149837428784,-0.016358150375015,-0.00862987674780669,2.37152428499752e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,24863,-0.0251738761771813,0.00397259668743486,-0.0329601656845536,-0.0173875866698089,2.38482532696311e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH1,Somatotropin,29428,-0.0736148662696006,0.0116323529735005,-0.0964142780976615,-0.0508154544415396,2.51186779313702e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,29269,-0.0119080386977809,0.00188292199412275,-0.0155985658062615,-0.00821751158930031,2.58166421131873e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,24235,-0.0373076070740808,0.00590584563864372,-0.0488830645258225,-0.0257321496223391,2.71212314755171e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,24800,-0.0315461669038531,0.00499557800591252,-0.0413374997954417,-0.0217548340122646,2.75066419158778e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,29288,-0.0232003302122435,0.00367592414122881,-0.030405141529052,-0.0159955188954351,2.80429707530638e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29561,-0.0298678185949109,0.00474171177941816,-0.0391615736825705,-0.0205740635072513,3.03879504142814e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,29815,-0.0144359965115721,0.00229430539155738,-0.0189328350790246,-0.00993915794411969,3.17552038387515e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,24728,-0.0191725649476294,0.00304940242868761,-0.0251493937078572,-0.0131957361874017,3.28396161195296e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,24376,-0.0304796293876106,0.00484811739293964,-0.0399819394777723,-0.0209773192974489,3.29360044247918e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,29561,-0.00900420792622469,0.00143328400928794,-0.011813444584429,-0.00619497126802033,3.38415640086334e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,24235,-0.0297089510567087,0.00474696722492033,-0.0390130068175525,-0.0204048952958648,3.95180928929883e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,29429,-0.0169804729038121,0.00271408795769931,-0.0223000853009027,-0.0116608605067214,3.99337311209101e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",29576,-0.0113049978925784,0.00180855541597649,-0.0148497665078923,-0.00776022927726445,4.13810892578762e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,24601,-0.0127056641822947,0.00203316464490268,-0.016690666886304,-0.00872066147828546,4.19314670401083e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,24863,-0.0124122558048504,0.00198838121942244,-0.0163094829949184,-0.00851502861478238,4.3789433104841e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,28792,-0.0156480978569999,0.00250796873681253,-0.0205637165811524,-0.0107324791328473,4.45504938057387e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24788,-0.0339573985425931,0.00544283574707033,-0.044625356606851,-0.0232894404783353,4.47740410156882e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,29308,-0.0284464490532102,0.0045632605342085,-0.0373904397002588,-0.0195024584061615,4.61459501282135e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29428,-0.0131122461456495,0.00210550053345789,-0.017239027191227,-0.00898546510007206,4.79990594001655e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29720,-0.0137212603845512,0.00220578512370341,-0.0180445992270099,-0.00939792154209252,5.01922808216223e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,29678,-0.00818732469722457,0.00131774950830601,-0.0107701137335044,-0.00560453566094478,5.26353040708551e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,24224,-0.0202043046088509,0.0032553041884347,-0.0265847008181829,-0.0138239083995189,5.50287136783357e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,29473,-0.0268259512534558,0.00432525940585767,-0.0353034596889368,-0.0183484428179747,5.64329424170732e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,29781,-0.0106633360459752,0.00171955460531669,-0.014033663072396,-0.00729300901955453,5.67630176037334e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29344,-0.0171835440005983,0.00277247008954362,-0.0226175853761039,-0.0117495026250928,5.79757831593977e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,24376,-0.0354310819346876,0.00572553370850751,-0.0466531280033623,-0.0242090358660129,6.18019590179707e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],28821,-0.0195648306611063,0.00316222327120614,-0.0257627882726704,-0.0133668730495423,6.21254920074704e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,29576,-0.0426052795733218,0.00691322493474537,-0.0561552004454227,-0.0290553587012209,7.23619559001764e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,29344,-0.0273413003187767,0.00443876536401748,-0.036041280432251,-0.0186413202053024,7.38461835867122e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELN,Elastin,24917,-0.0141447551287839,0.00230010777341829,-0.0186529663646837,-0.00963654389288402,7.88572507774756e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,24376,-0.0452034421022735,0.0073535476196356,-0.0596163954367592,-0.0307904887677877,8.01065167834702e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,29576,-0.0190760012656667,0.00310653419614698,-0.0251648082901147,-0.0129871942412186,8.32535148979004e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,24788,-0.0347328817092067,0.00566175460280156,-0.0458299207306977,-0.0236358426877156,8.6639319430653e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,24800,-0.0189607794433185,0.0030933522357561,-0.0250237498254005,-0.0128978090612366,8.9471524066752e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,28792,-0.0232254581725725,0.00378946979438786,-0.0306528189695727,-0.0157980973755723,8.96106755595337e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,29720,-0.0222741850485794,0.00363709758710103,-0.0294028963192974,-0.0151454737778614,9.2302741175677e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,24933,-0.0354571598245461,0.00579914609193549,-0.0468234861647397,-0.0240908334843526,9.84821104819896e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,29429,-0.0171863419502584,0.00281132396935857,-0.0226965369302012,-0.0116761469703156,9.88455556908678e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,24235,-0.0410614930770332,0.00672308756376232,-0.0542387447020074,-0.0278842414520591,1.02721854131938e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,28752,-0.0439293109910341,0.00719754963909279,-0.0580365082836559,-0.0298221136984122,1.05182364082629e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24235,-0.019182866230615,0.00314352997617279,-0.0253441849839136,-0.0130215474773163,1.06117352400241e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,29635,-0.0278336461730961,0.00456421224201829,-0.036779502167452,-0.0188877901787403,1.08570337975729e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,28769,0.0205829806823371,0.00337616083755307,0.013965705440733,0.0272002559239411,1.09750980215552e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,28792,-0.0321875124683443,0.00528515618292822,-0.0425464185868836,-0.021828606349805,1.14216697258947e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28911,-0.00857480297868761,0.00140880827975483,-0.0113360672070071,-0.00581353875036814,1.1680959406046e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,24106,-0.0246426016387169,0.00405302970867371,-0.0325865398677174,-0.0166986634097165,1.2195565363976e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,24917,-0.0124591528450376,0.00204982336062791,-0.0164768066318683,-0.00844149905820693,1.23335869985345e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,29627,-0.0289072725505629,0.00475644948396941,-0.038229913539143,-0.0195846315619829,1.23567659746925e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,24946,-0.0210166094968063,0.00346056548691756,-0.0277993178511647,-0.0142339011424479,1.2722163930449e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24917,-0.0134168747657441,0.0022106639688176,-0.0177497761446266,-0.00908397338686165,1.30437367556288e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,29374,-0.0214313762265563,0.00353381373399498,-0.0283576511451865,-0.0145051013079261,1.33847208622385e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,29531,-0.0280956261722716,0.0046448672054266,-0.0371995658949077,-0.0189916864496355,1.47730308536728e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",24961,-0.00658069765984169,0.00108885827278666,-0.00871485987450354,-0.00444653544517985,1.52785716328975e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,24190,-0.047804955727548,0.00793955930818829,-0.0633664919715971,-0.032243419483499,1.75723722565146e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,24917,0.0321783106991468,0.00534582309250301,0.0217004974378409,0.0426561239604527,1.77581598482035e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,29344,-0.0222707518307726,0.00370104845966878,-0.0295248068117234,-0.0150166968498218,1.79321509256434e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24863,-0.0304962173653665,0.0050699002700762,-0.0404332218947158,-0.0205592128360172,1.82230154195841e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24224,-0.023505446492554,0.00390768352923692,-0.0311645062098584,-0.0158463867752497,1.82256967168864e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,29473,-0.0314597082393851,0.00523624938833728,-0.0417227570405262,-0.021196659438244,1.89955523410821e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,24800,0.0394076052779235,0.00656106207678179,0.0265479236074311,0.0522672869484158,1.9246708538479e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29473,-0.0327708153625623,0.00545934217689885,-0.0434711260292841,-0.0220705046958406,1.96324978654876e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,29449,-0.0134627445843042,0.0022462153262466,-0.0178653266237475,-0.00906016254486088,2.07728590894839e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,29781,-0.0297058954649754,0.00495637505464555,-0.0394203905720807,-0.0199914003578701,2.07767629051062e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,28911,-0.0300789336167715,0.00502098966873731,-0.0399200733674966,-0.0202377938660463,2.11488649707373e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,29473,-0.0265480422810762,0.00443224940125021,-0.0352352511075266,-0.0178608334546257,2.12605053308145e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29781,-0.0387302039550075,0.00648106928798842,-0.0514330997594648,-0.0260273081505503,2.31426440657958e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELE,E-selectin,29815,0.0197097381376977,0.00329864157219686,0.0132444006561918,0.0261750756192035,2.325459269837e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,29473,-0.0119284331758265,0.00199705569979762,-0.0158426623474298,-0.00801420400422314,2.35584352827777e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,24788,-0.0369138762917254,0.00618577185627495,-0.0490379891300243,-0.0247897634534265,2.44121185970515e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,28792,-0.0340164824012518,0.00570402769133513,-0.0451963766762687,-0.022836588126235,2.49631797125265e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,29074,-0.0149043478886327,0.00249999180108487,-0.019804331818759,-0.0100043639585063,2.5241438037797e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,24863,-0.0268688520164096,0.00450949099177396,-0.0357074543602866,-0.0180302496725327,2.58323667670299e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",29438,-0.0146409416580092,0.00246668072122637,-0.0194756358716129,-0.00980624744440552,2.9626017482814e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,24946,-0.0101005082894092,0.00170182848508404,-0.0134360921201739,-0.00676492445864447,2.97562031568859e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29158,-0.0373399750744428,0.00629387263525916,-0.0496759654395507,-0.0250039847093348,3.01261443839758e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,24106,-0.0259077148914721,0.00437367789155298,-0.034480123558916,-0.0173353062240283,3.19334871840819e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,24376,-0.0368952964474175,0.00622953383711382,-0.0491051827681606,-0.0246854101266745,3.2106070244103e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,24224,-0.0192048797485734,0.00324402931899723,-0.0255631772138079,-0.0128465822833388,3.26141991529231e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,29618,-0.022938430767774,0.00387632784529729,-0.0305360333445567,-0.0153408281909913,3.30329535412437e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,29449,-0.0201794981038716,0.00341043090847641,-0.0268639426844854,-0.0134950535232579,3.31502544290989e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,29493,-0.0252790273258829,0.00427589844411536,-0.033659788276349,-0.0168982663754168,3.41736329282011e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,29815,-0.0114040720274948,0.00193035986763332,-0.0151875773680561,-0.00762056668693348,3.50586502571671e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,24106,0.0296370125124517,0.00501844933917458,0.0198008518076695,0.0394731732172339,3.56053721884134e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,24933,-0.0323897698988931,0.00548558339441601,-0.0431415133519485,-0.0216380264458377,3.58244396123972e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,28792,-0.0295076468038124,0.00499978724383089,-0.039307229801721,-0.0197080638059039,3.63623587453831e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,28769,-0.0275882520368507,0.00468187332414428,-0.0367647237521735,-0.018411780321528,3.84474580096644e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,24917,-0.027678965727636,0.00469919398308913,-0.0368893859344906,-0.0184685455207813,3.90796104020583e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,28472,0.0155231639656976,0.00263629756829239,0.0103560207318445,0.0206903071995507,3.94697794200357e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,24800,-0.0378458806439803,0.00643106228901216,-0.0504507627304442,-0.0252409985575165,4.03521248140739e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,28342,-0.0121760740029623,0.00206936350947648,-0.0162320264815362,-0.00812012152438843,4.05039390547054e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,29438,-0.0196948599633661,0.00335086286404416,-0.0262625511768926,-0.0131271687498395,4.20870122357341e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,24863,0.0172828672425649,0.00294164706033987,0.0115172390042987,0.023048495480831,4.27625011209468e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,24840,-0.026186636601931,0.00445849823051213,-0.0349252931337348,-0.0174479800701273,4.32331176493016e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,29781,-0.0174579012223862,0.00297302618365636,-0.0232850325423526,-0.0116307699024197,4.3487798665421e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,24946,-0.0230772989952249,0.00393744456913296,-0.0307946903507255,-0.0153599076397243,4.65921274834053e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MENT,Protein MENT,24376,0.00872110333032567,0.00148813151486851,0.00580436556118339,0.0116378410994679,4.67588306289165e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29213,-0.0282631010659966,0.00482374263888429,-0.0377176366382098,-0.0188085654937834,4.70189130444632e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24235,-0.0323865663041519,0.00553305917624101,-0.0432313622895843,-0.0215417703187195,4.88170337651221e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,24724,-0.0169964624502088,0.00290559643136721,-0.0226914314556885,-0.0113014934447291,4.99082049637496e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,29213,0.0504620506177998,0.00863995291295793,0.0335277429084023,0.0673963583271974,5.25805938596935e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,24224,-0.0346997024438563,0.00594233258804139,-0.0463466743164174,-0.0230527305712952,5.30558039317169e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,29429,-0.0153563192889473,0.00263140650506604,-0.0205138760388768,-0.0101987625390179,5.40991751325285e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24863,-0.0180649097929356,0.00309648217740132,-0.0241340148606422,-0.011995804725229,5.47814698765351e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,29689,-0.013256162776574,0.00227240086277892,-0.0177100684676207,-0.00880225708552736,5.48231137388816e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,24863,-0.0178213367034835,0.003055444998824,-0.0238100089011785,-0.0118326645057885,5.52300787303683e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,24292,-0.025089831760259,0.00430496955439583,-0.0335275720868749,-0.0166520914336432,5.67675189251514e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,29213,-0.0145840305163725,0.00250417053833871,-0.0194922047715164,-0.00967585626122864,5.80930622245043e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,24961,-0.00642759517870355,0.00110375127700188,-0.00859094768162722,-0.00426424267577987,5.83660977574023e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,24917,-0.0132264736912065,0.00227127901896102,-0.0176781805683701,-0.00877476681404293,5.83847322329447e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,24224,-0.0165766954889893,0.00284880950521853,-0.0221603621192176,-0.010993028858761,6.00128153055022e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,29689,-0.0108895764329859,0.00187260530923095,-0.0145598828390786,-0.00721927002689326,6.11812736383293e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,28792,-0.017886173960239,0.00307810536353347,-0.0239192604727646,-0.0118530874477134,6.28395937652028e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TF,Serotransferrin,24961,0.00822093126249396,0.00141614326317461,0.00544529046667172,0.0109965720583162,6.50852254761985e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,29537,-0.0195181182992888,0.00336541255785655,-0.0261143269126876,-0.0129219096858899,6.7141933122067e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,24224,-0.0317566683727159,0.00547686487388145,-0.0424913235255235,-0.0210220132199083,6.78107807698106e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,24783,-0.0163717849612207,0.0028257765251227,-0.0219103069504612,-0.0108332629719802,6.96735351409357e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,29213,-0.0300635077114276,0.00519634064529393,-0.0402483353762037,-0.0198786800466515,7.30280094474046e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,29034,-0.0260838574985511,0.00451051608062701,-0.03492446901658,-0.0172432459805221,7.41767474712275e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,29237,-0.0188272971324475,0.00325799179364523,-0.0252129610479921,-0.0124416332169028,7.59968562515806e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,28792,-0.0286116943439518,0.00495188021695808,-0.0383173795691896,-0.018906009118714,7.63971378163873e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,24863,-0.047860479216274,0.00828301637686945,-0.0640951913149381,-0.0316257671176099,7.64298844800456e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,29576,-0.0473568401319467,0.00819650265477207,-0.0634219853353,-0.0312916949285934,7.64929556088184e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,29429,-0.0243692012666443,0.00422082966346668,-0.032642027407039,-0.0160963751262496,7.8395005615825e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,24784,-0.0215540036737956,0.00373721397173212,-0.0288789430583905,-0.0142290642892006,8.14615505578234e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,28792,-0.0109282121441056,0.00189562315767738,-0.0146436335331532,-0.0072127907550579,8.25058539410192e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29561,-0.0359325430363794,0.00623335594446794,-0.0481499206875366,-0.0237151653852222,8.26858683854018e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29815,-0.0102866422520856,0.00178577612967759,-0.0137867634662537,-0.00678652103791752,8.47795588502135e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,29438,-0.009082978805078,0.00157841150516823,-0.0121766653552077,-0.00598929225494827,8.77569182008384e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,24376,-0.0311560343992897,0.00541824918403448,-0.0417758027999973,-0.0205362659985822,9.02013494514213e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29568,-0.0420829980166743,0.00732434778224376,-0.056438719669872,-0.0277272763634765,9.24774422311254e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,24799,-0.0221182623585275,0.00385041256853922,-0.0296650709928644,-0.0145714537241906,9.33334598834783e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLN,Promotilin,29429,-0.0334828481355655,0.00582965663053059,-0.0449089751314054,-0.0220567211397255,9.36318304859258e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELP,P-selectin,29589,-0.0213539247682002,0.00372211135900553,-0.028649263031851,-0.0140585865045493,9.72810457823367e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,29484,-0.0103423702404171,0.00180360106063826,-0.0138774283192681,-0.00680731216156615,9.8878149181228e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,24224,-0.0131997202532242,0.00230557265440897,-0.0177186426558658,-0.00868079785058261,1.04571812319627e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24106,-0.0152137248430258,0.00265764399811774,-0.0204227070793366,-0.010004742606715,1.0496095569035e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,24800,-0.0218814943017349,0.0038244721747816,-0.0293774597643069,-0.014385528839163,1.06840353783485e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29360,0.0250273530634821,0.00437665467343446,0.0164491099035506,0.0336055962234137,1.08590657136199e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24933,-0.0233482721384959,0.00408583238861525,-0.0313565036201818,-0.01534004065681,1.11316121876844e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29213,-0.035437138300092,0.00620225023054824,-0.0475935487519665,-0.0232807278482174,1.1168965754596e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24190,-0.0201952505953423,0.00353606053547495,-0.0271259292448732,-0.0132645719458114,1.13478615083462e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,24224,-0.0289929840367312,0.00508030529042371,-0.0389503824059617,-0.0190355856675008,1.16370074560833e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,29669,-0.0249994347512162,0.00438134998527632,-0.0335868807223578,-0.0164119887800746,1.16848472644747e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,29815,-0.0113404367336439,0.00199184066704412,-0.0152444444410504,-0.00743642902623747,1.25669744397203e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,29689,-0.0458548114317055,0.00805585625664359,-0.0616442896947269,-0.0300653331686841,1.26661816002859e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,29438,0.0153892897884284,0.00270392164352256,0.0100896033671242,0.0206889762097326,1.27146188161874e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,29613,0.0154634440684949,0.00271820495925231,0.0101357623483604,0.0207911257886295,1.2910751162948e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,29576,-0.014424627786203,0.00253632403759762,-0.0193958228998944,-0.0094534326725117,1.30342554118301e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24840,-0.0363181964615513,0.00638843302773096,-0.048839525195904,-0.0237968677271987,1.32285108863815e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,29211,-0.0217617633319169,0.00383139013275992,-0.0292712879921263,-0.0142522386717074,1.36084237952748e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29689,-0.0210859572761958,0.00371642488822362,-0.0283701500571141,-0.0138017644952775,1.41028564422743e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29438,-0.0141980843064766,0.00250775248415026,-0.0191132791754111,-0.0092828894375421,1.51295605122059e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,28792,-0.0111321030941989,0.00196834165036469,-0.0149900527289137,-0.00727415345948408,1.56797299661165e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,28792,-0.0303919705206185,0.00538252543786666,-0.0409417203788372,-0.0198422206623999,1.65370782470922e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,24840,-0.0245551955125859,0.00435083648257606,-0.033082835018435,-0.0160275560067368,1.6816283949424e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,24863,-0.028048520476332,0.00497655241733513,-0.0378025632143088,-0.0182944777383551,1.75793092317577e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",29438,-0.0284521955181399,0.0050515444342129,-0.0383532226091971,-0.0185511684270826,1.79364732040435e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,24788,-0.0179752848909405,0.00319299821651692,-0.0242335613953137,-0.0117170083865673,1.82587673246659e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,29561,-0.026312525829934,0.00467974906938379,-0.0354848340059262,-0.0171402176539418,1.89761465384535e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,24224,-0.0122928166572711,0.00218691138002079,-0.0165791629621119,-0.00800647035243038,1.91849098672646e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,29781,-0.0135344824536438,0.00240988490362264,-0.0182578568647442,-0.00881110804254341,1.96901336142248e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,29340,-0.0158672878890188,0.00282596326693246,-0.0214061758922064,-0.0103283998858312,1.98540113010406e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,29344,-0.00558371312707136,0.000995441621709389,-0.00753477870562176,-0.00363264754852095,2.04996210266225e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,24788,-0.0128349645857092,0.00229053693671449,-0.0173244169816696,-0.00834551218974883,2.12329029047884e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGN,Mimecan,29438,-0.0154216738356543,0.00276137961922748,-0.0208339778893402,-0.0100093697819685,2.36072074368218e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,29429,-0.0184190190937417,0.00330138192739614,-0.0248897276714381,-0.0119483105160453,2.43772700730966e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,29344,-0.0265276799126622,0.00475539365077165,-0.0358482514681746,-0.0172071083571498,2.44822808427147e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,29561,-0.0228680093882861,0.00410739061879556,-0.0309184950011254,-0.0148175237754468,2.60622102200206e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,29720,-0.0140158161445679,0.00251904669245623,-0.0189531476617821,-0.00907848462735365,2.66026908960474e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,29439,-0.020680362735548,0.00372097334613367,-0.02797347049397,-0.013387254977126,2.75587610829862e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,29429,-0.0304762831465407,0.00548424090389147,-0.0412253953181679,-0.0197271709749134,2.76722969583527e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,29164,-0.0325210756167571,0.00585515440081712,-0.0439971782423586,-0.0210449729911555,2.81213206853039e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,29344,-0.0423633089256833,0.00762874500666242,-0.0573156491387417,-0.027410968712625,2.83050048930478e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,29473,-0.0248764049798899,0.0044804460387021,-0.033658079215746,-0.0160947307440337,2.84499698343791e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAST,Gastrin,24840,0.0473307334657254,0.00852905151197464,0.0306137925022551,0.0640476744291957,2.89651905092861e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,24543,-0.00295470580498337,0.000533052064826414,-0.00399948785204314,-0.0019099237579236,3.00396318801591e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,29815,-0.00990667606918881,0.00178762984800219,-0.0134104305712731,-0.00640292156710451,3.0191877565151e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBIN,Erbin,29344,-0.0372034438238436,0.00671487426068705,-0.0503645973747902,-0.024042290272897,3.0427877043573e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,24235,0.0265307601089944,0.00479092332022,0.0171405504013632,0.0359209698166256,3.0962606546629e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28792,-0.0307558880476022,0.00555814116815051,-0.0416498447371772,-0.0198619313580272,3.16662356252876e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,24224,-0.0146838514100196,0.00265559884738708,-0.0198888251508983,-0.00947887766914096,3.24655915276284e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,29381,-0.0234468031343769,0.00424120636716921,-0.0317595676140285,-0.0151340386547252,3.26033535368649e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,28926,0.0288581234795124,0.00522026431374535,0.0186264054245715,0.0390898415344532,3.26517605119773e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,24376,0.0140982830994883,0.00255044508661616,0.00909941072972063,0.019097155469256,3.27642515879008e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,29473,-0.0228033185730111,0.00412601252315728,-0.0308903031183994,-0.0147163340276228,3.29031838691821e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,24376,0.0189345326775672,0.00342921368481029,0.012213273855339,0.0256557914997953,3.39473049220593e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,28926,-0.0181836907104269,0.00329355379630225,-0.0246390561511793,-0.0117283252696745,3.3998121287926e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,29473,-0.0102805456193713,0.00186216401053609,-0.013930387080022,-0.00663070415872059,3.40395386360108e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,29473,-0.0128152922827032,0.00232169304425238,-0.0173658106494379,-0.00826477391596853,3.42233415687148e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,24324,-0.0372429445690255,0.00675247568849548,-0.0504777969184767,-0.0240080922195744,3.51428427193589e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,29387,-0.0285229791713936,0.00517315719542245,-0.0386623672744216,-0.0183835910683656,3.54421299075451e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,24235,0.0220315065673561,0.00400024754650364,0.0141910213762089,0.0298719917585032,3.67587746164897e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,29378,-0.0170964243098319,0.00310516578101091,-0.0231825492406133,-0.0110102993790505,3.70566890509724e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,29720,-0.0103189928223176,0.00187441784019114,-0.0139928517890923,-0.00664513385554298,3.71854830311233e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,24235,-0.0219083595111002,0.00398597542874662,-0.0297208713514436,-0.0140958476707568,3.91615840991754e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,29344,-0.0304313420633946,0.00554309302268664,-0.0412958043878604,-0.0195668797389288,4.05359939312908e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",24847,-0.0144069749113979,0.00262533754430688,-0.0195526364982394,-0.00926131332455644,4.11258059971288e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,24863,-0.0197243895494478,0.00359483325138514,-0.0267702627221627,-0.012678516376733,4.13104918947806e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,28926,-0.0194983124502342,0.00355462816730681,-0.0264653836581555,-0.0125312412423128,4.16150404512103e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,29158,-0.0287615996202312,0.00525226182994186,-0.0390560328069172,-0.0184671664335451,4.38535803538341e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24863,-0.0151491107017156,0.00276949741338903,-0.0205773256319581,-0.00972089577147308,4.54410919108778e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,29438,-0.00958593373581839,0.00175479916300369,-0.0130253400953056,-0.00614652737633115,4.72753817135086e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,29164,-0.0143560934523797,0.00262813174519117,-0.0195072316729544,-0.00920495523180499,4.73387852271351e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,24376,-0.0240490715988467,0.00440804931914517,-0.0326888482643712,-0.0154092949333221,4.92502608713139e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,29448,-0.0178432926007059,0.00327152167023491,-0.0242554750743664,-0.0114311101270455,4.96099559514663e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,29473,-0.018410841712227,0.00337592486034897,-0.025027654438511,-0.0117940289859431,4.97650728030847e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,24933,-0.0178277176702752,0.00326907651111102,-0.0242351076320527,-0.0114203277084976,4.98735163161492e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,24440,-0.0252618141101744,0.00463465071038383,-0.0343457295025267,-0.0161778987178221,5.06742487065292e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EZR,Ezrin,29689,-0.00857342480089537,0.00157352084312809,-0.0116575256534264,-0.00548932394836432,5.11822944712706e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,24863,-0.0373147175389718,0.00685472698603736,-0.050749982431605,-0.0238794526463386,5.2694289548801e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,24800,-0.0228850354960551,0.00420549160206273,-0.0311277990360981,-0.0146422719560122,5.32734879275611e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,29745,-0.01924168928109,0.0035366824787682,-0.0261735869394756,-0.0123097916227043,5.35188594204318e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,29588,-0.00865101384743903,0.00159075418380566,-0.0117688920476981,-0.00553313564717994,5.4214082916918e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28792,-0.0168950892129048,0.00310876673069655,-0.02298827200507,-0.0108019064207395,5.53464636053815e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,24840,-0.0224420526052388,0.0041300779627642,-0.0305370054122566,-0.014347099798221,5.56824695099465e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,29689,-0.0225801941787157,0.00415633827864343,-0.0307266172048568,-0.0144337711525746,5.59395269047523e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24440,-0.0309950512919698,0.00571396923954353,-0.0421944310014751,-0.0197956715824644,5.86902478456634e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,24933,0.0166157853830347,0.00306346491136974,0.01061139415675,0.0226201766093194,5.88701239319935e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,29594,-0.0399128810816605,0.00736295975799929,-0.0543442822073391,-0.0254814799559819,5.98078941115543e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,28792,-0.0134220336614081,0.00247727269273569,-0.0182774881391701,-0.00856657918364618,6.07291967637726e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28926,-0.0194357074527433,0.00358788577021592,-0.0264679635623665,-0.0124034513431201,6.10781533970628e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28792,-0.0158116321237877,0.00291977274253855,-0.0215343866991632,-0.0100888775484121,6.1653494681352e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,24800,-0.0211170452446891,0.0039011635629702,-0.0287633258281107,-0.0134707646612675,6.25483316630036e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,24235,-0.0189097195647746,0.00349510012682103,-0.0257601158133438,-0.0120593233162054,6.34973662872079e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28792,-0.0240302488154895,0.00444274735470568,-0.0327380336307126,-0.0153224640002664,6.39282218133793e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,29576,-0.0303146983875557,0.00560930066266887,-0.0413089276863866,-0.0193204690887247,6.55415244244984e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,29018,-0.0265809081595347,0.00492637038022238,-0.0362365941047705,-0.0169252222142988,6.88150913430293e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,28911,-0.0392931608039462,0.00728822947453835,-0.0535780905740413,-0.025008231033851,7.04905784359919e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,29540,-0.00980728605457501,0.00181910804067604,-0.0133727378143001,-0.00624183429484997,7.05011483944846e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,29781,-0.0121493003406608,0.00225429658065119,-0.0165677216387372,-0.00773087904258451,7.12308979554878e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,28962,-0.0154902763921909,0.00287690195978891,-0.0211290042333772,-0.00985154855100464,7.32682457933435e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,29689,-0.0229124036806674,0.00425608867376623,-0.0312543374812493,-0.0145704698800856,7.36290915042024e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,29344,-0.00938954026752004,0.0017441510016146,-0.0128080762306847,-0.00597100430435541,7.36342984856499e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,24863,-0.0185676038197598,0.00345042277123271,-0.0253304324513759,-0.0118047751881437,7.46374962470055e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",29390,-0.0386035419857619,0.0071814739231108,-0.0526792308750591,-0.0245278530964648,7.69800155117249e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,24863,-0.0124178227608048,0.00231106350293518,-0.0169475072265577,-0.00788813829505183,7.80439819977319e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,29561,-0.00777321902477727,0.00144677141302405,-0.0106088909943044,-0.00493754705525013,7.81074062006182e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,29720,-0.0137885354629189,0.0025667764499684,-0.018819417304857,-0.00875765362098088,7.8484778024952e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,24946,-0.0166397978676995,0.00309846535243944,-0.0227127899584808,-0.0105668057769182,7.92932907949643e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,29429,-0.0294212801622945,0.00548877057716456,-0.040179270493537,-0.0186632898310519,8.37237072296983e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24235,-0.0173884744629237,0.00324625066230678,-0.023751125761045,-0.0110258231648024,8.56327519305446e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24235,-0.0115756134933904,0.00216271945786703,-0.0158145436308098,-0.00733668335597104,8.76123198954898e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,24917,0.0208322297349352,0.00389694259621392,0.0131942222463559,0.0284702372235144,9.08163164231007e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,24840,-0.0186379435557115,0.00348667732936786,-0.0254718311212725,-0.0118040559901505,9.0976212354359e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,24863,-0.0170501837340145,0.00319256234551054,-0.0233076059312151,-0.0107927615368138,9.34554229486962e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,28769,-0.0158985681315012,0.00297758909542361,-0.0217346427585314,-0.0100624935044709,9.39564388217492e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,29490,-0.0162981168939864,0.00305589444680429,-0.0222876700097228,-0.01030856377825,9.7133502067452e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,29576,-0.026921750916351,0.00504960030377461,-0.0368189675117493,-0.0170245343209528,9.8139367874026e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,28760,-0.0137953472323353,0.00259064938518736,-0.0188730200273025,-0.0087176744373681,1.01680370533193e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEXN,Nexilin,24946,-0.0239973739542524,0.00451633374529662,-0.0328493880950338,-0.015145359813471,1.08484082374345e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24106,-0.0174035464443485,0.00327735754913928,-0.0238271672406615,-0.0109799256480355,1.10452658587198e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24917,-0.0221360419894907,0.00417077205218416,-0.0303107552117716,-0.0139613287672097,1.12138383264188e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,29344,-0.0431907272537056,0.00813846882791313,-0.0591421261564154,-0.0272393283509959,1.12262440726302e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MME,Neprilysin,29344,0.0279338003429671,0.00526374678075636,0.0176168566526846,0.0382507440332495,1.12358504779377e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,29399,0.00690206901882366,0.00130484128330513,0.0043445801035456,0.00945955793410173,1.23470786098528e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,24190,-0.0212450998209134,0.00401763641311087,-0.0291196671906107,-0.013370532451216,1.24762605617082e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,29429,-0.0108226757537312,0.00204854314439578,-0.0148378203167469,-0.00680753119071544,1.2791310032121e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,24800,-0.0138571053031179,0.00262309537567732,-0.0189983722394454,-0.00871583836679031,1.28346868409289e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,24796,-0.013287345410012,0.00251651277169001,-0.0182197104425244,-0.00835498037749957,1.30227578522869e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,24863,-0.0250062632209021,0.00473615782892308,-0.0342891325655913,-0.0157233938762128,1.30366728599431e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,24917,-0.0370834103547915,0.00702533667806557,-0.0508530702438,-0.023313750465783,1.31318933131595e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24440,-0.0131838037762571,0.00250106601243095,-0.0180858931606218,-0.00828171439189249,1.36630761081607e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,29429,-0.0220038167158381,0.00417874087359266,-0.0301941488280797,-0.0138134846035964,1.40669244574159e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,29429,-0.0164748159231365,0.00313063198971938,-0.0226108546229865,-0.0103387772232865,1.43138335603875e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,24750,-0.0303988465788281,0.00577809622102723,-0.0417239151720415,-0.0190737779856148,1.44428088627803e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,24946,-0.0077681082355329,0.00147671429617872,-0.0106624682560432,-0.00487374821502261,1.44928515835928e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPART,Spartin,24376,-0.02668847837284,0.00507738656593367,-0.03664015604207,-0.01673680070361,1.48186774676047e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,24863,-0.0159673816735103,0.00304496004089799,-0.0219355033536704,-0.00999925999335026,1.58527320021367e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24106,-0.023417139871348,0.00446866936802022,-0.0321757318326676,-0.0146585479100284,1.61670496632627e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,29473,-0.0197397492308623,0.0037746821089651,-0.0271381261644339,-0.0123413722972907,1.71116859070678e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBN1,Drebrin,24224,-0.0175823162375731,0.00336451907780281,-0.0241767736300666,-0.0109878588450796,1.74836916518645e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29473,-0.0096217803364494,0.00184164880242793,-0.0132314119892081,-0.00601214868369065,1.75769083476318e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,29429,-0.0222444835977587,0.00427628791194008,-0.0306260079051612,-0.0138629592903561,1.98666566458375e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,29815,-0.00773485360773532,0.00149167668593058,-0.0106585399121593,-0.00481116730331139,2.17026261577143e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,24096,-0.0337327905702963,0.00650882891735237,-0.0464900952483069,-0.0209754858922856,2.20554510425883e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,29381,-0.023052316855266,0.00445498210393466,-0.031784081778978,-0.0143205519315541,2.30020212423148e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,29449,-0.00854899506923244,0.00165371354957633,-0.011790273626402,-0.00530771651206284,2.36160120264554e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,28926,-0.0133824700258306,0.00259269287431011,-0.0184641480594784,-0.00830079199218276,2.46452917923547e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,24840,-0.0254428216012128,0.0049334130408224,-0.0351123111612247,-0.0157733320412009,2.52532865533507e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,29213,-0.0272811421823776,0.00529474418997714,-0.0376588407947328,-0.0169034435700224,2.58714391698352e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',24840,-0.0140639144818622,0.00273098957128565,-0.0194166540415821,-0.00871117492214232,2.62824206020055e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",28769,-0.00934729593157317,0.00181535888670261,-0.0129053993495103,-0.00578919251363605,2.63592768229991e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,24642,-0.0147888054593565,0.00287572672013019,-0.0204252298308117,-0.00915238108790133,2.72988631317677e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28911,-0.0323185602516595,0.00628830190093689,-0.0446436319774959,-0.0199934885258232,2.77301362467704e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,29429,-0.0192124583906898,0.00374213971394037,-0.0265470522300129,-0.0118778645513667,2.8532601299051e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,24800,-0.0345713447513619,0.006734960069307,-0.0477718664872036,-0.0213708230155202,2.87132581704585e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29213,-0.026349556026469,0.00513497560135816,-0.036414108205131,-0.016285003847807,2.89452111559502e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,29213,-0.0194248973309248,0.00378968758567409,-0.026852684998846,-0.0119971096630036,2.9828257957064e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POSTN,Periostin,24933,-0.012707942123913,0.0024817419812661,-0.0175721564071946,-0.0078437278406315,3.0687367480824e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,28792,-0.022584227601648,0.00441177691762772,-0.0312313103601983,-0.0139371448430977,3.09008420729356e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,29344,-0.03012611111521,0.00588828692966844,-0.0416671534973602,-0.0185850687330599,3.1358621719228e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29344,-0.0190523589005796,0.00373213071320708,-0.0263673350984655,-0.0117373827026938,3.32938908099831e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_A,,24863,-0.0109396872388917,0.00214375162673558,-0.0151414404272934,-0.00673793405048995,3.36669959674012e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,29296,-0.0086470860340344,0.00169465358628972,-0.0119686070631622,-0.00532556500490655,3.37165705779525e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,24917,-0.0304817362151645,0.00597842655733535,-0.0421994522675417,-0.0187640201627872,3.44639774880271e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29678,-0.010013323495613,0.00196570164292729,-0.0138660987157505,-0.00616054827547554,3.52695449248919e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24235,0.0122869731809386,0.00241775521915447,0.00754817295139587,0.0170257734104814,3.76305422419441e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,24676,-0.020123657863814,0.00396242325625346,-0.0278900074460708,-0.0123573082815573,3.82946059239225e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,29429,-0.0173411704643076,0.00341518111811307,-0.0240349254558092,-0.010647415472806,3.84416440002738e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28792,-0.0169633321519066,0.0033415935799829,-0.0235128555686731,-0.0104138087351401,3.87007389967422e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,29473,-0.0425425174228901,0.00838483270187075,-0.0589767895185567,-0.0261082453272234,3.924255259663e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24917,-0.0255581312858935,0.00504273529637273,-0.0354418924667841,-0.015674370105003,4.0424041279412e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,24190,-0.0162388186426955,0.00320511307376788,-0.0225208402672806,-0.00995679701811047,4.08102804732439e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,24106,-0.0199913286749864,0.00394657395100265,-0.0277266136189516,-0.0122560437310212,4.1035808290967e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,24917,-0.0247663527816117,0.00489192865305674,-0.0343545329416029,-0.0151781726216205,4.16310631098422e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,24788,-0.0269290947079964,0.00533408464116871,-0.0373839006046871,-0.0164742888113057,4.48460040604615e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,24788,-0.0369801155718517,0.00732745241915399,-0.0513419223133936,-0.0226183088303099,4.52471932650374e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,29395,-0.029070892869396,0.00576108128835557,-0.0403626121945729,-0.0177791735442191,4.53647005391898e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,29429,-0.0179330130318415,0.00355887748245024,-0.024908412897444,-0.010957613166239,4.708581471615e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,29438,-0.0189936702799066,0.00377136491708079,-0.026385545517385,-0.0116017950424283,4.77455262454825e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,29187,-0.0157669649561036,0.00313149831941992,-0.0219047016621666,-0.00962922825004057,4.80795293513438e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,29576,-0.0288747164103201,0.00573613297272737,-0.0401175370368657,-0.0176318957837744,4.83597121735425e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24788,-0.0179065982822429,0.00355823146655711,-0.0248807319566949,-0.010932464607791,4.87655422598101e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,29689,-0.00878864452664687,0.00175142489319085,-0.0122214373173009,-0.00535585173599281,5.25144642053191e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,29784,-0.018943169218512,0.00377541074669538,-0.026342974282035,-0.0115433641549891,5.26459999693352e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,24840,-0.0327242957481811,0.00652213505056328,-0.0455076804472851,-0.019940911049077,5.2731171050836e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,29781,-0.0208270478061899,0.00415115371930646,-0.0289633090960306,-0.0126907865163492,5.27394971727952e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,29657,-0.0133966944314089,0.00267247042200288,-0.0186347364585345,-0.00815865240428322,5.39382971302554e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,24788,-0.0168577160127986,0.00336333495787703,-0.0234498525302375,-0.0102655794953596,5.41811278261219e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,29585,-0.0135159554817227,0.00269862593901384,-0.0188052623221898,-0.00822664864125557,5.51832924068876e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,29576,-0.0303131188069069,0.00605745601348025,-0.0421857325933282,-0.0184405050204856,5.63969285686849e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,29213,-0.032858685469303,0.00658660733171985,-0.0457684358394739,-0.0199489350991321,6.1131908498699e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29449,-0.00966915519501564,0.00193897219325591,-0.0134695406937972,-0.00586876969623406,6.17546519816209e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLG,Plasminogen,24416,-0.00721816247974528,0.00145123110328967,-0.010062575442193,-0.00437374951729753,6.60918119453351e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,28792,-0.0142281344305827,0.00286264073219712,-0.019838910265689,-0.00861735859547634,6.72388409703904e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,29689,-0.0075896549554231,0.00152878646812037,-0.010586076432939,-0.00459323347790718,6.92610528356289e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,28792,-0.0150236718678852,0.00302746828908977,-0.0209575097145012,-0.0090898340212693,7.00050311124284e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29576,-0.00876527807639399,0.00176683033211751,-0.0122282655273443,-0.00530229062544368,7.05133159699781e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,29492,-0.0106893063680779,0.00215486030344728,-0.0149128325628345,-0.0064657801733212,7.06822233453098e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,24106,-0.0216656633352323,0.00437044463159048,-0.0302317348131497,-0.013099591857315,7.19598041340865e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29429,-0.0198304643040565,0.0040049317441485,-0.0276801305225875,-0.0119807980855254,7.40467203945354e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,24224,-0.00857108643143916,0.00173150597008175,-0.0119648381327994,-0.00517733473007893,7.46826917525091e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,28666,-0.0154084513741848,0.00311479300839177,-0.0215134456706326,-0.00930345707773689,7.58461398913318e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,28599,-0.0226545174410406,0.00458334189497726,-0.031637867555196,-0.0136711673268852,7.74460220825872e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28792,-0.0163913462750895,0.00331790405067223,-0.0228944382144071,-0.00988825433577193,7.84511811394936e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,29781,-0.030485767931192,0.00617732107784956,-0.0425933172437771,-0.0183782186186068,8.05372781774927e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,29669,-0.0185672528701556,0.00376382189385566,-0.0259443437821127,-0.0111901619581985,8.13787006860878e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,29438,0.0130096062279775,0.00263742175911697,0.00784025958010829,0.0181789528758468,8.1543236292879e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,24190,-0.017474056302487,0.00354731199590153,-0.024426787814454,-0.01052132479052,8.4484274791873e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,29781,-0.0160179718206317,0.00325254612643549,-0.0223929622284453,-0.00964298141281814,8.49210367175841e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,28926,-0.0177963602156662,0.00361968283176828,-0.0248909385659321,-0.0107017818654004,8.85639760341931e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29429,-0.0309310790771904,0.00629159736375919,-0.0432626099101584,-0.0185995482442224,8.86914436115506e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24376,-0.0221055458589372,0.00449890774873921,-0.030923405046466,-0.0132876866714084,9.00283910033735e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,29561,-0.0293938108841721,0.00598564715005413,-0.0411256792982782,-0.017661942470066,9.12286075540129e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPSE,Heparanase,24683,-0.0301488187762613,0.00614564672141971,-0.0421942863502439,-0.0181033512022786,9.36780535532041e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29561,-0.00867549548159019,0.00176912686880608,-0.0121429841444501,-0.00520800681873028,9.44849328273219e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,29689,-0.0210353760243778,0.00429186267218902,-0.0294474268618682,-0.0126233251868873,9.574388975654e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29599,-0.0185998063084844,0.00379548456517793,-0.0260389560562331,-0.0111606565607356,9.60937717338033e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,24440,-0.0236123949874723,0.00483046344600785,-0.0330801033416477,-0.014144686633297,1.02394115294542e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,28792,-0.0126446594322714,0.00258964151170334,-0.0177203567952099,-0.00756896206933284,1.05158924670071e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,24828,-0.0082448625005126,0.00169371372852229,-0.0115645414084163,-0.00492518359260891,1.13471838212503e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,29473,-0.018203092318676,0.00373971118428538,-0.0255329262398754,-0.0108732583974767,1.13595764833907e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,28769,-0.0197653855872284,0.00406121636972567,-0.0277253696718907,-0.0118054015025661,1.13983586124183e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,24788,-0.0142945737628119,0.0029375817980088,-0.0200522340869091,-0.00853691343871461,1.14519824424206e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,24235,-0.0179969615115975,0.00369954246761307,-0.0252480647481191,-0.0107458582750759,1.15382015915498e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,24376,-0.0117732322762403,0.00242288346580919,-0.0165220838692263,-0.00702438068325429,1.18603985717425e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OCLN,Occludin,24863,-0.0139618583182535,0.00287672718629615,-0.019600243603394,-0.00832347303311309,1.22108989739711e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29531,-0.0283584193029368,0.00584405012177228,-0.0398127575416104,-0.0169040810642631,1.22518864711201e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,29349,-0.0283464191831005,0.00584166473796395,-0.0397960820695099,-0.0168967562966912,1.22567659765079e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,28911,-0.0165696543894453,0.00341588281550707,-0.0232647847078392,-0.00987452407105148,1.23624139807613e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28792,-0.0214545348066929,0.00442471775245599,-0.0301269816015066,-0.0127820880118791,1.24863506211126e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,29430,-0.0125874474756056,0.00259798300982723,-0.017679494174867,-0.00749540077634427,1.27201456685332e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29781,-0.0123304643439794,0.00254645259109213,-0.0173215114225199,-0.00733941726543878,1.29045300578572e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,29473,-0.0214243307674629,0.00443282103445047,-0.0301126599949858,-0.01273600153994,1.35089750822757e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,24788,-0.0129356140767691,0.00267929115217257,-0.0181870247350273,-0.00768420341851082,1.38733971049839e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,24449,-0.00794510458748221,0.00164747373389293,-0.0111741531059124,-0.00471605606905206,1.42552494649223e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,29344,-0.0333263689266086,0.00693499981870697,-0.0469189685712743,-0.0197337692819429,1.55102797871896e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24917,-0.0125986829265373,0.00262406837224937,-0.0177418569361461,-0.00745550891692856,1.58631136640011e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24863,-0.0208310210274835,0.00433904530788636,-0.0293355498309408,-0.0123264922240263,1.58927640577766e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,24376,0.0293940187875052,0.00613183517013736,0.017375621854036,0.0414124157209744,1.64719883986836e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28792,-0.0259098134542128,0.00541028272307753,-0.0365139675914448,-0.0153056593169809,1.68452453579439e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,29429,-0.011071915869233,0.00231293370621274,-0.0156052659334099,-0.006538565805056,1.70150633557927e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,24840,-0.0118643920456059,0.0024790264831188,-0.0167232839525187,-0.00700550013869303,1.71194981390515e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24800,-0.0221042455728121,0.0046196345840861,-0.0311587293576209,-0.0130497617880034,1.72102144200089e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,29449,-0.0124140057782561,0.00259888993112813,-0.0175078300432672,-0.00732018151324494,1.79091058098908e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,29473,-0.00888638867533646,0.00186044124142112,-0.0125328535085219,-0.00523992384215106,1.79234329423237e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,28842,-0.0278693328649572,0.00585094354221477,-0.0393371822076981,-0.0164014835222162,1.91453719043104e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,29689,-0.00676113788489901,0.00142015876583634,-0.00954464906593824,-0.00397762670385978,1.93704620232004e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,24376,-0.0167202115583732,0.00351544721396164,-0.0236104880977381,-0.00982993501900842,1.98388011636256e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24917,-0.027531359543509,0.00579764202317562,-0.0388947379089332,-0.0161679811780848,2.05850161614305e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29213,-0.0292453772297127,0.00617173313940388,-0.0413419741829443,-0.0171487802764811,2.16211635191911e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,28792,-0.0196488785394756,0.00414679367685884,-0.0277765941461189,-0.0115211629328322,2.16514503945089e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,28728,-0.00891855091181167,0.0018824349041795,-0.0126081233240035,-0.00522897849961985,2.17111621479058e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24735,-0.0338354005553342,0.00714149451289013,-0.0478327298005989,-0.0198380713100696,2.17186703640692e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,24235,-0.0177481091556771,0.00375619783568633,-0.0251102569136223,-0.0103859613977319,2.31383836628112e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29457,-0.0179764830432781,0.00381140735811435,-0.0254468414651823,-0.010506124621374,2.41041790688411e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,24106,-0.0101156232909794,0.00214471398048945,-0.0143192626927387,-0.00591198388922004,2.41236289825179e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,29589,-0.00919520957626469,0.00195331350161304,-0.0130237040394263,-0.00536671511310312,2.51917387954371e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29213,-0.0322900636712545,0.00686135910426868,-0.0457383275156211,-0.0188417998268878,2.5368968118061e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,28792,-0.0149159141180245,0.00317184263760802,-0.0211327256877362,-0.00869910254831278,2.58057099873124e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,29074,-0.0117416038190342,0.00249751539606805,-0.0166367339953276,-0.00684647364274084,2.59677949347629e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,29561,-0.0130482132453436,0.00277557573700973,-0.0184883416898826,-0.0076080848008045,2.59951360493208e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,24946,-0.0444526481828019,0.00946928002303952,-0.0630124370279593,-0.0258928593376444,2.68803318412904e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,29486,-0.0325178059205474,0.00694867332478202,-0.0461372056371201,-0.0188984062039746,2.88550820811912e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,29344,0.0109496602238268,0.00234052269310906,0.00636223574533307,0.0155370847023206,2.90556844607954e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,28911,-0.0100686744805045,0.00215419280361992,-0.0142908923755995,-0.00584645658540941,2.96736329911186e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,29689,-0.0204126838535343,0.00436991903471017,-0.0289777251615663,-0.0118476425455024,3.00784234211685e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,24800,-0.0106538330594447,0.00228126295800927,-0.0151251084571429,-0.00618255766174654,3.02562008162732e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,29473,-0.026463202695141,0.00567884602808344,-0.0375937409101845,-0.0153326644800974,3.17651445589102e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',24106,-0.0131558700291194,0.00282518258285601,-0.0186932278915171,-0.00761851216672157,3.23119229962563e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,24106,-0.0208611472982106,0.00448568735791129,-0.0296530945197167,-0.0120692000767044,3.32723465466207e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,29634,0.00775165682487002,0.0016691595943269,0.00448010401998929,0.0110232096297508,3.43114595657671e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24440,-0.0322100813488639,0.00694113085269006,-0.0458146978201364,-0.0186054648775914,3.49428593259111e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,28792,-0.0123415702255353,0.00266056304913527,-0.0175562738018405,-0.0071268666492302,3.52138761017818e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",29473,-0.0238183098712201,0.00515113900037079,-0.0339145423119468,-0.0137220774304933,3.78204138417869e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24440,-0.0150226680950874,0.00324958174630668,-0.0213918483178485,-0.00865348787232628,3.8024806827069e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,24933,-0.0123433825890413,0.00267236229516247,-0.0175812126875597,-0.00710555249052282,3.87701504739293e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,29561,-0.00992699829695728,0.00215041762065552,-0.0141418168334421,-0.00571217976047246,3.92261957892777e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,24840,-0.0176075502477555,0.00381559044086833,-0.0250861075118575,-0.0101289929836536,3.95758260139613e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,24863,-0.0115906300244746,0.00251304759529344,-0.0165162033112497,-0.00666505673769942,4.00451571357611e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28782,-0.0236910221258401,0.0051569207218164,-0.0337985867406002,-0.0135834575110799,4.36620218353668e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,24917,-0.0142972395383515,0.00311567421531746,-0.0204039610003737,-0.0081905180763293,4.47951824007071e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,29344,-0.00611935221086057,0.00133377005867583,-0.00873354152586521,-0.00350516289585593,4.49339110158329e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,29473,-0.00774068510527052,0.00168996182461664,-0.0110530102815191,-0.00442835992902191,4.66007567565296e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,24224,-0.00887982748782431,0.00194015870007964,-0.0126825385399804,-0.00507711643566821,4.74359530946805e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24235,-0.00843408491446882,0.00184290191279758,-0.0120461726635521,-0.00482199716538556,4.75111378079479e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,24106,-0.0110586759165251,0.00241937462779495,-0.0158006501870032,-0.00631670164604698,4.88087268795064e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,24190,-0.0207050849674153,0.00453445230880052,-0.0295926114926643,-0.0118175584421663,4.99161493563037e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,29390,-0.0120596864491574,0.00264318875092262,-0.0172403364009657,-0.00687903649734904,5.07398262609716e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,24376,-0.0251905557159308,0.00552278201837344,-0.0360152084719428,-0.0143659029599189,5.11079574167455e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,24840,-0.0211702368631904,0.00464470001979604,-0.0302738489019906,-0.0120666248243901,5.190543734197e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,29484,0.0240758996994101,0.00528688661608326,0.0137136019318869,0.0344381974669333,5.28735818592528e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",24933,-0.0124644506311358,0.00273904934550191,-0.0178329873483196,-0.00709591391395207,5.37332278065305e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,29815,-0.00896815428661013,0.0019731748358182,-0.0128355769648138,-0.00510073160840645,5.51410403097065e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,29525,0.0146529693598549,0.00322787073028975,0.00832634272848696,0.0209795959912228,5.66061413569309e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,29429,-0.0182071432633861,0.00402710687292509,-0.0261002727343192,-0.0103140137924529,6.17451451438887e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,24800,-0.0141832173633641,0.00313913325724283,-0.0203359185475601,-0.00803051617916818,6.26568224236398e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,29815,-0.0116883059422334,0.00258758925198808,-0.0167599808761301,-0.00661663100833678,6.29434261879753e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,24917,-0.00955387455070655,0.00211797173979517,-0.0137050991607051,-0.00540264994070802,6.48600397734458e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,24224,-0.0083896011303607,0.00186095584436933,-0.0120370745853246,-0.00474212767539681,6.56796657523296e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,24840,-0.0247680331750601,0.00549977037962528,-0.0355475831191257,-0.0139884832309946,6.71580958585393e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24800,-0.0190391727167289,0.00423342068540698,-0.0273366772601266,-0.0107416681733313,6.91178412540309e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,24840,-0.0065702771204824,0.00146110325275576,-0.0094340394958837,-0.00370651474508111,6.92986800260848e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,24799,0.025070773784485,0.00557542770436323,0.014142935483933,0.0359986120850369,6.93438047726596e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,24788,-0.0106119863434075,0.00236180366697677,-0.015241121530682,-0.00598285115613307,7.04878332988887e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,24800,-0.00754601917795262,0.00167957584446389,-0.0108379878331018,-0.00425405052280339,7.06062266374093e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,24096,-0.0160914158473744,0.0035838328843245,-0.0231157283006505,-0.0090671033940984,7.15529700735121e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,29473,-0.0358179295752876,0.00797802175243128,-0.0514548522100529,-0.0201810069405222,7.16357380998964e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,29344,-0.0404081937393627,0.00900977785974225,-0.0580673583444575,-0.0227490291342678,7.32154966663504e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,24190,-0.0237893237671468,0.00532115628129406,-0.0342187900784832,-0.0133598574558104,7.83162469329629e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,24106,-0.0195564782957608,0.00437496233490521,-0.028131404472175,-0.0109815521193465,7.85428514037671e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",29561,-0.0179030175450816,0.00401176693284044,-0.0257660807334489,-0.0100399543567143,8.12599950558833e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,29576,-0.0118810250937253,0.0026632373266823,-0.0171009702540226,-0.00666107993342797,8.18323445006562e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24800,0.00882820316702319,0.00197888077312617,0.0049495968516959,0.0127068094823505,8.18564289898607e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,28926,-0.0143437317136182,0.00321824260969126,-0.0206514872286131,-0.00803597619862333,8.34237471575249e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,28792,-0.0175134996630122,0.00393007435399786,-0.025216445396848,-0.00981055392917638,8.37097025721261e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,24190,-0.0199346911608042,0.00447594044257539,-0.028707534428252,-0.0111618478933564,8.4763844992123e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,24235,-0.0268115180756949,0.0060280841159998,-0.0386265629430545,-0.0149964732083353,8.71532120928188e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,29473,0.0115551965448997,0.00260050401272039,0.00645820867996774,0.0166521844098317,8.88522587805104e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,23901,-0.0155301614997062,0.00350216132488583,-0.0223943976964824,-0.00866592530292994,9.2718947644764e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,29720,-0.00856667407894734,0.00193276845005021,-0.0123549002410457,-0.00477844791684894,9.35522462855568e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29213,-0.0128006874663304,0.0028883623642897,-0.0184618777003383,-0.00713949723232264,9.37831710994159e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARTN,Artemin,28926,-0.0130203931829497,0.00294092972176453,-0.0187846154376082,-0.00725617092829121,9.57669569385964e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,29473,-0.013076366827026,0.00295388382932841,-0.0188659791325097,-0.00728675452154231,9.59675951390968e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,29790,-0.00982195640611272,0.00222060886577379,-0.0141743497830293,-0.00546956302919609,9.76429847413346e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,27437,0.0118021252344296,0.00267228084379589,0.00656445478058967,0.0170397956882696,1.00695956699362e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,29720,0.0110486282686869,0.0025018073941169,0.0061450857762178,0.015952170761156,1.0077828453292e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NADK,NAD kinase,29473,-0.0156657927070458,0.00354808013043905,-0.0226200297627064,-0.0087115556513853,1.01234584331414e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,28911,0.0387837756511249,0.008800976427019,0.0215338618541677,0.0560336894480822,1.0530665098289e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,29213,-0.0278649756658841,0.00632685898571926,-0.0402656192778938,-0.0154643320538743,1.06534784395831e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,24840,-0.0133909764258052,0.00304430271378434,-0.0193578097448225,-0.00742414310678792,1.09353820900062e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,29576,-0.00837320568364086,0.00190437076523876,-0.0121057723835088,-0.00464063898377289,1.10223266087251e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28714,-0.0138244624256329,0.00314664206148641,-0.0199918808661463,-0.00765704398511959,1.11990216774834e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29531,-0.0147002228323318,0.00334710215518096,-0.0212605430564865,-0.0081399026081771,1.12741878049193e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,24800,-0.0252099452795392,0.0057415320144656,-0.0364633480278918,-0.0139565425311866,1.13399209580666e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,24224,-0.0228717082885173,0.00521615844479798,-0.0330953788403214,-0.0126480377367133,1.16592163616864e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24235,-0.0293553656181279,0.00669490266570817,-0.0424773748429159,-0.0162333563933399,1.16616807975108e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,28769,-0.0106629246174602,0.00243210739880689,-0.0154298551191217,-0.00589599411579867,1.16807968045494e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,29158,-0.0183185575498137,0.00418491273530127,-0.0265209865110042,-0.0101161285886232,1.20584325996221e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,24235,-0.0274358576829266,0.00626909966906838,-0.0397232930343006,-0.0151484223315526,1.21180350042413e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,24224,-0.0258569827376707,0.00590907506953014,-0.0374387698739498,-0.0142751956013917,1.21488828211735e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,29560,-0.0110724642822024,0.00253265880293043,-0.016036475535946,-0.00610845302845872,1.23605240619171e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24376,-0.0166614324103277,0.00381113498123182,-0.024131256973542,-0.00919160784711329,1.23749557515998e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,28769,-0.0192171945873221,0.00439808820711971,-0.0278374474732767,-0.0105969417013675,1.24999914456434e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,24747,-0.0124443162401552,0.00284892884271383,-0.0180282167718743,-0.00686041570843611,1.25859702765137e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,24224,-0.0107268716033124,0.0024567178687566,-0.0155420386260753,-0.00591170458054943,1.26868185253811e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,28792,-0.0212975320692702,0.00487808813595509,-0.0308585848157422,-0.0117364793227982,1.27007532215759e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,24800,-0.0243885085485893,0.00558603183769552,-0.0353371309504725,-0.013439886146706,1.27065867854296e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRNN,Cornulin,28575,-0.0191662541387808,0.00439064275996612,-0.0277719139483143,-0.0105605943292472,1.27423089890276e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,24190,-0.0374484559033637,0.00859432181828448,-0.0542933266672013,-0.0206035851395261,1.32189847071137e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,28717,-0.0153319883008933,0.00352480168320096,-0.0222405995999672,-0.00842337700181947,1.36765628084539e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,29669,-0.00882162337675589,0.00202926057974386,-0.0127989741130539,-0.00484427264045792,1.38338557559457e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD248,Endosialin,24933,-0.0114447281287067,0.00263461663228224,-0.0166085767279798,-0.00628087952943349,1.4047544661841e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,29561,-0.0238110872233982,0.00548291797873093,-0.0345576064617108,-0.0130645679850856,1.41161333756197e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,29589,-0.0094654649570626,0.00218139890124523,-0.0137410068035033,-0.00518992311062194,1.43494438168473e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,28926,-0.0107343940977233,0.00247443744540541,-0.0155842914907179,-0.00588449670472868,1.44196608985851e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,28792,0.0146704623175615,0.00339296828423154,0.00802024448046767,0.0213206801546553,1.53890624935062e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,24946,-0.00629922512464837,0.00145699096040929,-0.00915492740705058,-0.00344352284224616,1.54204677659993e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,28911,-0.0138544152898347,0.0032133339312662,-0.0201525497951165,-0.00755628078455297,1.62658525186919e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,29344,-0.0158715188608282,0.00368127933184012,-0.0230868263512349,-0.0086562113704216,1.62742772065856e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,24800,-0.00733970793960867,0.00170697373503738,-0.0106853764602819,-0.00399403941893541,1.71576971399737e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,24224,-0.0151004010656889,0.00351855638141409,-0.0219967715732605,-0.00820403055811723,1.78041388927618e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,28926,-0.0223541306172617,0.00521840333138193,-0.0325822011467702,-0.0121260600877531,1.84394917739766e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,28926,-0.0185535421583975,0.00433445192903434,-0.0270490679393048,-0.0100580163774902,1.87089278742616e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29213,-0.0109115466562408,0.00255248380898813,-0.0159144149218576,-0.0059086783906241,1.9185168941565e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,24800,-0.0140818293499667,0.00330176485330317,-0.0205532884624409,-0.00761037023749254,2.0069612531258e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,28911,-0.0185204062402139,0.00434425877004786,-0.0270351534295077,-0.0100056590509201,2.02166679803126e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTG,Protogenin,29720,0.0069694892664417,0.00163550266918926,0.00376390403483076,0.0101750744980526,2.03798978156087e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",29213,-0.0162649857883251,0.00381915227940522,-0.0237505242559594,-0.00877944732069087,2.06174311590178e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,29815,-0.0155438477772097,0.00365119824433302,-0.0227001963361024,-0.00838749921831695,2.07644514589216e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,28769,-0.0220301319171125,0.00518001561756372,-0.0321829625275374,-0.0118773013066876,2.11677963938956e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28769,-0.0312127695479337,0.00734269583354534,-0.0456044533816825,-0.0168210857141848,2.13622516341091e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,28792,-0.0155700237044095,0.00366373461822064,-0.022750943556122,-0.00838910385269709,2.14664654168284e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,24424,-0.0122437071029576,0.00288152715986081,-0.0178915003362848,-0.00659591386963039,2.15489960111837e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,24523,-0.00781772645886174,0.00184012608526389,-0.011424373585979,-0.00421107933174451,2.16026406020992e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,29213,-0.0170078203369769,0.00400456942374197,-0.0248567764075111,-0.00915886426644262,2.17221693610118e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,24096,-0.0308847281422058,0.00728054769007282,-0.0451546016147486,-0.0166148546696631,2.22276017499775e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,24917,-0.00702926774664997,0.00165757719022528,-0.0102781190394915,-0.00378041645380843,2.23639134464231e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29344,-0.00549246492726998,0.00129735507266054,-0.00803528086968464,-0.00294964898485532,2.3069313345595e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,28792,-0.0131656761369215,0.00311250864550893,-0.019266193082119,-0.00706515919172397,2.34492132622126e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,24224,-0.00565492573052361,0.00133806505053513,-0.00827753322957247,-0.00303231823147474,2.38544645089266e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24440,-0.0312056391424093,0.00739327508534657,-0.0456964583096886,-0.01671481997513,2.44300675863858e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,29213,-0.013119026373589,0.00310999025396117,-0.0192146072713529,-0.00702344547582513,2.46838518735093e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,29213,-0.0187426332575825,0.00444842329283333,-0.0274615429115359,-0.0100237236036292,2.52398368611489e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,29781,-0.00960753710795169,0.00228297994961582,-0.0140821778091987,-0.00513289640670468,2.58016468808291e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,28792,-0.00986833433085458,0.00234813437179577,-0.0144706776995743,-0.00526599096213487,2.64629691301545e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,24917,0.0251764019470732,0.00599164675314115,0.0134327743109166,0.0369200295832299,2.65585716791928e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,24759,-0.0112750177785407,0.00268570152694408,-0.0165389927713511,-0.00601104278573031,2.70026357032692e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,29296,-0.0183265330888876,0.00436670852185627,-0.0268852817917259,-0.00976778438604932,2.71419801172122e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,29720,-0.0122756161470168,0.002928956248417,-0.0180163703939141,-0.0065348619001195,2.78379118632925e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24840,0.0236950158055203,0.0056575010126094,0.0126063138208059,0.0347837177902347,2.82086230790864e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,24788,0.0108409619815393,0.00258933470095303,0.00576586596767136,0.0159160579954072,2.83922699605236e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29522,-0.0157271102694154,0.00375754647523549,-0.023091901360877,-0.00836231917795387,2.8539617979882e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,29344,0.0235243558678952,0.00564321404771562,0.0124636563343726,0.0345850554014178,3.07342223356888e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,29720,-0.0105071477873478,0.0025214608638827,-0.0154492110805578,-0.00556508449413765,3.09388445506601e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,24840,0.0114694557264854,0.00275285663342259,0.00607385672497713,0.0168650547279937,3.10516709630295e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,29473,-0.00482091846657265,0.00115748138841893,-0.00708958198787376,-0.00255225494527154,3.12228463062598e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24800,-0.0138302701200401,0.00332166856174034,-0.0203407405010511,-0.00731979973902901,3.14256207337077e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,29781,-0.0212097647513806,0.00509611068485401,-0.0311981416936945,-0.0112213878090668,3.16425649430563e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,24338,0.01573939668338,0.00378808407686938,0.00831475189271603,0.023164041474044,3.26433444604298e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,28769,-0.0167398881009667,0.00402926891180867,-0.0246372551681117,-0.00884252103382174,3.26837900386155e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24235,-0.017069553909798,0.00411275562170896,-0.0251305549283476,-0.00900855289124844,3.33037917377559e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,29692,-0.00722351150394404,0.00174104353170853,-0.0106359568260928,-0.00381106618179533,3.34925839565085e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,24440,-0.00952661702749647,0.00229664738647578,-0.014028045904989,-0.00502518815000394,3.36446769855039e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24800,-0.012806992076991,0.00308783407009167,-0.0188591468543707,-0.00675483729961133,3.37148926835344e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24376,-0.0114620501318646,0.0027659671921916,-0.0168833458285601,-0.00604075443516903,3.42515597697315e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,28911,-0.016509669158503,0.00400265678012417,-0.0243548764475464,-0.00866446186945966,3.72292091732899e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,24541,-0.00925542096948669,0.00224471017783191,-0.0136550529180372,-0.00485578902093615,3.74850990144908e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,29429,-0.0151151492231912,0.0036698139832573,-0.0223079846303755,-0.00792231381600692,3.81927121188757e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29429,-0.0269679220071178,0.00654937618136064,-0.0398046993225846,-0.0141311446916509,3.83829406434093e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,29429,-0.0182937146874376,0.00444781626779289,-0.0270114345723116,-0.00957599480256352,3.91669997027819e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGRN,Neugrin,24840,-0.00596980850446869,0.00145180566439183,-0.00881534760667668,-0.00312426940226069,3.93527207685181e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,24788,-0.0186833361992464,0.00454550603430277,-0.0275925280264799,-0.00977414437201299,3.96438687726865e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,24800,0.0305131402649444,0.00742588278020435,0.0159584100157439,0.045067870514145,3.98609125911959e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,28926,-0.0306918814079156,0.00747008990327406,-0.0453332576183328,-0.0160505051974985,3.99098222876065e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,24440,-0.0151470452393516,0.0036878635244278,-0.0223752577472301,-0.00791883273147307,4.0166912770318e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,28717,-0.0243471371826421,0.00593153691718567,-0.035972949540326,-0.0127213248249582,4.05970986504268e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,24863,-0.0318127962973815,0.00775376405490789,-0.047010173845001,-0.0166154187497621,4.09331663030052e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,29429,-0.0162448276296308,0.00395982122445079,-0.0240060772295544,-0.00848357802970727,4.099610835492e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24863,-0.0262113102263789,0.00639025803883229,-0.0387362159824902,-0.0136864044702676,4.11323132295644e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,29378,-0.00777295379186167,0.0018954624943208,-0.0114880602807304,-0.0040578473029929,4.12793461948423e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,29627,-0.0159753215249261,0.00389643083321478,-0.0236123259580271,-0.00833831709182517,4.14272335570492e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,24235,-0.0164402458015413,0.00401262110624209,-0.0243049831697758,-0.00857550843330684,4.1965731043058e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,29727,-0.0185198634302188,0.00452312248467026,-0.0273851835001725,-0.00965454336026508,4.24223872110815e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,29429,-0.0150404063814344,0.00367390360278149,-0.0222412574428861,-0.00783955531998269,4.25403160728398e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI3,Elafin,29009,-0.0147309098397131,0.00361216560825527,-0.0218107544318935,-0.00765106524753282,4.55189609311678e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29429,-0.0245036038548915,0.00601116388664175,-0.0362854850727094,-0.0127217226370737,4.58684087771685e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,29781,-0.0179957591517019,0.00441581783547168,-0.0266507621092264,-0.00934075619417736,4.60752379570608e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,29678,-0.0168165072688939,0.00412684581623559,-0.0249051250687156,-0.00872788946907211,4.61527133838103e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,24800,-0.00755990732432859,0.00185744394941004,-0.0112004974651723,-0.00391931718348491,4.71467819703117e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,29213,-0.0112586995454789,0.00276914895727493,-0.0166862315017378,-0.00583116758922009,4.8001259987217e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,29473,-0.00961454266666871,0.00236841865318861,-0.0142566432269184,-0.00497244210641903,4.93095520849667e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,29689,-0.0173902991409254,0.00428626394080811,-0.0257913764649093,-0.00898922181694153,4.9788100899272e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24800,-0.0202778955675054,0.00500253697947509,-0.0300828680472766,-0.0104729230877343,5.06061112926889e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,24800,-0.0178600272657558,0.00442371444514903,-0.0265305075782479,-0.00918954695326373,5.42237829979514e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOC,Myocilin,29438,-0.0120931617988514,0.00299572656554186,-0.0179647858673135,-0.0062215377303894,5.43213138772537e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,24376,0.0106687243420423,0.00264463936148476,0.00548523119353214,0.0158522174905524,5.49804103569529e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,24224,-0.0168929093392833,0.00418970528487011,-0.0251047316976287,-0.00868108698093783,5.54725025897058e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,24190,-0.013014151680629,0.00322784465449078,-0.019340727203431,-0.00668757615782711,5.55116074859552e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,29689,-0.0123509356701036,0.00306486788337419,-0.018358076721517,-0.00634379461869019,5.59532654872676e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,24788,-0.013952841992091,0.00346419115860012,-0.0207426566629472,-0.00716302732123473,5.64847088729804e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,24800,-0.0146406668920069,0.00364099002677825,-0.0217770073444923,-0.0075043264395215,5.81064457924184e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,28769,-0.0161397544511429,0.00401555624391911,-0.0240102446892244,-0.00826926421306144,5.85181387620646e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,24376,-0.0218427169697866,0.00544540767830206,-0.0325157160192586,-0.0111697179203146,6.05865223848727e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,29158,-0.00619834759622804,0.00154690907248374,-0.00923028937829617,-0.00316640581415992,6.16673148885314e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,24840,-0.0178131486564049,0.00445053623558005,-0.0265361996781418,-0.00909009763466795,6.28659612764751e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,29678,-0.015140515224825,0.00378323657139041,-0.0225556589047502,-0.00772537154489979,6.2961645852144e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24863,-0.0175552481620749,0.00439515447291385,-0.026169750928986,-0.00894074539516371,6.50922410928475e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,29291,-0.00809049654566489,0.00202566155356739,-0.012060793190657,-0.0041201999006728,6.51259222877921e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24235,-0.0110423197276851,0.00276622245597783,-0.0164641157414017,-0.0056205237139686,6.57555274623261e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,24096,-0.0103882741553164,0.00260808122884581,-0.0155001133638542,-0.00527643494677862,6.82191647856431e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,29164,-0.0119725513913777,0.00300964076360854,-0.0178714472880504,-0.00607365549470493,6.96457486152369e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,24235,-0.00832234381314194,0.00209317765096965,-0.0124249720090425,-0.00421971561724142,7.03059222863913e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,24106,-0.0103445207614063,0.0026026814061821,-0.0154457763175232,-0.00524326520528941,7.0714082905846e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,28911,-0.0150187867912536,0.00377941654695848,-0.0224264432232923,-0.00761113035921502,7.08955050314164e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,24106,-0.0100144073233916,0.00252260579804992,-0.0149587146875695,-0.00507009995921377,7.21216131870341e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,29430,0.0117348644363339,0.00295771497525158,0.00593774308484081,0.017531985787827,7.27891905772653e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,29429,-0.0199583132572825,0.00503432107818676,-0.0298255825705286,-0.0100910439440365,7.37392563805794e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29393,-0.006350688778225,0.00160198487443992,-0.00949057913212725,-0.00321079842432276,7.37973161196284e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,24190,-0.0208713286408704,0.00527158733707343,-0.0312036398215343,-0.0105390174602065,7.54128135211133e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28792,-0.0169303522690423,0.00428438709262276,-0.0253277509705829,-0.00853295356750169,7.78028724623077e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,28769,-0.00903335142988246,0.00228722611756836,-0.0135163146203165,-0.00455038823944847,7.85081281323286e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,28769,-0.0101447321406834,0.00257555971110594,-0.015192829174451,-0.00509663510691573,8.20677022069196e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAYN,Layilin,29158,-0.00902167155813774,0.00229287042130395,-0.0135156975838935,-0.00452764553238199,8.35067530524897e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24800,-0.02639635464377,0.00671436902984232,-0.039556517942261,-0.0132361913452791,8.4709154695723e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,24733,-0.00699173615019946,0.00178011775427144,-0.0104807669485715,-0.00350270535182744,8.60014297660237e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29429,-0.025977386004004,0.00661821859249317,-0.0389490944452906,-0.0130056775627174,8.68792013397316e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29213,-0.0144568793114399,0.00368461716685672,-0.0216787289584791,-0.00723502966440074,8.744354843643e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,24440,-0.0174306412204226,0.00444270065188762,-0.0261383344981224,-0.00872294794272289,8.75346838118867e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24096,-0.0158898967847446,0.00405533268643255,-0.0238383488501524,-0.00794144471933675,8.94323095787241e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,28700,-0.0178960538638027,0.00456898012215979,-0.0268512549032359,-0.00894085282436951,8.99176116286118e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24840,-0.010428886539375,0.00266356549707666,-0.0156494749136453,-0.00520829816510479,9.05008740367869e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,25972,0.00803123806931354,0.00205169965996061,0.00400990673579074,0.0120525694028363,9.08486965139422e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,28926,-0.017201035042896,0.00439492195575856,-0.0258150820761828,-0.00858698800960922,9.104669718921e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,29421,-0.0118996204097449,0.00304095700392668,-0.0178598961374412,-0.00593934468204862,9.13173765105029e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,28717,0.0158192435087735,0.00404341396505417,0.00789415213726729,0.0237443348802796,9.16135215063253e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,24224,-0.00815545579456692,0.0020874892445527,-0.0122469347138902,-0.00406397687524364,9.37707834112585e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,28769,-0.00716423197520177,0.00183453530236706,-0.0107599211678412,-0.00356854278256233,9.43614689650872e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,24440,-0.0192200126725318,0.00492534670829695,-0.0288736922207938,-0.00956633312426978,9.55518555110109e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,28769,-0.0174034579734216,0.00446107557445891,-0.0261471660993611,-0.00865974984748217,9.59427475335529e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,24106,-0.0130291340816466,0.0033436928872896,-0.0195827721407342,-0.00647549602255902,9.78041343197259e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,24235,0.0132832672142344,0.00341161975397263,0.00659649249644808,0.0199700419320208,9.90580372400825e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,28911,-0.0136860814963273,0.00351802112928364,-0.0205814029097232,-0.00679076008293133,0.000100353542370982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,29344,-0.0139525629265466,0.00358699424537604,-0.0209830716474837,-0.0069220542056096,0.000100562838168059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,24235,-0.0299097963646007,0.00769188825089605,-0.044985897336357,-0.0148336953928444,0.000101140769190965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,29689,-0.00922954720550523,0.00237488790799344,-0.0138843275051724,-0.00457476690583808,0.000102001233968162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29344,-0.0195552311238683,0.00503286059353519,-0.0294196378871973,-0.00969082436053931,0.000102339486079303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24863,-0.012077535656344,0.0031125256387668,-0.0181780859083269,-0.00597698540436108,0.000104596494606788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,29731,-0.0127623341490394,0.00329187987063415,-0.0192144186954823,-0.00631024960259648,0.000106017272262813
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,24235,-0.00783366151000711,0.00202175694719335,-0.0117963051265061,-0.00387101789350814,0.000107045854825234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB1,Calbindin,29344,-0.0110830402510522,0.00286876441690142,-0.016705818508179,-0.00546026199392546,0.000112083095737285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,24106,-0.0175316079135562,0.00454446304944166,-0.0264387554904618,-0.00862446033665054,0.000114712249337815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,29438,-0.0102881603416117,0.00266695443985917,-0.0155153910437357,-0.00506092963948771,0.000114729233354893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,24235,-0.0137876727139282,0.00357654972905667,-0.0207977101828793,-0.00677763524497717,0.000116018701438237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,28769,-0.0101120224389606,0.00262664157636931,-0.0152602399286445,-0.00496380494927677,0.000118474176428727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,28769,-0.0214522242248656,0.00557522623172142,-0.0323796676390396,-0.0105247808106917,0.000119452107932304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,29708,-0.00535059368617088,0.00139326813683516,-0.00808139923436779,-0.00261978813797397,0.000123129732809984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29438,-0.0115790842986643,0.00301704690307284,-0.0174924962286871,-0.00566567236864153,0.000124357023095387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,23902,-0.0178428214468886,0.00465043978062602,-0.0269576834169156,-0.00872795947686155,0.000124966917642013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,29344,-0.0149785994633026,0.00390437968257765,-0.0226311836411548,-0.00732601528545042,0.00012513357345856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,24840,-0.0117147614222971,0.00305582987865605,-0.0177041879844629,-0.0057253348601312,0.000126604374305764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,29815,-0.00874402266955421,0.00228106180646199,-0.0132149038102197,-0.00427314152888872,0.00012668887634239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,24961,-0.00428787289444746,0.00112026843787486,-0.00648359903268219,-0.00209214675621274,0.000129745876532666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,24106,-0.0181526620566204,0.00474279868848345,-0.0274485474860479,-0.0088567766271928,0.000129822888288942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,24961,-0.00649171798275481,0.00169668179263046,-0.00981721429631051,-0.00316622166919912,0.000130492980949432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,24235,-0.0193298449692761,0.00505362861902833,-0.0292349570625717,-0.00942473287598059,0.000131129874769426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,24440,-0.0185900281294624,0.00486680919727741,-0.0281289741561261,-0.00905108210279868,0.000133913619496697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,29589,-0.00757046410930836,0.00198208128567572,-0.0114553434292328,-0.00368558478938395,0.000134021608166321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,29689,-0.0151545027628389,0.00397262535353238,-0.0229408484557623,-0.0073681570699154,0.000136606677743854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29473,0.0261176067450844,0.00685405237403347,0.0126836640919788,0.03955154939819,0.000138948082849905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,24376,-0.0173009433539325,0.00454077082460946,-0.0262008541701671,-0.008401032537698,0.000139232870779616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,24190,-0.00799089163910444,0.00209730367515973,-0.0121016068424175,-0.00388017643579137,0.00013926649805207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_DRA,,29317,-0.00902158954995164,0.00237044708236518,-0.0136676658313874,-0.00437551326851589,0.000141599649555231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,24224,-0.0110561412999692,0.00290732338796324,-0.0167544951403771,-0.00535778745956121,0.000143386683247145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,24190,-0.0104056468704889,0.00274090318700491,-0.0157778171170186,-0.00503347662395932,0.000147153260361802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,24863,-0.0110609810787214,0.00291811387521956,-0.0167804842741517,-0.00534147788329102,0.000150726304913084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,24706,-0.012003103031644,0.00317182980141759,-0.0182198894424225,-0.00578631662086556,0.000154516154058376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,28447,0.0149538769528396,0.00395313653734001,0.00720572933965322,0.0227020245660261,0.000155399164215007
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24800,-0.0201252676989333,0.00532628179306669,-0.030564780013344,-0.00968575538452258,0.000158155451881017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,29815,-0.0217657967028195,0.00576553200805124,-0.0330662394385999,-0.0104653539670391,0.000160216069144699
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",24324,-0.0212188614988104,0.0056244715932352,-0.0322428258215514,-0.0101948971760694,0.000161940588271708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,28329,-0.0118641282815146,0.00314530250095526,-0.0180289211833869,-0.00569933537964227,0.000162263955182425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,29429,-0.0118172026815204,0.00313527960816541,-0.0179623507135246,-0.00567205464951616,0.000164152900805451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,28792,-0.0164553058949642,0.00437123543802436,-0.025022927353492,-0.00788768443643647,0.000167246340627835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,29438,-0.00705176481324328,0.00187337572806443,-0.0107235812402496,-0.003379948386237,0.000167406289821632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,29755,-0.00944428123642461,0.00251194401149165,-0.0143676914989482,-0.00452087097390098,0.00017040872145609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,24788,-0.0090875620244622,0.00241764594559318,-0.0138261480778248,-0.00434897597109958,0.000171089712173999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29213,-0.0131521266863161,0.00350457147001683,-0.0200210867675491,-0.00628316660508314,0.000175174719568708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,24106,-0.0302638837315011,0.00806926239611747,-0.0460796380278913,-0.0144481294351108,0.0001768852916988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,28792,-0.00973666617737794,0.00259796096092592,-0.0148286696607927,-0.00464466269396314,0.000178733248836777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24788,-0.00864854660862005,0.00230980564453894,-0.0131757656719164,-0.00412132754532372,0.000181324895156203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,24910,-0.0061032127901685,0.00163021213017546,-0.0092984285653124,-0.0029079970150246,0.000181654793634405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,28769,-0.0209404480884596,0.00559580390206405,-0.0319082237365051,-0.00997267244041407,0.000182792924807544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,29727,-0.00876630806193164,0.00234917309376069,-0.0133706873257026,-0.00416192879816069,0.00019057860514194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,24224,-0.0259706105593182,0.00696143337794057,-0.0396150199800817,-0.0123262011385547,0.000191429053192474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,24788,-0.00663574893620896,0.00178161057350139,-0.0101277056602717,-0.00314379221214623,0.000196075417898474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29429,-0.0207137416346265,0.00557579822396477,-0.0316423061535975,-0.00978517711565559,0.000203629819787267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,24946,-0.0221843292269541,0.00598739399504957,-0.0339196214572513,-0.010449036996657,0.000211703076128069
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24863,-0.0259671721987746,0.00701243548906923,-0.0397115457573503,-0.0122227986401989,0.000213510890274771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,24376,-0.0154658675074977,0.00418012588948951,-0.0236589142508972,-0.00727282076409828,0.000216195494509641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",24917,0.0169110317941771,0.00457943001603073,0.00793534896275692,0.0258867146255974,0.000222250714632147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,24224,-0.0139672700927446,0.00379085691753035,-0.0213973496511041,-0.0065371905343851,0.000229685075952622
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29781,-0.00917436678478163,0.00249143792206262,-0.0140575851120244,-0.00429114845753889,0.000231494958584015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,24235,-0.017031457616783,0.00463055143965972,-0.0261073384385161,-0.00795557679504999,0.000235520806795501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,29748,-0.0126314824515897,0.00343563482647618,-0.019365326711483,-0.00589763819169634,0.00023677168027551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,24096,-0.0106289645232868,0.00289112268229912,-0.016295564980593,-0.00496236406598047,0.000237049161452185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24440,-0.0174730021557202,0.00475387999704792,-0.0267906069499342,-0.00815539736150632,0.000237869187466841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,24917,-0.0175183744432951,0.004775958455938,-0.0268792530169336,-0.00815749586965664,0.000244932451846996
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,24933,-0.0104242649468839,0.0028489077411746,-0.0160081241195861,-0.00484040577418169,0.000253684754856647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,24817,-0.02330994356575,0.00637579889786098,-0.0358065094055575,-0.0108133777259424,0.000256706906326873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,24096,-0.0175760876160639,0.00481160594614787,-0.0270068352705137,-0.00814533996161408,0.000259892977146406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,28769,-0.00803958472856446,0.0022027450520903,-0.0123569650306615,-0.00372220442646748,0.000262906413379667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,28769,-0.0161619098929124,0.00443146920726427,-0.0248475895391504,-0.00747623024667442,0.000265708540571363
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,24788,-0.00776287619930859,0.00212851441423567,-0.0119347644512105,-0.00359098794740668,0.000265774111951332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,24096,-0.0141158618750597,0.00387226894546106,-0.0217055090081634,-0.00652621474195604,0.000267566835905739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24788,-0.0118063828887557,0.00323955661064282,-0.0181559138456156,-0.00545685193189576,0.000268517982189946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,29187,-0.00884588788485821,0.00243017397055949,-0.0136090288671548,-0.0040827469025616,0.000273085116530994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,24800,-0.0111108525687578,0.00305378404258666,-0.0170962692922276,-0.00512543584528792,0.000274906284812928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,29720,-0.0156838717761548,0.00431419700093117,-0.0241396978979799,-0.00722804565432969,0.000278008207939188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,24788,-0.00821182496506999,0.00225986385744826,-0.0126411581256686,-0.00378249180447141,0.000279874634966131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,29164,-0.00801250811345607,0.00220635386327703,-0.0123369616854791,-0.00368805454143308,0.000282195057421891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,24863,-0.0161760192740233,0.00445957862459584,-0.0249167933782311,-0.00743524516981545,0.000287026080810338
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29689,-0.0169198880990288,0.00466778148993522,-0.0260687398193018,-0.00777103637875577,0.000289641249575364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,29815,-0.0170434094453826,0.00470479530717734,-0.0262648082474502,-0.007822010643315,0.000292184705825387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,24440,-0.0126541135776046,0.00349521432595725,-0.0195047336564808,-0.00580349349872841,0.000294729718099688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,29438,0.0124425867027558,0.00343868524476893,0.00570276362300868,0.0191824097825029,0.000296910421704627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,29390,-0.0157628361172443,0.00435955848275178,-0.0243075707434378,-0.00721810149105079,0.000300043340007094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,24788,-0.0196365542052222,0.00543449588387073,-0.0302881661376088,-0.00898494227283557,0.000302903404174774
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,24133,-0.0118605356802642,0.00328570529088557,-0.0183005180503999,-0.00542055331012851,0.000307126967893308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,28769,-0.00906095006241463,0.00251488579411809,-0.0139901262188861,-0.00413177390594318,0.000315184488740583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28792,-0.0136773612614602,0.00379918335243722,-0.0211237606322372,-0.00623096189068329,0.000318654639786663
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,27580,-0.0115709889355047,0.00321779382648023,-0.017877864835406,-0.00526411303560345,0.000323788566410627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,29539,-0.00721452315188931,0.00200778868822544,-0.0111497889808112,-0.00327925732296745,0.000327087190195009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,24376,-0.00913548374142477,0.00254539142392557,-0.0141244509323189,-0.00414651655053066,0.000332563114123865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,24190,-0.0154128511510248,0.00429591313897281,-0.0238328409034115,-0.00699286139863814,0.000334146196566701
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,24376,-0.0158314066145097,0.0044135560759895,-0.0244819765234491,-0.00718083670557028,0.000335164804616086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,24863,-0.00842973035763068,0.00235198170199964,-0.01303961449355,-0.00381984622171138,0.000338893805777903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,24376,-0.00640692614371297,0.00178865317551965,-0.00991268636773148,-0.00290116591969445,0.000341659512955593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,24840,-0.0561354095964198,0.0156865485340165,-0.086881044723092,-0.0253897744697475,0.000346137505758821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,24840,-0.00899741959854104,0.00251453796188983,-0.0139259140038451,-0.00406892519323697,0.000346680094784537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,29429,-0.0144210269365955,0.00403198400585861,-0.0223237155880784,-0.00651833828511265,0.000348573524101348
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,24796,-0.007533403625895,0.00210717709658716,-0.0116634707352058,-0.00340333651658416,0.000350737450382412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,24915,0.00862767884204836,0.00241542826813542,0.00389343943650294,0.0133619182475938,0.000355063026435409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,29429,0.00569354406433718,0.00159457885514928,0.00256816950824458,0.00881891862042977,0.000356782668712008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,24863,-0.0112586121893813,0.00315340006261104,-0.0174392763120989,-0.00507794806666367,0.000357233150807481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24376,-0.00882166777723681,0.00247262942571359,-0.0136680214516355,-0.00397531410283817,0.000360781793655377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,24235,-0.00696930624634375,0.00195611807007656,-0.0108032976636938,-0.00313531482899371,0.000367589828491544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,29429,-0.0243219610924781,0.0068380468322672,-0.0377245328837218,-0.0109193893012343,0.00037590663905184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",24096,0.0169586407144092,0.00477689762337558,0.00759592137259304,0.0263213600562253,0.000385764546748378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28769,-0.011662626916855,0.00329137123825347,-0.0181137145438318,-0.00521153928987822,0.000395637141471466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,24376,-0.012316355445003,0.00347752376077804,-0.019132302016128,-0.00550040887387808,0.000398295468217934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,29344,-0.00606660376741412,0.0017145572039099,-0.00942713588707753,-0.00270607164775071,0.000403346918356123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,28792,-0.00947893663439921,0.0026804835202713,-0.0147326843341309,-0.00422518893466747,0.000406444099975947
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,28847,-0.0170162208967522,0.00481562202849711,-0.0264548400726065,-0.00757760172089782,0.000410666299610088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,24376,-0.00499655558816993,0.00141541661446693,-0.0077707721525251,-0.00222233902381475,0.000416176093259972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24224,-0.00816496028466837,0.00232070600915414,-0.0127135440626105,-0.00361637650672626,0.000435102742176515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,29561,-0.0131269945565957,0.00373512508769023,-0.0204478397284685,-0.00580614938472282,0.000441287196123059
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24440,-0.015339325470528,0.00436732752662041,-0.023899287422704,-0.006779363518352,0.00044506307430895
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,24788,0.00922627047833121,0.00262693983521061,0.00407746840131841,0.014375072555344,0.000445247365143368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28769,-0.00696109518806441,0.00198456121641975,-0.0108508351722471,-0.0030713552038817,0.000452816804516489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28926,-0.00838131639910829,0.00239242155827323,-0.0130704626533238,-0.00369217014489275,0.000460264663126886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,29076,-0.0083117028502311,0.00237258415863593,-0.0129619678011575,-0.00366143789930467,0.000460346727811701
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29344,-0.00895008970406118,0.00255506121741536,-0.0139580096901953,-0.00394216971792708,0.00046093026754702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,24863,-0.00883814450974262,0.00252363189726984,-0.0137844630283915,-0.00389182599109373,0.000462324948811477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,24224,-0.00694024893201975,0.00198203304784009,-0.0108250337057863,-0.00305546415825317,0.000463339405105211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,28926,-0.0159162737449997,0.0045530985961999,-0.0248403469935515,-0.00699220049644787,0.00047352559916599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,28714,-0.00972053237193037,0.00278277222744715,-0.0151747659377268,-0.00426629880613397,0.000478146505422545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29213,-0.0159768811339679,0.00458272870720273,-0.0249590294000852,-0.00699473286785051,0.000490425075910598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24376,-0.0238182171454817,0.00683479214011162,-0.0372144097401004,-0.0104220245508629,0.000493280690286322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,24376,0.00736798720040297,0.0021152640065333,0.00322206974759771,0.0115139046532082,0.000496240096800402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,29438,-0.0167081348339228,0.00480486365707901,-0.0261256676017977,-0.00729060206604794,0.000507150015226589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,24811,-0.0192836106249841,0.00554631882074761,-0.0301543955136494,-0.00841282573631881,0.000508247027965571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,24190,-0.01360305086238,0.00391884955222332,-0.0212839959847377,-0.00592210574002227,0.000519071729038206
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24224,-0.0127403760475013,0.00367250900444273,-0.019938493696209,-0.00554225839879355,0.00052307339550773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,24224,-0.0124368883181115,0.00358769393212189,-0.0194687684250704,-0.00540500821115261,0.000528115510041073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,24190,-0.00985970408805434,0.00284746117021093,-0.0154407279816678,-0.00427868019444091,0.000535848799330587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,24106,-0.00824112265256944,0.00238516077928742,-0.0129160377799728,-0.0035662075251661,0.000550904109431114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,28769,-0.0111438079075856,0.00322650292090923,-0.0174677536325677,-0.00481986218260356,0.0005534718676057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,29689,-0.0111897436045895,0.00324126601444701,-0.0175426249929056,-0.00483686221627333,0.00055665404182305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,29815,-0.00687589079730313,0.00199184039032527,-0.0107798979623407,-0.00297188363226559,0.000557159568915405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,29720,-0.0142450739553487,0.00412989982295694,-0.0223396776083444,-0.00615047030235314,0.000562917208291024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,24440,-0.0119519082103787,0.0034659947069639,-0.018745257836028,-0.00515855858472949,0.000565006295408772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,29720,-0.0130255694672427,0.00378005978725009,-0.0204344866502529,-0.00561665228423252,0.000570024882811999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,28769,-0.0152079247491146,0.0044136761342783,-0.0238587299723,-0.00655711952592909,0.000570528855717325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,24106,-0.010780878744624,0.00313410529809807,-0.0169237251288962,-0.00463803236035177,0.00058300392920132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,29395,-0.0206197893764014,0.00601755960320292,-0.0324142061986791,-0.00882537255412367,0.000612017751906389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,29473,-0.0157583993443038,0.00460061350963977,-0.0247756018231978,-0.00674119686540985,0.000614998321528964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,24946,-0.00547857763918167,0.00160016914849052,-0.00861490917022308,-0.00234224610814026,0.000618629313071945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,29209,-0.0075611987156541,0.00220887374452666,-0.0118905912549263,-0.00323180617638186,0.000619959312946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,29815,-0.00919093981088957,0.00268679749131452,-0.014457062893866,-0.00392481672791311,0.00062525822815091
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,29335,-0.00769702728297646,0.00225623834472549,-0.0121192544386384,-0.0032748001273145,0.000647073057476061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24440,-0.00793454048924297,0.00232986758410821,-0.0125010809540951,-0.00336800002439088,0.000661309358387566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24440,-0.0117041519880881,0.00343687695958647,-0.0184404308288775,-0.00496787314729857,0.000661586061869943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,24224,-0.00760500579682954,0.0022356570270682,-0.0119868935698832,-0.00322311802377587,0.000670795143460657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24106,-0.00578717403915078,0.00170129371514826,-0.00912170972084136,-0.0024526383574602,0.000670937360739473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,29561,-0.0176928529030983,0.00520518340632008,-0.0278950123794857,-0.00749069342671096,0.000677013688684831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,24224,-0.0128703454277889,0.00379341416898591,-0.0203054371990012,-0.00543525365657648,0.000692895605483482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,24800,-0.00969031402538754,0.00285685716231912,-0.015289754063533,-0.00409087398724207,0.000695057479712857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24106,-0.0114535683936554,0.00337734689198497,-0.0180731683019459,-0.00483396848536483,0.000696757502449933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24190,-0.0121456948494915,0.00358339790153633,-0.0191691547365027,-0.00512223496248031,0.000701486338573263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,24252,0.00624919429028068,0.00184628881883268,0.00263046820536864,0.00986792037519273,0.000713605011964453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24106,-0.00811067682160597,0.00239789134584156,-0.0128105438594554,-0.00341080978375651,0.000719643515379498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,24190,-0.013756503646433,0.00407350518568334,-0.0217405738103723,-0.00577243348249361,0.000733783986021603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,28769,-0.0158427168831426,0.00469246875416656,-0.0250399556413091,-0.00664547812497616,0.00073591515162803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXN,Paxillin,28769,-0.0113995958404201,0.0033785376779661,-0.0180215296892337,-0.00477766199160659,0.000741495132488564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,24224,-0.0199796663119108,0.00593328000117423,-0.0316088951142122,-0.00835043750960926,0.000760014927864183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,24224,-0.013875271682353,0.00413021837185522,-0.0219704996911893,-0.0057800436735168,0.000782176472315779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,28926,-0.00639914333821385,0.00190569004957764,-0.010134295835386,-0.00266399084104167,0.000786343394006442
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,23820,0.00706151826204279,0.00210494493022782,0.00293582619879626,0.0111872103252893,0.000795670078836384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,24788,-0.00637803035632466,0.00190248224434451,-0.0101068955552399,-0.00264916515740941,0.000802113874033008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,29428,-0.00656064519042216,0.00195701825446757,-0.0103964009691786,-0.00272488941166572,0.00080224434577163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,24909,-0.00618474584384779,0.00184847134215115,-0.00980774967446405,-0.00256174201323153,0.000821459369662934
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29213,-0.00653298884978984,0.00195259644155322,-0.0103600778752341,-0.00270589982434554,0.000821502113415339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSPN,Claspin,28714,-0.00763196272594036,0.00228133497970576,-0.0121033792861637,-0.00316054616571707,0.000822712733710785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,28792,-0.0108274244621667,0.00324196464256593,-0.0171816751615959,-0.00447317376273743,0.00083953535918823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,24800,-0.011746442829201,0.00351853484971644,-0.0186427711346452,-0.00485011452375675,0.000843721074430598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,24863,-0.0145585823852153,0.00436683197839462,-0.0231175730628687,-0.0059995917075618,0.000857625122432024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28792,-0.0273565247510207,0.00820914983335251,-0.0434464584243917,-0.0112665910776498,0.000861955285421411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,24235,-0.0160198877065216,0.00480986094384766,-0.025447215156463,-0.0065925602565802,0.000867778147464694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,28792,-0.00679925663921342,0.0020432152697369,-0.0108039585678977,-0.0027945547105291,0.00087668276534078
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24235,-0.0151069479126394,0.00454223362301047,-0.0240097258137399,-0.00620417001153885,0.000882691814983755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24168,-0.00839985648548561,0.00252730873717949,-0.0133533816103574,-0.00344633136061382,0.000889838900816153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,24096,-0.0104982641898479,0.00316093043507724,-0.0166936878425993,-0.00430284053709648,0.000897460442362265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,24840,-0.0121007475634298,0.00364712616621691,-0.0192491148492149,-0.00495238027764464,0.000908319471509346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,24198,-0.0151292983623935,0.00457699347387566,-0.0241002055711898,-0.00615839115359718,0.000949415997614446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,24235,-0.0110912966538014,0.00335716522909789,-0.0176713405028333,-0.00451125280476956,0.00095532884142227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24011,-0.0124319637736812,0.00376717445284145,-0.0198156257012504,-0.00504830184611193,0.000967993484903537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,24863,-0.00583197049265761,0.00176732435103402,-0.0092959262206843,-0.00236801476463093,0.000968598897847706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24440,-0.0148930128879149,0.00452193946418649,-0.0237560142377204,-0.00603001153810935,0.000990885545891908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,24840,-0.00685297063400846,0.00208303867483515,-0.0109357264366853,-0.00277021483133158,0.00100365699024736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,29438,-0.00950260779937133,0.00289049281502325,-0.0151679737168169,-0.00383724188192576,0.0010118562765193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,24933,-0.00710708530891704,0.0021638112336253,-0.0113481553268226,-0.00286601529101145,0.00102296448357978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,29344,-0.0165273620656937,0.00504661374038929,-0.0264187249968567,-0.00663599913453066,0.00105806542890849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24863,0.00907000721393134,0.00277035057985541,0.00364012007741474,0.0144998943504479,0.00106197872213715
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,24840,-0.0203257036652838,0.00621072022319751,-0.0324987153027509,-0.00815269202781671,0.00106678290926857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,28926,-0.0175848857520474,0.0053766369579719,-0.0281230941896723,-0.00704667731442248,0.0010744113415297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,24190,-0.014893063008031,0.00456893884646326,-0.023848183147099,-0.00593794286896298,0.00111710706897788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24863,-0.0139906424807775,0.00431111577367735,-0.0224404293971852,-0.00554085556436993,0.00117503349643041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,29158,-0.0131882526749648,0.00407135478997894,-0.0211681080633235,-0.00520839728660605,0.0011996666386615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,24224,-0.0110960980488549,0.00343645442411452,-0.0178315487201193,-0.00436064737759039,0.00124416443617656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29561,-0.00756261357681158,0.0023531570817631,-0.0121748014570673,-0.0029504256965559,0.00131124202007175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,28714,-0.0139744614030361,0.00435108614773196,-0.0225025902525907,-0.00544633255348143,0.00132089275581592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24863,-0.0168121863794969,0.00524033324001908,-0.0270832395299343,-0.00654113322905954,0.00133724687064567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,28926,-0.0095395219082881,0.0029768678860034,-0.0153741829648548,-0.00370486085172144,0.00135420589073916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,28926,-0.0074691975858325,0.00233104212480411,-0.0120380401504486,-0.00290035502121644,0.00135570637501688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,24224,-0.00587319403604228,0.0018341538040103,-0.00946813549190248,-0.00227825258018209,0.00136592973562941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,24440,-0.00957472474761263,0.00299089902474825,-0.0154368868361192,-0.00371256265910607,0.00136990484449237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,24376,-0.0106374433107213,0.00332595144037635,-0.0171563081338589,-0.00411857848758361,0.0013840951907306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,29561,-0.0143980034074857,0.00450353393481703,-0.0232249299197271,-0.00557107689524435,0.00138989119656581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24840,-0.00998612255348434,0.00312771847375823,-0.0161164507620505,-0.00385579434491822,0.00141085064885756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,28926,-0.00988679698930785,0.00309810106190527,-0.0159590750706422,-0.00381451890797352,0.00141812875933312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,28645,-0.00638363117061013,0.00200133732401857,-0.0103062523256865,-0.00246101001553374,0.00142582460527666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,24106,-0.00897348052145871,0.00281666279920374,-0.014494139607898,-0.00345282143501938,0.00144510632139189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,28926,-0.0124968690612187,0.00392582182745488,-0.0201914798430302,-0.0048022582794071,0.00145786420803626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24224,-0.0167072866534788,0.00524959804248584,-0.026996498816751,-0.00641807449020655,0.00146151602541709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,24235,-0.0155114256878392,0.00487740314751464,-0.0250711358569678,-0.00595171551871047,0.00147326674429569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,24096,-0.0123256306550097,0.00387855494210968,-0.0199275983415447,-0.00472366296847472,0.00148537156398184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBN,Nibrin,28926,-0.0109388000863152,0.00344422424162073,-0.0176894795998918,-0.00418812057273856,0.00149486113564193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,24106,0.0106288905458026,0.00335231166954883,0.00405835967348691,0.0171994214181183,0.00152306945823811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24224,-0.00926598861599077,0.00292686768026989,-0.0150026492693197,-0.00352932796266179,0.00154828566112378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,28769,-0.0115636128063671,0.00365447281956388,-0.0187263795327123,-0.00440084608002185,0.00155652810921502
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,24190,-0.0056896395506257,0.00179813080050529,-0.00921397591961606,-0.00216530318163533,0.00155704261660322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,28830,-0.00801814570006802,0.00253794712704205,-0.0129925220690704,-0.0030437693310656,0.00158309997369423
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,29720,0.012350128090868,0.00392489433931924,0.00465733518580232,0.0200429209959338,0.00165335872061497
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,24788,0.0163407846507325,0.00520250917774923,0.00614386666234403,0.026537702639121,0.00168602911739891
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,28590,-0.00403721720231776,0.00128761639088674,-0.00656094532845578,-0.00151348907617974,0.00171782540456496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,28911,-0.00749049025503509,0.00238999031173584,-0.0121748712660373,-0.00280610924403284,0.00172549224657611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,28911,-0.00919448796625007,0.00293451244255445,-0.0149461323536568,-0.00344284357884335,0.00173069586559758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALLD,Palladin,24224,-0.0082134915662538,0.00262170082026785,-0.0133520251739788,-0.00307495795852881,0.00173302658159266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,24106,-0.0127780703377601,0.00408413309390106,-0.0207829712018062,-0.00477316947371404,0.00175784515636169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,24235,-0.0184917548455184,0.00592697973638479,-0.0301086351288326,-0.0068748745622042,0.00181107092711431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,28792,-0.0187026192286314,0.00599767077857116,-0.0304580539546309,-0.00694718450263196,0.00182068413386972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,23796,-0.00800887755640267,0.00256935124205811,-0.0130448059908366,-0.00297294912196877,0.00182868620566378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,28792,-0.0148765757006001,0.00477466949915714,-0.0242349279189481,-0.00551822348225213,0.00183671261451088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,24840,-0.0197399641557142,0.00633971246192577,-0.0321658005810887,-0.00731412773033971,0.00184967139669761
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24440,0.00904682902024291,0.00290939882822025,0.00334440731693123,0.0147492507235546,0.00187608110288382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,24639,-0.00647222441585499,0.00208537010442489,-0.0105595498205278,-0.00238489901118221,0.0019137650686561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,29720,-0.00931508305880564,0.00300885530838883,-0.0152124394632477,-0.00341772665436355,0.00196406117160743
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,24800,-0.00869099739391171,0.0028075529043152,-0.0141938010863695,-0.00318819370145392,0.00196649012143572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,24224,-0.0118085893104929,0.00382392408280986,-0.0193034805128002,-0.00431369810818555,0.00201681035953863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,24863,0.0139392974228507,0.0045172603790053,0.00508546708000028,0.0227931277657011,0.00203238180267849
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,29429,-0.0172715153701013,0.00559959869087871,-0.0282467288042235,-0.00629630193597899,0.00204138319093451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARC,SPARC,29561,-0.0142141222474046,0.00461170846893841,-0.0232530708465239,-0.00517517364828532,0.00205678627231129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,29576,-0.0210331457468294,0.00682642429509886,-0.0344129373652232,-0.00765335412843564,0.00206401437506145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24190,-0.020956102982169,0.00681488965344188,-0.0343132867029151,-0.00759891926142293,0.00210704396949848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,29438,-0.0047253033567636,0.00153682753594221,-0.00773748532721033,-0.00171312138631686,0.00210898288886368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,24224,-0.0196097357465967,0.00637879042552236,-0.0321121649806205,-0.00710730651257283,0.00211296222207692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,29576,-0.00820840637283554,0.00267558633742843,-0.0134525555941953,-0.00296425715147581,0.00215770384985437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24800,-0.00860999159509327,0.00280712571244644,-0.0141119579914883,-0.00310802519869825,0.00216313348045102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,24800,0.0100139720075781,0.0032806517464657,0.00358389458450535,0.0164440494306509,0.00227234168510082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,24190,0.0125299237458601,0.00410945571232123,0.0044753905497105,0.0205844569420097,0.00229816699800862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,24788,-0.00744725268522852,0.00244353155893054,-0.0122365745407324,-0.00265793082972466,0.00230810972329193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,24863,-0.00746267171438169,0.00245088886181262,-0.0122664138835344,-0.00265892954522896,0.00233013833227257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24840,-0.0109550886600091,0.00359797219770277,-0.0180071141675066,-0.00390306315251171,0.00233082620335505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,24106,-0.0120061278202874,0.00395177597220312,-0.0197516087258056,-0.00426064691476933,0.00238282356735001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24224,-0.00886781334150677,0.00292590816209474,-0.0146025933392125,-0.00313303334380107,0.00244172366060459
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,29160,0.00950827672380348,0.00315443332681169,0.00332558740325257,0.0156909660443544,0.00257829895510939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,24440,-0.00813380142838996,0.00269948469296703,-0.0134247914266053,-0.00284281143017458,0.00258863647366843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,24933,0.00552961947641506,0.00183971066461926,0.00192378657376132,0.00913545237906881,0.00265233457434781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24800,-0.0161950992679993,0.00538821541360618,-0.0267560014786674,-0.00563419705733114,0.00265277451137098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,28840,-0.00869939712503455,0.0028960764119328,-0.0143757068924228,-0.00302308735764626,0.00266810115668859
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,24933,-0.016330605401867,0.0054416411429197,-0.0269962220419896,-0.00566498876174441,0.0026932180816385
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,28769,-0.0102572595339587,0.00341849730848149,-0.0169575142585824,-0.00355700480933495,0.00269752637240993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,24946,0.00454003096043295,0.0015157545883349,0.00156915196729656,0.00751090995356934,0.00274508889487788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,28769,-0.00970539220758621,0.00324054782379791,-0.0160568659422301,-0.00335391847294231,0.00274691959404938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,24840,-0.00732729095839668,0.00244795231672904,-0.0121252774991856,-0.00252930441760776,0.0027631078788455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,29574,-0.0299211903502212,0.00999708938257766,-0.0495154855400734,-0.010326895160369,0.00276486853414279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,24224,-0.00757071539180392,0.00253088054201208,-0.0125312412541476,-0.00261018952946025,0.00278038825639786
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,24190,-0.00614862384134451,0.00205624840582165,-0.0101788707167549,-0.00211837696593408,0.00279062233504106
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,24235,-0.0117890152075203,0.00394733772832626,-0.0195257971550397,-0.00405223326000079,0.00282405016156636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,28792,-0.00958433355313551,0.00321510171241736,-0.0158859329094735,-0.00328273419679749,0.00287515368257862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29531,-0.0168469912121675,0.00565176234759834,-0.0279244454134603,-0.00576953701087478,0.00287694590159397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,29623,-0.00543113070968103,0.00182252016857824,-0.00900327024009438,-0.00185899117926768,0.0028847172212753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,29110,-0.00706042462914064,0.00237176186091212,-0.0117090778765284,-0.00241177138175288,0.00291447937393505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24106,-0.00943485353385599,0.00317392596937894,-0.0156557484338387,-0.00321395863387328,0.0029556845291881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,29520,-0.0232515221724138,0.00783405308760811,-0.0386062662241257,-0.00789677812070191,0.00299978378639475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,24863,-0.0120663526980879,0.00407298893856786,-0.020049411017681,-0.00408329437849494,0.00305410764903489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,29438,-0.00615997056067489,0.00208247653136542,-0.0102416245621511,-0.00207831655919867,0.00309885911963352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,24224,-0.00508006063488977,0.00171958103163376,-0.00845043945689194,-0.0017096818128876,0.0031373834880708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24235,-0.0148182867206877,0.0050166150120054,-0.0246508521442182,-0.00498572129715708,0.00314146527534499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,24224,-0.0108692266799561,0.00368262839077183,-0.0180871783258689,-0.00365127503404332,0.00316551898697285
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24204,-0.0154033115541683,0.00522761502216593,-0.0256494369976135,-0.00515718611072312,0.00321670259678563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,24224,-0.0196878776920365,0.00668566670478132,-0.0327917844334079,-0.00658397095066514,0.00323482240174199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,24440,-0.0144159938731426,0.0049020925669346,-0.0240240953043345,-0.00480789244195083,0.00327690041574076
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,24840,-0.00639120772348532,0.00217856182836909,-0.0106611889070887,-0.0021212265398819,0.00335273475690873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,24096,-0.0173999733663445,0.00593433417277604,-0.0290312683449855,-0.00576867838770343,0.00337011157975129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24946,-0.00829394331274616,0.00283252932199649,-0.0138457007838593,-0.00274218584163303,0.00341343240119558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,24788,-0.0085359234345526,0.0029177572272118,-0.0142547275998877,-0.00281711926921747,0.00344205796068561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,29689,-0.00559391076558557,0.0019134470786007,-0.00934426703964295,-0.0018435544915282,0.00346411783197439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24863,-0.00935374407003632,0.00320044210060381,-0.0156266105872198,-0.00308087755285285,0.00347388950665381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24933,-0.026398158541756,0.00903680882268935,-0.0441103038342271,-0.00868601324928481,0.00349019442703765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,24190,-0.0155095924014921,0.00531465239961489,-0.0259263111047373,-0.00509287369824688,0.00352303326081095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,24096,-0.00664867228072245,0.0022800776862336,-0.0111176245457403,-0.0021797200157046,0.0035489456525838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,24840,-0.0168348249243307,0.00578830131841945,-0.0281798955084329,-0.0054897543402286,0.00363579288459086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24788,-0.0137566100510865,0.00473084861753993,-0.0230290733414647,-0.00448414676070819,0.00364242871620745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24173,-0.0052896812785335,0.00181945356768878,-0.00885581027120351,-0.00172355228586349,0.00364905217117862
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29344,-0.00840211777648226,0.00289140124520072,-0.0140692642170757,-0.00273497133588886,0.00366474338772882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",23970,-0.00492811293765137,0.00169700738669758,-0.00825424741557862,-0.00160197845972412,0.003687622316312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,24840,-0.0203718136111354,0.00703684656283631,-0.0341640328742946,-0.00657959434797623,0.00379464415187377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,28926,-0.00740500861797265,0.00256064768693447,-0.0124238780843642,-0.00238613915158108,0.00383266371073438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,28911,-0.0177215329927788,0.00613345259898853,-0.0297431000867963,-0.00569996589876132,0.00386357793859067
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,24011,-0.00967052045863602,0.00334707769548992,-0.0162307927417963,-0.00311024817547578,0.00386516293985087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,24800,-0.0202195628646059,0.00699970062750813,-0.0339389760945218,-0.00650014963468992,0.00387255983929148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,24096,-0.00901837056821348,0.00312263359677199,-0.0151387324178866,-0.00289800871854039,0.00387964266106616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,24800,0.0209531471660175,0.0072696792003024,0.00670457593342482,0.0352017183986102,0.00395165769482264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,28792,-0.00998939124548513,0.00346828960142825,-0.0167872388642845,-0.00319154362668576,0.00397707668628146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,29429,-0.0110663659151409,0.00384388028706628,-0.0186003712777908,-0.00353236055249097,0.00399280362554853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,24961,0.00617168350343552,0.00214742388329163,0.00196273269218392,0.0103806343146871,0.00405658901637286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,24011,-0.0119555690061195,0.00416121575525749,-0.0201115518864242,-0.00379958612581482,0.00406828104215976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,28792,-0.0109256776232798,0.0038097737560898,-0.0183928341852158,-0.00345852106134382,0.00413634093967025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,24011,-0.0105581505257414,0.00368440570921815,-0.017779585715809,-0.00333671533567379,0.00416539440098041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZN,Kazrin,24800,-0.0195459429786544,0.00682395390115541,-0.032920892624919,-0.00617099333238984,0.00418265171914014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,28621,-0.012630328535322,0.00441163238797906,-0.021277128015761,-0.00398352905488306,0.00420007939911628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,24224,-0.00732289702028814,0.00256120792651607,-0.0123428645562596,-0.00230292948431665,0.00425130553400073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,28926,-0.00888700653275793,0.00311307640724317,-0.0149886362909545,-0.00278537677456133,0.00431034576142826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,24917,-0.0103073512825028,0.00361243388696095,-0.0173877217009462,-0.00322698086405931,0.00433036544920359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,24096,-0.0107974205904364,0.00378432431133758,-0.018214696240658,-0.00338014494021469,0.00433187449747159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,29031,-0.0275649755767096,0.0096619987591518,-0.0465024931446471,-0.00862745800877206,0.00433492199320765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC1,Hamartin,24224,-0.0140553083070931,0.00492754638920053,-0.0237132992299261,-0.00439731738426001,0.00434279008674305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,28911,-0.00996390137401542,0.00350213971604964,-0.0168280952174727,-0.00309970753055813,0.0044430136958708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMD,Dystrophin,24235,-0.00962334237306978,0.00338622348613868,-0.0162603404059016,-0.00298634434023798,0.00448816058992916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,28769,0.0067023805304738,0.00235847197175207,0.00207977546583974,0.0113249855951079,0.00448867105372121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,24376,-0.0145437105313774,0.00512154904791884,-0.0245819466652983,-0.00450547439745647,0.00451920525917601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,29164,-0.00598754472705058,0.002110198094675,-0.0101235329926136,-0.00185155646148757,0.00455093388479719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24800,-0.00949992576443853,0.00334857086489704,-0.0160631246596367,-0.00293672686924033,0.00455752622442381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,29689,-0.0178007237724924,0.00628209358386836,-0.0301136271968744,-0.00548782034811045,0.0046062919086587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24788,-0.00689220280359119,0.00243334694226612,-0.0116615628104328,-0.0021228427967496,0.00462378262337843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,24224,-0.00496389318910885,0.00175586942261298,-0.00840539725743029,-0.00152238912078742,0.00470206435516936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,24190,-0.0126908870279196,0.0044954919393143,-0.0215020512289756,-0.00387972282686354,0.00476116933194788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,24863,-0.0144139927451621,0.00510753083970098,-0.024424753190976,-0.00440323229934816,0.00477472973769817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,29720,-0.003073284385172,0.00108966893914018,-0.00520903550588675,-0.000937533264457252,0.00479980541684709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,24224,0.00849084094505074,0.00301203889808673,0.00258724470480075,0.0143944371853007,0.00482174336904156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,24096,-0.0142577086106468,0.00505847929807227,-0.0241723280348685,-0.0043430891864252,0.00482765149961167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,24800,-0.0112952342610793,0.00400829293538139,-0.0191514884144268,-0.00343898010773179,0.00483671458499639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,28769,-0.0155858450394531,0.00553249114060026,-0.0264295276750297,-0.00474216240387663,0.00484852547655248
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24224,0.0128647166377788,0.00456906501104344,0.00390934921613369,0.021820084059424,0.00487236833815982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,29132,-0.0115669184812553,0.00410876616372546,-0.0196201001621572,-0.00351373680035339,0.00487825726911942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,24224,-0.0122794415388865,0.0043644913514214,-0.0208338445876724,-0.00372503849010054,0.0049046793513229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29781,-0.00644465458053482,0.00229657241204112,-0.0109459365081354,-0.00194337265293422,0.00501612276135115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,29429,-0.0125004485558818,0.00445685312338464,-0.0212358806777157,-0.00376501643404793,0.00503854958006246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,28714,-0.00846210633036965,0.00301794988923211,-0.0143772881132646,-0.00254692454747472,0.00505184820806162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,24376,-0.00420236882985577,0.00149943683856916,-0.00714126503345132,-0.00126347262626022,0.0050727584123974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,24190,-0.0131171213026911,0.00469509194605398,-0.0223195015169569,-0.00391474108842526,0.00521345814769044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,29213,-0.00651310456026839,0.00233458174103969,-0.0110888847727062,-0.00193732434783059,0.00527686162849247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,24376,0.00739968757401096,0.00265372371345875,0.0021983890956318,0.0126009860523901,0.00530074299087661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,29473,-0.00651568862475896,0.00234028716855305,-0.0111026514751229,-0.00192872577439498,0.00537039774761995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,29781,0.00723283736402535,0.00259875368052461,0.00213928015019712,0.0123263945778536,0.00538604252790626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,24011,-0.00750628142783175,0.00270154296716508,-0.0128013056434753,-0.00221125721218818,0.00546501929083353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,24863,-0.00548182467126055,0.00197383612809574,-0.0093505434823282,-0.0016131058601929,0.00548630692962194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,28926,0.00784065257399222,0.0028342631010817,0.00228549689587209,0.0133958082521124,0.00567181943405425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,24800,-0.010913510744275,0.00394648888503101,-0.0186486289589358,-0.00317839252961424,0.00568999282660327
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,24096,-0.017563051741311,0.00635140041731454,-0.0300117965592475,-0.0051143069233745,0.00569268243822244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,24788,-0.00943448371340563,0.00341823196062076,-0.0161342183562223,-0.00273474907058893,0.00578353685854513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,24224,-0.0217219317088283,0.00787132325634442,-0.0371497252912634,-0.00629413812639324,0.0057910531705702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,29374,-0.0186749525328733,0.00676885893575064,-0.0319419160469446,-0.00540798901880207,0.00580230699091253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,29438,-0.00612517804970215,0.00222428227551949,-0.0104847713097204,-0.00176558478968395,0.00589479909253303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,24096,-0.00521940210522019,0.00189765882510209,-0.00893881340242028,-0.00149999080802009,0.00595592069071344
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,29429,-0.00948356257137942,0.00345144053377297,-0.0162483860175745,-0.00271873912518439,0.006004935154278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,24106,-0.019975921759585,0.00729700437740025,-0.0342780503392894,-0.00567379317988047,0.00619439357934488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28911,-0.00563156956314625,0.00205890967014503,-0.0096670325166305,-0.001596106609662,0.00623767373744088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28926,-0.00764984670855165,0.00279755464953771,-0.0131330538216456,-0.00216663959545775,0.00625176511677608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,24391,-0.0116345552187163,0.0042703714853472,-0.0200044833299968,-0.00326462710743576,0.0064448119614431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,29429,0.00916044970799394,0.0033629927018412,0.00256898401238519,0.0157519154036027,0.00645544732302381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,29429,0.00495569717600041,0.00181966089779947,0.00138916181631345,0.00852223253568737,0.00646483715873333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,24106,-0.021151187148939,0.00777442031585975,-0.0363890509680241,-0.00591332332985389,0.00652078003172494
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,24106,-0.00855231914970643,0.00314727395034054,-0.0147209760923739,-0.00238366220703896,0.00658492996011787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,24946,0.00466503875159937,0.00171935495310425,0.00129510304351504,0.0080349744596837,0.00666726968157904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29344,-0.0080060979265074,0.00295124681796446,-0.0137905416897177,-0.00222165416329706,0.00667593119804501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,24917,-0.0114269257254599,0.00421952529584444,-0.019697195305315,-0.00315665614560481,0.0067714419123565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,24224,-0.00385593456174708,0.00142393889989648,-0.00664685480554418,-0.00106501431794999,0.00677507391206834
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,29473,-0.00641023647085031,0.00236743099013437,-0.0110504012115137,-0.00177007173018693,0.00677951857933016
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24863,-0.0121089796655447,0.0044722697214722,-0.0208746283196303,-0.00334333101145922,0.00678242897914494
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,28879,-0.00732484659488717,0.00271020041024974,-0.0126368393989767,-0.00201285379079769,0.00688199393106938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,24828,-0.00555853946859245,0.00205840021375321,-0.00959300388754875,-0.00152407504963616,0.00692995341834961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,29720,-0.0106397842513482,0.00394877680012606,-0.0183793867795953,-0.00290018172310115,0.00705443961657351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29158,-0.0196704841653817,0.0073131894704025,-0.0340043355273706,-0.00533663280339281,0.00715511793861066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,24190,-0.0102114890539255,0.00380387470994421,-0.0176670834854162,-0.00275589462243489,0.00726886149760991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,23897,-0.00771191227044511,0.00288000583822086,-0.013356723713358,-0.00206710082753223,0.00741709937303972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,24235,-0.00918646102265053,0.00343316131101893,-0.0159154571922476,-0.00245746485305343,0.00746007354673322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,24190,-0.00796789861372891,0.00298128864030178,-0.0138112243487204,-0.00212457287873742,0.00753084069127247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,24190,0.0119973843315628,0.00449086253666634,0.00319529375969682,0.0207994749034289,0.00755613979273484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29429,-0.00655934250926221,0.00246404203938545,-0.0113888649064577,-0.00172982011206673,0.00777142380382191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,24946,-0.00457138378926122,0.00171854563453463,-0.0079397332329491,-0.00120303434557334,0.00781835547651597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCN,Decorin,28911,-0.0039977133053964,0.00150459418749565,-0.00694671791288787,-0.00104870869790492,0.00788817562659068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24933,-0.00690729460749066,0.00260132489936299,-0.0120058914102421,-0.00180869780473919,0.00792886000974362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,24106,-0.00971176116100625,0.00365904083618942,-0.0168834811999375,-0.00254004112207498,0.00795530929522861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,28825,-0.00849753397068156,0.00320188575372775,-0.0147732300479879,-0.00222183789337517,0.00796074459824782
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,24096,-0.00977682582787504,0.00368678847471979,-0.0170029312383258,-0.00255072041742424,0.00801035111070661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANG,Angiogenin,29430,-0.00585854451983928,0.00221109332684242,-0.0101922874404504,-0.00152480159922814,0.00806267844827121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,28792,-0.0167187005463012,0.00632310496108979,-0.0291119862700372,-0.00432541482256521,0.00819613503669321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,29668,-0.00526807770404732,0.00199684086941014,-0.00918188580809119,-0.00135426960000344,0.00833894388908069
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,29438,0.00647670281148236,0.00245921262077034,0.00165664607477248,0.0112967595481922,0.00845169488376103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,24235,-0.00815271445676359,0.00309921768685448,-0.0142271811229984,-0.00207824779052881,0.00852953130387995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,29720,-0.0111864404820034,0.00425346090796006,-0.0195232238616051,-0.00284965710240168,0.00854384356878189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24224,-0.0149904214432967,0.00570747308237466,-0.0261770686847511,-0.0038037742018424,0.00863337029903177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,24096,-0.00926763951463502,0.0035292485127964,-0.016184966599716,-0.00235031242955407,0.00864614795042408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,29344,-0.0325870951422549,0.012416584880991,-0.0569236015089973,-0.00825058877551249,0.00868260223369647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,24840,0.0046508429526256,0.00177346811873613,0.00117484543990278,0.00812684046534842,0.00873517181229579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,24096,-0.0109861108418253,0.00419891223301442,-0.0192159788185336,-0.00275624286511701,0.00889130953016409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,28769,-0.00882904451491497,0.00337726062635787,-0.0154484753425764,-0.00220961368725356,0.00894670181494997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,24840,0.012129046810478,0.00464199076608548,0.00303074490895051,0.0212273487120056,0.00898322870088716
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29344,-0.00929330306761833,0.00355734938345065,-0.0162657078591816,-0.00232089827605505,0.00899486447509765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,24106,-0.00644148427407188,0.0024663819632421,-0.0112755929220264,-0.00160737562611737,0.0090145445450469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,28792,-0.00950989609745833,0.00364646039142058,-0.0166569584646427,-0.00236283373027398,0.00911252859490339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,24129,-0.00674740306890232,0.00259423149949388,-0.0118320968079103,-0.00166270932989431,0.00930293676230153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,28926,-0.0130083646094597,0.00503356796347417,-0.022874157817869,-0.0031425714010503,0.00976189717759702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24224,-0.00501151747165556,0.00194009409040422,-0.00881410188884784,-0.00120893305446329,0.00979661867836367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,29720,0.00780557822874334,0.00302237329215438,0.00188172657612076,0.0137294298813659,0.00981066043921147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,28769,-0.00597665323633875,0.00231804670800055,-0.0105200247840198,-0.00143328168865768,0.00993328812433594
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,29429,0.00663512064580859,0.00257553939315611,0.00158706343522261,0.0116831778563946,0.00999393604286257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,29286,-0.00948508480922692,0.00368195594453491,-0.0167017184605153,-0.0022684511579385,0.00999704507099252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,24917,-0.00499747525552477,0.00194211166101818,-0.00880401411112041,-0.00119093639992913,0.0100815261918272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24800,-0.0182785812358423,0.00710634671592392,-0.0322070207990531,-0.00435014167263138,0.010112713037378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,24440,0.00518731667796752,0.00201726108295532,0.00123348495537509,0.00914114840055994,0.0101327793844587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,29429,-0.0131557613176011,0.00511927464427828,-0.0231895396203865,-0.00312198301481568,0.0101791718546938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,24800,-0.0118717801940754,0.00463062145899907,-0.0209477982537136,-0.00279576213443724,0.0103604948160657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,29473,-0.00644957670035646,0.00252033233250607,-0.0113894280720684,-0.00150972532864458,0.0105017702474982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24106,-0.00818694802246031,0.00320221345942759,-0.0144632864029384,-0.00191060964198223,0.0105745388924915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,24096,-0.0129361451398932,0.00507613755510747,-0.0228853747479038,-0.00298691553188253,0.010827272330015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24788,-0.0162273302517005,0.00637775113915432,-0.028727722484443,-0.00372693801895804,0.0109536606863274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,29531,-0.0144445318953058,0.0056857330923678,-0.0255885687563467,-0.00330049503426491,0.0110748937151724
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,24235,0.00414512920574449,0.00163509084435925,0.000940351150800359,0.00734990726068863,0.0112475558072367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,24840,-0.0102402868323669,0.00404392340194321,-0.0181663767001756,-0.00231419696455817,0.0113389317665205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,24788,-0.00584033338908868,0.00230735312332065,-0.0103627455107972,-0.00131792126738021,0.0113739793775843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24235,-0.0034845781145366,0.00137667179465365,-0.00618285483205775,-0.000786301397015457,0.0113748344220468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,24788,-0.00564227762369451,0.00223506606466587,-0.0100230071104396,-0.0012615481369494,0.0115946565505887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,24917,-0.0135654415294435,0.00538080829450989,-0.0241118257866828,-0.00301905727220408,0.0117057567288346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,28792,-0.00506110625759305,0.00200852942084208,-0.00899782392244353,-0.00112438859274256,0.0117472904217196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,29561,0.00622309205416254,0.00247465042807634,0.00137277721513291,0.0110734068931922,0.0119174262730777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,24917,-0.00881596533668317,0.00350726129769235,-0.0156901974801602,-0.00194173319320615,0.0119557514879146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,24224,-0.0114291520422029,0.00455113452528998,-0.0203493757117713,-0.00250892837263459,0.0120360397498495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,24224,-0.00691421044812828,0.00276274215042165,-0.0123291850629547,-0.00149923583330185,0.0123328490916143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",28769,-0.00696345022225288,0.00278645512136497,-0.0124249022601282,-0.00150199818437754,0.0124587163545897
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,24788,-0.00907740429409265,0.00363916190421977,-0.0162101616263634,-0.0019446469618219,0.0126246744781143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28769,-0.0111339875308511,0.00446730375985671,-0.0198899029001703,-0.00237807216153194,0.0126964523763776
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24096,-0.0052585226054365,0.00211078942777609,-0.00939566988387763,-0.00112137532699536,0.0127358168426625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,28926,-0.00952128174116531,0.0038268619692717,-0.0170219312009378,-0.00202063228139278,0.0128514971302002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24788,-0.0175760066433065,0.00706889340073102,-0.0314310377087393,-0.00372097557787368,0.0129112804063468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24011,-0.0109019597964627,0.00438476690955302,-0.0194961029391866,-0.00230781665373874,0.0129137167205723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,24106,0.00595049186253317,0.00239602981407228,0.0012542734269515,0.0106467102981149,0.0130173162992673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,29344,-0.0031133941500166,0.00125505655479123,-0.00557330499740741,-0.000653483302625789,0.01311875492229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24376,-0.00803759365870315,0.0032460618224066,-0.0143998748306201,-0.00167531248678622,0.0132891498150669
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,24190,-0.0168167022096648,0.00679217786115849,-0.0301293708175354,-0.00350403360179414,0.0132971546801242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,29683,-0.0151637987350019,0.00613236989554407,-0.0271832437302682,-0.00314435373973549,0.0134134671931683
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,24190,-0.012254791958741,0.00496085472447904,-0.02197806721872,-0.00253151669876212,0.0135068834227113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,28911,-0.00379510768207238,0.00154010953377544,-0.00681372236827224,-0.000776492995872514,0.0137384758440078
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,24440,-0.00628148802455487,0.00255023798706263,-0.0112799544791976,-0.00128302156991211,0.0137810419276791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,24011,-0.0231987639422928,0.00944124651089331,-0.0417036071036437,-0.00469392078094191,0.0140105967002281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,24946,-0.00395583466710534,0.00161089159099075,-0.00711318218544721,-0.000798487148763472,0.0140685950619508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,24106,-0.0104873861754332,0.00428940619281331,-0.0188946223133473,-0.0020801500375191,0.0144943107380316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,24440,-0.00591997824304446,0.00242302208401548,-0.0106691015277148,-0.00117085495837413,0.014563854050005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,24106,-0.0144644764394704,0.00593666831055654,-0.0261003463281612,-0.0028286065507796,0.0148388531466454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,29344,-0.0181435602390923,0.00746137432414104,-0.0327678539144087,-0.00351926656377582,0.0150355605808218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,29473,-0.0122779701350736,0.00506005281200167,-0.0221956736465969,-0.00236026662355033,0.0152532697294178
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,28769,-0.0104341389171869,0.00430156230719509,-0.0188652010392892,-0.00200307679508448,0.015286580134712
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,24224,-0.0147321781956852,0.00607478866990603,-0.026638763988701,-0.0028255924026694,0.0153099905717071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,24020,-0.00990792432022805,0.00411269654857623,-0.0179688095554375,-0.00184703908501865,0.0159991075159901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,29158,-0.00767348697896593,0.00318526911630877,-0.0139166144469311,-0.00143035951100074,0.0160000702310528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,24106,-0.00801051253142578,0.00332597364682863,-0.0145294208792099,-0.00149160418364166,0.0160269395077363
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,24224,-0.00910859739576025,0.00378211432228333,-0.0165215414674356,-0.00169565332408491,0.0160329036055162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,24096,-0.0117823088398973,0.00489953112688531,-0.0213853898485925,-0.00217922783120212,0.0161895726318288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24224,-0.00491204242556415,0.0020479487134768,-0.00892602190397868,-0.000898062947149623,0.0164690732595236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24788,-0.00706945579787975,0.00294788017779333,-0.0128473009463547,-0.00129161064940483,0.0164855130541756
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,24840,-0.0213560254824357,0.00894413283959883,-0.0388865258480494,-0.00382552511682195,0.0169609914317045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,24917,-0.00554534621091128,0.00232513695877058,-0.0101026146501016,-0.000988077771720951,0.0170886620437899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28926,0.00934081056538514,0.00392019329790543,0.00165723170149051,0.0170243894292798,0.0171906390926811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24800,-0.00619546303045126,0.00260186440031447,-0.0112951172550676,-0.0010958088058349,0.0172655833142655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,28792,-0.00893394759302918,0.00375233942366022,-0.0162885328634032,-0.00157936232265515,0.0172768330988541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,28769,-0.00800890479202908,0.00336896798885891,-0.0146120820501925,-0.00140572753386562,0.0174484034861082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,24011,0.00648570614471939,0.00273048944318093,0.00113394683608477,0.011837465453354,0.0175429441470594
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,24096,-0.0118938028088445,0.00500845306756253,-0.0217103708212671,-0.00207723479642195,0.0175688274409856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,24788,-0.00816785141173608,0.00344059518728193,-0.0149114179788087,-0.00142428484466349,0.0176058113820637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,28769,-0.011418408543136,0.00481033735451163,-0.0208466697579788,-0.0019901473282932,0.0176162844105123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,24096,-0.00438242270164969,0.00184833486142969,-0.00800515903005189,-0.0007596863732475,0.0177473156273119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,29781,-0.00585443415193704,0.00246922787813365,-0.010694120793079,-0.00101474751079508,0.0177484045199566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,24106,-0.00945732210998993,0.0039888864421642,-0.0172755395366318,-0.0016391046833481,0.0177517948243325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,29438,-0.00373866635714095,0.00157899303110582,-0.00683349269810835,-0.000643840016173547,0.0179028811595673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,24574,0.00405785372117701,0.00171400311162842,0.000698407622385305,0.00741729981996871,0.0179177980986238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,28769,-0.00800489514082564,0.00338918351954945,-0.0146476948391426,-0.00136209544250871,0.0181884232907664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,29720,-0.00834419647248067,0.00353329360750219,-0.015269451943185,-0.00141894100177638,0.0182030920740603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,24235,-0.00744198548045699,0.00315271258465703,-0.0136213021463848,-0.00126266881452922,0.0182580816212277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29344,-0.00837174688893966,0.00355053905512149,-0.0153308034369778,-0.00141269034090154,0.0183861347043173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24863,-0.0178616465147153,0.00757601974859082,-0.0327106452219533,-0.00301264780747728,0.018398445423981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,28792,-0.0141653629810635,0.00601276169221264,-0.0259503758978003,-0.00238035006432678,0.0184854061964116
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24106,-0.00315674896727384,0.00134306712101431,-0.00578916052446189,-0.000524337410085793,0.0187611145403791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,24961,0.0111989260124277,0.00476666666032814,0.00185625935818452,0.0205415926666708,0.0188101827070904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,29456,-0.0289055080884793,0.0123130855933098,-0.0530391558513665,-0.0047718603255921,0.0189042339666208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24096,-0.00757214855596357,0.00322709466709713,-0.0138972541034739,-0.0012470430084532,0.0189623369580571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,24224,-0.00837275702566605,0.00357420416220008,-0.0153781971835782,-0.0013673168677539,0.0191604500389678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,29720,-0.00325648511389048,0.00139031753408545,-0.00598150748069795,-0.000531462747083003,0.0191739254337217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29158,-0.0112175640591954,0.00479627796200199,-0.0206182688647193,-0.00181685925367153,0.0193521932593491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,24224,-0.00873753737418985,0.0037376017862893,-0.0160632368753169,-0.00141183787306282,0.0194088944433916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,28926,-0.00945601902188021,0.00404713171671136,-0.0173883971866345,-0.00152364085712595,0.0194733324394168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,29731,0.00712726614965772,0.00305046820336057,0.00114834847107101,0.0131061838282444,0.0194744156655587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28733,-0.00894134555392176,0.00382691861945574,-0.016442106048055,-0.00144058505978852,0.0194754359220537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,24224,-0.0095768983071733,0.00410347899924746,-0.0176197171456983,-0.00153407946864828,0.0196117951063938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,23493,0.0188637947658275,0.00809281630659764,0.00300187480489616,0.0347257147267589,0.0197654302713837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,29338,-0.00471493379915987,0.00202412032204349,-0.00868220963036511,-0.000747657967954623,0.0198460018251449
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,24096,-0.0165620733996272,0.00711022465538881,-0.0304981137241892,-0.00262603307506511,0.0198497133120461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,28911,-0.00524274492687682,0.00225353222393637,-0.0096596680857921,-0.000825821767961535,0.020001083168821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,24096,-0.00751717040390424,0.00323619279961109,-0.013860108291142,-0.0011742325166665,0.0201958332610419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,24190,-0.00745274540169112,0.00320872541485068,-0.0137418472147984,-0.00116364358858378,0.0202062319444306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,24933,0.00566554009859969,0.00244064866147445,0.000881868722109762,0.0104492114750896,0.0202773045112681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24106,-0.0131661451021397,0.00567387314410929,-0.0242869364645939,-0.00204535373968549,0.0203228910950008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,24224,-0.00980869669382846,0.00422888623466912,-0.0180973137137799,-0.00152007967387699,0.02037884305532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,24796,-0.0056716712193577,0.00244700976985504,-0.0104678103682736,-0.000875532070441829,0.0204684731986933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,28792,-0.0124127426436867,0.00535910616708895,-0.0229165907311811,-0.00190889455619239,0.0205545349629838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,29781,-0.00927992668499239,0.00400918057769599,-0.0171379206172765,-0.00142193275270824,0.0206378135210447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTTG1,Securin,24440,-0.00628653076705775,0.00272111626433024,-0.011619918645145,-0.000953142888970479,0.020881146473293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORT1,Sortilin,29428,-0.00563932447842556,0.00244183628029667,-0.010425323587807,-0.000853325369044092,0.0209249319888174
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29344,-0.00423402079803232,0.00183398367671787,-0.00782862880439935,-0.000639412791665285,0.0209700990607671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LXN,Latexin,29112,-0.0101767137405905,0.0044124593702961,-0.0188251341063709,-0.00152829337481018,0.0210975930988295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24863,-0.00888329251486031,0.00385281076466912,-0.0164348016136118,-0.00133178341610884,0.0211375287043968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",24917,-0.00762076134483461,0.00332161013115107,-0.0141311172018907,-0.00111040548777851,0.0217817060259777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,24863,-0.00412774313302267,0.0017996714150455,-0.00765509910651186,-0.000600387159533484,0.0218212556472962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,24276,-0.00644203010865139,0.00280957290245043,-0.0119487929974542,-0.000935267219848552,0.021863088530013
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24917,-0.0045156723540175,0.0019739047372192,-0.00838452563896713,-0.000646819069067878,0.0221642123922685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,28792,-0.024844272996519,0.0108644355070354,-0.0461385665903084,-0.00354997940272956,0.0222175118755994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23845,-0.00496459367914852,0.00217247606526292,-0.00922264676706383,-0.000706540591233204,0.0223084598880279
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,24440,-0.00585760036225834,0.00256500582056814,-0.0108850117705719,-0.000830188953944789,0.0224000841299921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,24440,0.00515999512413048,0.00225994073238079,0.000730511288664122,0.00958947895959684,0.0224245739718897
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24096,-0.00490688895084075,0.00215346982413495,-0.00912768980614525,-0.000686088095536247,0.0226997734274803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,24440,-0.00507316432159374,0.00223216406944149,-0.00944820589769907,-0.00069812274548841,0.0230495347297699
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29422,0.0109899371412287,0.00483847238202221,0.00150653127246513,0.0204733430099922,0.023132081089739
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,24788,-0.0060716024526829,0.00267328357160287,-0.0113112382530245,-0.000831966652341279,0.0231424906436789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,28792,-0.00948630039070898,0.00419794251450674,-0.0177142677191422,-0.00125833306227577,0.0238442187083266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,28926,-0.00450995123484924,0.00199678663546271,-0.00842365304035615,-0.000596249429342334,0.0239154181748313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24840,-0.0102438283452743,0.00453648219611604,-0.0191353334496618,-0.00135232324088687,0.023948099459842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,24771,-0.0139609066960679,0.00618886010342881,-0.0260910724987884,-0.00183074089334745,0.0240910795209607
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,24376,-0.00507973406742566,0.00225306104690545,-0.00949573371936034,-0.000663734415490976,0.0241677745665863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,24235,-0.00641047568825636,0.00285470023060011,-0.0120056881402326,-0.000815263236280152,0.0247394995575591
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24235,0.00543765658712777,0.00243941991299998,0.000656393557647816,0.0102189196166077,0.0258178699185286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,24096,-0.00919375520989626,0.00412754157412817,-0.0172837366951875,-0.00110377372460505,0.0259286390779639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,24106,-0.00711623350329776,0.00319557875336529,-0.0133795678598937,-0.000852899146701783,0.0259631807650765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,28792,-0.00767626327195628,0.00344840562547585,-0.0144351382978889,-0.000917388246023621,0.0260197127477019
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,24815,-0.0158899906176603,0.00714961388991066,-0.0299032338418852,-0.00187674739343543,0.0262587649717018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,29720,0.00627718680831728,0.0028273908754726,0.00073550069239098,0.0118188729242436,0.0264171860516223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NENF,Neudesin,24788,-0.0160058409197612,0.00721613093402232,-0.030149457550445,-0.00186222428907747,0.026559496238818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",24190,-0.00568760497390623,0.00256514603485076,-0.0107152912022137,-0.000659918745598745,0.0266143472503175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",28911,-0.00634645636237773,0.00286433224878303,-0.0119605475699925,-0.000732365154762988,0.0267208854795498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,24800,-0.0120653493944035,0.00545200884338743,-0.0227512867274429,-0.00137941206136418,0.0269060406903346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24440,-0.0102440375950248,0.00463225839300115,-0.019323264045307,-0.00116481114474252,0.0270134699319089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,24224,-0.00701030704051656,0.00317442437557967,-0.0132321788166527,-0.0007884352643804,0.0272277500079916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24224,-0.00707592121560332,0.00320498599623146,-0.013357693768217,-0.000794148662989666,0.0272685785080757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29213,-0.00413894688927899,0.00187555792681018,-0.00781504042582695,-0.000462853352731031,0.0273370673180346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,24933,-0.0162812892434854,0.007388577603775,-0.0307629013468844,-0.00179967714008644,0.0275633187322171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,24106,-0.00975603333398867,0.00443110998721899,-0.0184410089089379,-0.00107105775903944,0.0276950174078146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,29561,-0.00773872992122269,0.00351687174165543,-0.0146317985348673,-0.000845661307578047,0.0277820987361918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29340,0.0267769374611606,0.0121786251237957,0.00290683221852099,0.0506470427038003,0.0279082434807297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,28792,-0.0125312679147421,0.00570583797099559,-0.0237147103378935,-0.00134782549159076,0.0280842440656265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,28792,-0.00652001545189727,0.00297077465772624,-0.0123427337810407,-0.000697297122753834,0.028191724762757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,28926,-0.0094025695810913,0.00428447106514659,-0.0178001328687786,-0.00100500629340399,0.0282024172867124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,24863,-0.00793501316282659,0.00362045167876632,-0.0150310984532086,-0.000838927872444613,0.0284090408905955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,29815,-0.00358496918398393,0.00163719048092872,-0.00679386252660422,-0.000376075841363628,0.0285531416925958
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,24440,-0.00509758328112604,0.00232861565041822,-0.00966166995594575,-0.000533496606306324,0.0285986674883507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24096,-0.00882720551711167,0.004033445697572,-0.0167327590843528,-0.000921651949870558,0.0286425990254283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",24106,-0.00902589003404174,0.00412640817953945,-0.0171136500659391,-0.000938130002144422,0.0287267184348542
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,28926,-0.0204215638787513,0.00934201622181373,-0.0387319156735063,-0.00211121208399643,0.0288242515151886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,29815,-0.00585275428617047,0.00267753076946073,-0.0111007145943135,-0.00060479397802744,0.0288323222515261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERVV_1,,24106,-0.00662910604154387,0.00303424226217113,-0.0125762208753993,-0.000681991207688449,0.0289156896339559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,28769,-0.00968090357007963,0.00443265571014883,-0.0183689087619713,-0.00099289837818793,0.0289705724204326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,24096,-0.0066106959897294,0.0030311587415972,-0.0125517671232599,-0.000669624856198894,0.0291994331367825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,24840,-0.00736773588437566,0.00337839576506258,-0.0139893915838983,-0.000746080184852995,0.029204710078706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,29429,-0.0130461244857417,0.00599946439250817,-0.0248050746950577,-0.00128717427642566,0.0296719318526586
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,24224,-0.00626728601923727,0.00288379312423967,-0.011919520542747,-0.000615051495727513,0.0297690129003913
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24440,-0.00924388653182181,0.00426215527246275,-0.0175977108658488,-0.000890062197794819,0.0301052748826137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,29756,-0.00852776485541611,0.00393711684087884,-0.0162445138635386,-0.000811015847293593,0.0303196922939621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29421,-0.00867773162176792,0.00401733907741587,-0.016551716213503,-0.000803747030032812,0.0307753431778661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,24863,-0.0108314961118833,0.0050184120421478,-0.020667583714493,-0.00099540850927362,0.0309100759527953
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,28649,-0.00999822073732083,0.00463326110413285,-0.0190794125014212,-0.000917028973220445,0.0309421057019733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,24788,0.00958044195949914,0.00443989626208062,0.00087824528582113,0.0182826386331772,0.0309523726772501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,29720,0.00647264116077275,0.00300184377237342,0.000589027366920837,0.0123562549546247,0.0310743466460617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,29815,-0.00447853382999917,0.00207800501343296,-0.00855142365632777,-0.000405644003670573,0.03115351423207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,24440,-0.00325968942302976,0.00151336080628596,-0.00622587660335024,-0.000293502242709283,0.0312545746847595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,28874,-0.00604245939811336,0.00280697109905023,-0.0115441227522518,-0.000540796043974903,0.0313535324192536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,24106,-0.00955446481192666,0.00443848457203255,-0.0182538945731105,-0.00085503505074286,0.031356785471611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,24788,-0.00861884541311639,0.00400822521783835,-0.0164749668400796,-0.000762723986153215,0.0315419533073869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,24011,-0.0131806563314071,0.00613630718401146,-0.0252078184120696,-0.00115349425074466,0.0317254383581455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,24440,-0.00587166375989414,0.00273576498402944,-0.0112337631285918,-0.000509564391196448,0.0318620381282018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,29493,-0.0130916739606459,0.00610190198086697,-0.0250514018431452,-0.00113194607814668,0.0319204679904908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28911,-0.00683747223862568,0.00319793109582142,-0.0131054171864357,-0.0005695272908157,0.0325176058808595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,24840,-0.0066040110699901,0.00309720070366576,-0.012674524449175,-0.000533497690805213,0.0329959564315437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAT,Catalase,24582,-0.00747905369121232,0.00351393802264756,-0.0143663722156015,-0.000591735166823095,0.0333141383365035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,28792,-0.0055647829630951,0.00261511088373573,-0.0106904002952171,-0.000439165630973062,0.033351043050103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,24800,-0.0205082101466254,0.00965937846656962,-0.0394405919411019,-0.00157582835214897,0.0337520259409239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,29213,-0.0046151034620427,0.00217615077699691,-0.00888035898495664,-0.000349847939128758,0.0339500249230042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,24376,-0.00397034060893968,0.00187448325247799,-0.00764432778379654,-0.000296353434082813,0.0341768040082674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29815,-0.00972585468439531,0.00459488930792301,-0.0187318377279244,-0.000719871640866203,0.0342963081801146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,24440,-0.0233885400089276,0.0110722876736162,-0.0450902238492155,-0.00168685616863983,0.0346666148089065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,24946,-0.00883792163173871,0.00418474651498953,-0.0170400248011182,-0.000635818462359225,0.0347017599718864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,24106,-0.00864162620062424,0.00409229204881128,-0.0166625186162943,-0.000620733784954126,0.03472386026625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,24788,-0.00553261504374701,0.00262369858253866,-0.0106750642655228,-0.000390165821971232,0.0349797765178084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,24788,-0.00603269386226038,0.00286116487307189,-0.0116405770134813,-0.000424810711039473,0.0349999581993569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,24344,-0.00508513829288533,0.00241192293212883,-0.00981250723985783,-0.000357769345912832,0.0350123354177593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24863,-0.00522983936412885,0.00248150186953582,-0.0100935830284191,-0.000366095699838634,0.0350816641422791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEO1,Neogenin,24863,-0.00302927289857511,0.00143801195374967,-0.00584777632792447,-0.000210769469225748,0.035164864863114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,24917,-0.00779122780267169,0.00370157163150252,-0.0150463082004166,-0.000536147404926745,0.0353149530145127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,24440,-0.00404201506557384,0.00192114202818518,-0.00780745344081678,-0.00027657669033089,0.0353917185797861
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,24054,-0.0117873542343352,0.00560323462737622,-0.0227696941039926,-0.000805014364677803,0.0354176407970102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,28769,-0.00535075576786779,0.00254624496090352,-0.0103413958912387,-0.000360115644496887,0.0356119077767908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,24011,-0.0100697647256072,0.00479530229458115,-0.0194685572229863,-0.000670972228228187,0.0357460435001282
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,24224,-0.00574238391304759,0.00273508116209296,-0.0111031429907498,-0.000381624835345384,0.0357805640658781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24106,-0.00519542486765968,0.0024749236127544,-0.0100462751486583,-0.00034457458666105,0.0358073297822829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",27981,-0.00401024801609417,0.00191600699701786,-0.00776562173024917,-0.00025487430193916,0.0363560273233236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,24788,-0.00765184365358285,0.00365839236003941,-0.0148222926792601,-0.000481394627905604,0.0364856884995228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,28792,-0.0134292794844034,0.0064245606446405,-0.0260214183478987,-0.00083714062090799,0.036599327857856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,24917,-0.0144980817855763,0.00694502588195146,-0.0281103325142011,-0.000885831056951432,0.0368486756712896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,24788,-0.00935702484163007,0.00448574529204525,-0.0181490856140388,-0.000564964069221381,0.0369936712631291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,24106,-0.0134506391292059,0.00645268358005306,-0.0260978989461099,-0.000803379312301851,0.0371249318440841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24917,0.0037571038566866,0.00180464934972029,0.000219991131234832,0.00729421658213837,0.0373615690694321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,24440,-0.0103180769054589,0.00495609266414939,-0.0200320185271917,-0.000604135283726142,0.0373622183408353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,24096,-0.00683647118832535,0.00328515488946754,-0.0132753747716817,-0.00039756760496897,0.0374426674015622
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,24106,-0.0100788466485384,0.00485436175356409,-0.019593395685524,-0.000564297611552779,0.0378818303358981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24011,0.00416921165397687,0.00200969628951068,0.000230206926535938,0.0081082163814178,0.0380390687788077
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28493,0.0116684472339642,0.00562976330217412,0.000634111161702896,0.0227027833062255,0.0382151895394156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,29815,-0.00373533950749405,0.00180253670493851,-0.00726831144917353,-0.000202367565814567,0.0382490141885637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24106,-0.0101067730300528,0.00487868182562291,-0.0196689894082737,-0.000544556651831851,0.0383115450585133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24376,-0.00297208659358033,0.00143505483122994,-0.00578479406279101,-0.000159379124369637,0.0383635674819832
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,24096,-0.00595165172424358,0.00287494280859696,-0.0115865396290936,-0.000316763819393535,0.0384460399279665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,24610,-0.00871307807524071,0.00421273083112663,-0.0169700305042489,-0.000456125646232508,0.0386247724126075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24096,0.00618019324119726,0.00299417719570644,0.000311605937612641,0.0120487805447819,0.0390217050761674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29082,-0.00804242108196968,0.00390108820663889,-0.0156885539669819,-0.000396288196957455,0.0392562277034486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,28769,-0.00744747969246177,0.00361576472950526,-0.0145343785622921,-0.000360580822631448,0.0394338529217794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,28769,-0.0195967008574905,0.00953375016740857,-0.0382828511856113,-0.000910550529369718,0.0398389623285252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,28792,0.0103078625397009,0.00501927411263699,0.0004700852789324,0.0201456398004694,0.0400180109352168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,24011,-0.011780684651379,0.00573847866988047,-0.0230281028443447,-0.000533266458413294,0.0400903602742385
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,24190,0.00649386350845724,0.00317990709278602,0.000261245606596642,0.0127264814103178,0.0411469755470377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,24106,-0.00458024696074689,0.00224287907946849,-0.00897628995650514,-0.00018420396498864,0.0411496665647892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,28926,-0.00646183320318687,0.00316611546206477,-0.0126674195088338,-0.000256246897539907,0.0412664340427456
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,24224,-0.00626391191512896,0.00307423235928563,-0.0122894073393288,-0.000238416490929133,0.0416054887093392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,28769,-0.00643514774600799,0.00315897281468147,-0.0126267344627837,-0.000243561029232316,0.0416490261542819
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,28911,0.00759239529690964,0.00373041804071789,0.000280775937102579,0.0149040146567167,0.0418331594080135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24917,-0.0098456316305915,0.00484499945577868,-0.0193418305639177,-0.000349432697265289,0.0421518636537781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",24106,-0.00636010403263391,0.00314382622501669,-0.0125220034336666,-0.000198204631601196,0.0430794608714332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,29328,-0.00454195571616992,0.00224607265947799,-0.00894425812874677,-0.000139653303593058,0.0431671683211719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,28792,0.00440331622543685,0.00217796764680807,0.000134499637693029,0.00867213281318068,0.0432109403159713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,28769,-0.00764123611432159,0.00378027673666806,-0.015050578518191,-0.000231893710452189,0.043253511392148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24376,0.00850746895821811,0.00421201673897949,0.0002519161498183,0.0167630217666179,0.0434141375297136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29492,-0.00353473318510817,0.00175225950656996,-0.0069691618179853,-0.000100304552231052,0.0436792091635103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,24106,-0.00529562433050194,0.00262630686303618,-0.0104431857820529,-0.000148062878951032,0.0437716609999896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,24054,-0.00454598964628707,0.00225988738762378,-0.00897536892602967,-0.000116610366544461,0.0442732488383729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,28769,-0.00978388636607653,0.00486617758422028,-0.0193215944311483,-0.00024617830100478,0.0443781345937736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,24106,-0.00506535752588163,0.00252646451226092,-0.010017227969913,-0.000113487081850234,0.0449828390025243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,24727,0.00654440161321422,0.00326712760866958,0.000140831500221845,0.0129479717262066,0.0451768549134465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,24011,0.00539594216386472,0.00269406827459639,0.000115568345655803,0.0106763159820736,0.0451995362414416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,29429,-0.00450194803769603,0.00224789255064094,-0.00890781743695227,-9.60786384397849e-05,0.0452141856506144
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,24863,0.0058002521256928,0.00289987302395466,0.000116500998741669,0.0114840032526439,0.0454922851690513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,24106,-0.00728608258822767,0.00364502851352238,-0.0144303384747315,-0.00014182670172381,0.0456293468071386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,24224,-0.00437954150714276,0.002191099648384,-0.00867409681797539,-8.49861963101205e-05,0.045642564482848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,28769,0.00560829547808798,0.00281078204971103,9.9162660654367e-05,0.0111174282955216,0.046021836229923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",29344,0.0135610985394259,0.00680021846889049,0.000232670340400587,0.0268895267384513,0.0461377909994128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,24440,-0.0070015925333549,0.00351186820522483,-0.0138848542155956,-0.000118330851114235,0.0461965450566872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,24788,-0.00757146510388125,0.00379939004867434,-0.015018269599283,-0.000124660608479547,0.0462931322202843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,29441,0.0056674186356692,0.00284597874857516,8.93002884618868e-05,0.0112455369828765,0.0464486070570794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,24096,-0.00642643305453125,0.00322927892418906,-0.0127558197459418,-9.7046363120694e-05,0.0465964926342777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,29576,-0.00368015143765097,0.00185217677340655,-0.0073104179135278,-4.98849617741382e-05,0.0469390197293914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,29429,0.00853414589586875,0.00429903942260436,0.000108028627564198,0.0169602631641733,0.047139443200857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23489,-0.00652326015778474,0.00329103402996972,-0.0129736868565254,-7.28334590440801e-05,0.0474762367467399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,29561,-0.0127792536291791,0.00645772322220711,-0.025436391144705,-0.000122116113653186,0.0478353996675239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,29213,-0.0114835288084214,0.00580570415568093,-0.022862708953556,-0.000104348663286735,0.047941085106452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,24715,-0.0036464395879122,0.00184358666248259,-0.00725986944637808,-3.30097294463298e-05,0.0479505012041636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,24376,-0.00371434811794408,0.00188063500319373,-0.00740039272420379,-2.83035116843736e-05,0.0482737480355005
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,24106,-0.00862418637387283,0.00436724250649993,-0.0171839816866127,-6.4391061132962e-05,0.0483085953711071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,29815,-0.00937684826818579,0.00475969044486349,-0.0187058415401182,-4.78549962533437e-05,0.0488414007629004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,29635,-0.00934214057100815,0.00474967842868447,-0.0186515102912297,-3.27708507865902e-05,0.0492041071722227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,24224,-0.0112828747176331,0.00573949014055646,-0.0225322753931238,-3.34740421424305e-05,0.0493294038579412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",24190,-0.0108839167468676,0.00555641631605243,-0.0217744927263304,6.65923259513847e-06,0.0501475136339053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,29438,-0.00461053288171926,0.00235773671412964,-0.00923169684141335,1.06310779748259e-05,0.0505345978884357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,29438,-0.00345672613396279,0.00176882498377792,-0.00692362310216751,1.01708342419389e-05,0.0506811233938846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28926,-0.00714736058088417,0.00365876120266261,-0.0143185325381029,2.38113763345463e-05,0.0507709600799197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,24788,-0.00729465700409015,0.00373748521477564,-0.0146201280250504,3.08140168700944e-05,0.0509785015831093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,24096,-0.0122411469746684,0.0062780705694255,-0.0245461652907424,6.38713414055758e-05,0.0512084171737339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,28911,-0.0137520716175135,0.00705330974221149,-0.027576558712248,7.2415477221038e-05,0.0512175948555414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,29650,-0.00401047895000327,0.00205780630248081,-0.00804377930286566,2.28214028591151e-05,0.051315615240415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",24224,-0.00372639085554822,0.00191370795450169,-0.00747725844637153,2.4476735275085e-05,0.0515211353983272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,24224,-0.00519673740926761,0.00268145936491781,-0.0104523977645065,5.89229459712964e-05,0.0526316876090361
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24096,-0.00718782355241823,0.00371143508695341,-0.0144622363228469,8.65892180104584e-05,0.0527974255427443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,24096,-0.00715821026840774,0.00369806663796245,-0.0144064208788141,9.00003419986636e-05,0.0529206953546906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,29720,0.00337312429020427,0.00174333633650562,-4.38149293467568e-05,0.00679006350975529,0.0530160759517534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,24190,0.00479694565093859,0.00247958676641084,-6.30444112266499e-05,0.00965693571310384,0.0530541680532998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,24800,0.01071288563038,0.00554299244085032,-0.000151379553686642,0.0215771508144466,0.0532857857590723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,24106,-0.0125730227603989,0.00653081241540416,-0.025373415094591,0.000227369573793261,0.0542179637144202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,29473,-0.00359335334042598,0.00187120029068492,-0.00726090591016843,7.41992293164621e-05,0.0548237620687624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,24440,-0.00427285281982288,0.00222824657774195,-0.0086402161121971,9.45104725513408e-05,0.0551752680847993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,28792,-0.00700611245581509,0.00365508821864092,-0.0141700853643513,0.000157860452721107,0.0552718681876931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,28926,0.00886786882291826,0.00462691059292731,-0.000200875939219273,0.0179366135850558,0.0553004842748412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,24224,-0.00513705699792203,0.00268102603734901,-0.0103918680311261,0.000117754035282035,0.0553668367500581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,24933,-0.00418674079362756,0.00218526796929606,-0.00846986601344783,9.63844261927162e-05,0.0553900770850391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,24011,-0.00749692517297695,0.00391479961437597,-0.0151699324171538,0.000176082071199948,0.0555016448393399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,24840,-0.00477726734331606,0.00250104500690839,-0.0096793155568565,0.000124780870224375,0.0561307542245306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,24822,-0.00298583086669483,0.00156338703634762,-0.00605006945793616,7.84077245465013e-05,0.0561643680800616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,24235,-0.00502869109210271,0.00263881281655484,-0.0102007642125502,0.00014338202834478,0.0567056152553919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGN,Biglycan,28745,0.0149645403449028,0.0078572438939862,-0.000435657687310187,0.0303647383771157,0.0568481296018421
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,29513,-0.00564978442058604,0.00296914365160619,-0.0114693059777342,0.000169737136562091,0.0570720705517575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,24096,-0.0117567743088543,0.00618950626979704,-0.0238882065976565,0.000374657979947859,0.0575147958585914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,24440,-0.00917345581083094,0.0048317585131205,-0.0186437024965471,0.000296790874885246,0.0576321549907498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,24863,-0.00823949685342345,0.00434106668015708,-0.0167479875465313,0.00026899383968443,0.0577030377631538
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24106,-0.00462525325940189,0.00244099514706589,-0.00940960374765103,0.000159097228847251,0.0581278431798755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,24106,-0.00825827872057801,0.00436369475390991,-0.0168111204382414,0.000294562997085426,0.0584367852169945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,29344,0.0117145461051068,0.00619190795040414,-0.00042159347768529,0.023850685687899,0.0585125227501535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,29213,0.00288633922290415,0.00152948915068445,-0.000111459512437363,0.00588413795824566,0.0591532484796406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24224,-0.00540059475684695,0.00286192802162744,-0.0110099736792367,0.000208784165542823,0.0591658600987457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,29211,-0.00640222125773466,0.00339571392238917,-0.0130578205456174,0.000253378030148119,0.0593880693594737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,24106,-0.00414394902915167,0.00220034154920939,-0.00845661846560208,0.000168720407298734,0.0596689400447957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,24224,-0.003995200161116,0.00212395534053621,-0.00815815262856696,0.000167752306334967,0.0599813373416083
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24235,0.00322362358598285,0.00171439889431673,-0.000136598246877948,0.00658384541884364,0.060076067181633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,29213,-0.00365631958922237,0.00195125852052938,-0.00748078628945996,0.000168147111015221,0.0609643452696642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24190,-0.0095832574961467,0.0051191895411913,-0.0196168689968817,0.000450354004588259,0.0612150272984709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,24011,-0.00372014994405088,0.00198857031105395,-0.00761774775371662,0.000177447865614863,0.0613896680856346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",28769,-0.00623664571490241,0.00334292991760738,-0.0127887883534129,0.000315496923608055,0.062104355764859
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,24096,-0.0111487051244923,0.00598140685567478,-0.0228722625616149,0.000574852312630237,0.0623488270366378
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,29429,-0.00995839794247112,0.00534603920647075,-0.0204366347871538,0.00051983890221155,0.0625057388469918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,28792,-0.00409124298300507,0.00219650475013804,-0.00839639229327562,0.000213906327265478,0.0625266159427264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,24096,-0.00583056836424156,0.00313478371741783,-0.0119747444503805,0.000313607721897394,0.062903547415448
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,29344,-0.00729315578256332,0.00392580619960151,-0.0149877359337823,0.000401424368655653,0.0632149253041818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,29438,-0.00534020685132743,0.00287561497824136,-0.0109764122086805,0.000295998506025633,0.0633117478599807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,24190,-0.00738972652396762,0.00397926667840558,-0.0151890892136426,0.000409636165707309,0.0633151450428299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,28586,-0.010268898074828,0.00553726086216108,-0.0211219293646637,0.000584133215007715,0.0636767220064569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,24190,-0.00525955161365781,0.00283827767213762,-0.0108225758510475,0.000303472623731913,0.0638832700343064
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,24106,-0.00418333409901864,0.00226084470269936,-0.00861458971630938,0.000247921518272099,0.0642766228156687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,24224,-0.0079615181735332,0.00430791073719792,-0.0164050232184411,0.000481986871374719,0.0645977711811622
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,24011,-0.00494543957649506,0.00268176732185701,-0.0102017035273348,0.000310824374344688,0.0651812968220962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,24224,-0.00361913283317134,0.00197166887900403,-0.00748360383601925,0.000245338169676561,0.0664337919605646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,24224,-0.00496055336454117,0.00270433323565992,-0.0102610465064346,0.000339939777352269,0.0666220188206472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,29344,0.00252666952910195,0.00137783367903872,-0.000173884481813943,0.00522722354001784,0.0666940160176413
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,29033,-0.0205857385414641,0.0112752256690407,-0.0426851808527838,0.00151370376985569,0.0678982625902537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,24840,-0.00355276051097081,0.00195108857362217,-0.00737689411527027,0.00027137309332865,0.068632272921956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,24190,-0.00274093189889632,0.00150574196966384,-0.00569218615943745,0.000210322361644814,0.0687226781311074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,24224,-0.00553863832033656,0.00304312818074155,-0.01150316955459,0.000425892913916888,0.0687640895773804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,24788,0.00707818009977116,0.00390376622898807,-0.00057320170904546,0.0147295619085878,0.0698181641783653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24096,-0.00877357456405773,0.00484217162761095,-0.0182642309541752,0.000717081826059731,0.0700127020037237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,24917,-0.0058476884538672,0.0032284795755742,-0.0121755084219926,0.000480131514258234,0.0701091810276163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,24011,-0.00704235726815189,0.00390120224077475,-0.0146887136600704,0.000603999123766622,0.0710596495162278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24224,0.00528790422434786,0.00293047563053082,-0.000455828011492554,0.0110316364601883,0.0711728134858831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24224,-0.00579656474683722,0.00321328164083997,-0.0120945967628836,0.000501467269209122,0.0712532619122484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,24788,-0.0117236217932716,0.00650595103167039,-0.0244752858153455,0.00102804222880241,0.071560022781335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,28911,-0.00578262802804846,0.0032094053691959,-0.0120730625516724,0.000507806495575493,0.071591149194053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,24235,0.0026946536519557,0.00149759986878719,-0.000240642090867184,0.00562994939477858,0.0719813356122792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7,Complement component C7,24369,0.00382891537943982,0.00213061562882849,-0.000347091253064018,0.00800492201194367,0.0723331705428519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,24106,-0.0052771271864723,0.00294851692988865,-0.0110562203690541,0.000501965996109445,0.0735056283536173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,24096,-0.00390096591586209,0.00218024169183779,-0.00817423963186416,0.000372307800139986,0.0735894532258208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24096,-0.00672344615005486,0.00376619483870209,-0.014105188033911,0.000658295733801243,0.07423995140107
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,28769,-0.00851146195393612,0.00477895175563488,-0.0178782073949805,0.00085528348710825,0.074917914844371
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,29689,0.00367551724584567,0.00206478339564884,-0.000371458209626046,0.00772249270131739,0.0750701174767697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24106,-0.00613441519088694,0.00345168504206944,-0.012899717873343,0.00063088749156916,0.0755441152850851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,24190,-0.00982071449926365,0.00552877555039551,-0.0206571145780388,0.00101568557951154,0.0756975320444929
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,28792,-0.00611124980616274,0.00345102225233469,-0.0128752534207387,0.000652753808413256,0.0765958921971101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,24096,-0.0105952266690565,0.00599746413135827,-0.0223502563665188,0.00115980302840567,0.0773049296250982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,24190,0.00387725145620791,0.00220754138671473,-0.000449529661752964,0.00820403257416878,0.0790385306755166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",28911,-0.0105811792461567,0.0060260085387206,-0.0223921559820491,0.0012297974897357,0.0791129364183281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,24106,-0.00809545024692276,0.00461289241294889,-0.0171367193763026,0.000945818882457055,0.079278541537468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,24788,-0.013059760573933,0.00747581299726043,-0.0277123540485635,0.0015928329006974,0.0806609774646227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24440,-0.00724737246361994,0.00414873972945893,-0.0153789023333594,0.000884157406119551,0.0806698036699685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,29438,-0.00642332265476729,0.00367851331073727,-0.0136332087438123,0.000786563434277761,0.080791234664549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,28769,-0.00440022039830704,0.0025244491688695,-0.00934814076929126,0.00054769997267718,0.0813370040459213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,24235,0.00676380492591881,0.00388463488730897,-0.000850079453206773,0.0143776893050444,0.0816666975747794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28769,-0.00542329213664787,0.00312216695494875,-0.0115427393683474,0.000696155095051685,0.0823928963857627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,29344,-0.00522708360769465,0.00301994746910614,-0.0111461806471427,0.000692013431753385,0.0834885936260971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,24788,-0.00712217542869282,0.0041200748919687,-0.0151975222169515,0.000953171359565829,0.0838838678859736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRN1,Neuritin,24863,0.00405217826967463,0.00234435718516048,-0.00054276181323991,0.00864711835258918,0.0839143382371959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,24497,-0.00483341927656566,0.00279729962734167,-0.0103161265461553,0.000649287993024024,0.0840209917697574
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24190,-0.00716419568219789,0.00414984983216188,-0.0152979013532352,0.000969509988839394,0.084292803076011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",24106,-0.00446909962264263,0.00258938771540192,-0.00954429954483038,0.000606100299545128,0.0843729893632248
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,24800,-0.00776307740010692,0.00450334014387743,-0.0165896240821067,0.00106346928189284,0.0847476161512442
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,29344,-0.00378576811206063,0.00220295600578062,-0.00810356188339065,0.000532025659269388,0.0857169824685323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,28926,-0.00361295974901104,0.00210337041790614,-0.00773556576810707,0.000509646270084995,0.0858620242233619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24106,-0.00706766839423003,0.00411478139213205,-0.0151326399228088,0.000997303134348783,0.0858771335620597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,24235,-0.00966818156517581,0.00563466920906341,-0.0207121332149401,0.00137577008458848,0.0862044195650615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,24224,-0.00514872151251972,0.00300113952087111,-0.0110309549734271,0.000733511948387649,0.0862501147103402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28911,-0.00306535963434134,0.00179297164056715,-0.00657958404985295,0.00044886478117027,0.0873407647490766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,28769,-0.00573123901240975,0.00335612002091334,-0.0123092342533999,0.000846756228580393,0.0877032118062422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28792,-0.00866851930626574,0.00507820631391018,-0.0186218036815297,0.0012847650689982,0.0878320665991277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",24106,0.00445749401205099,0.00261588063731125,-0.000669632037079061,0.00958462006118104,0.0883915967085575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,24011,-0.0073814748660368,0.00433331249633106,-0.0158747673588457,0.00111181762677208,0.0885014231661608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,29421,0.00939722145619165,0.00552071288315746,-0.00142337579479697,0.0202178187071803,0.0887330690169052
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24106,-0.00312647172542882,0.00183923234077508,-0.00673136711334798,0.00047842366249035,0.0891666681237883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24096,0.00606551567734979,0.00357108079942523,-0.000933802689523662,0.0130648340442233,0.0894245052808893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,24224,-0.00503335671930492,0.00297033089309747,-0.010855205269776,0.000788491831166117,0.0901747983793337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,29561,-0.00266311651796995,0.00157187013102401,-0.00574398197477702,0.000417748938837114,0.0902312808819452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",24788,-0.00481422232749151,0.00284596736413722,-0.0103923183612005,0.000763873706217447,0.0907359203479536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,29473,-0.00344477617595341,0.0020394559862462,-0.00744210990899596,0.000552557557089132,0.0912173265720638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,24863,-0.0064088263531063,0.00379455955274078,-0.0138461630764782,0.00102851037026563,0.0912413060376753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,24190,-0.00563996581523094,0.0033409897918011,-0.0121883058071611,0.000908374176699226,0.0914025799969611
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,24321,-0.00599297006107647,0.00356284860013827,-0.0129761533173475,0.000990213195194532,0.0925676048027137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,24190,-0.00666587985718434,0.00396347310337592,-0.0144342871398011,0.00110252742543246,0.0926151217291251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,24096,-0.00473295764677358,0.00281470629989688,-0.0102497819945715,0.000783866701024307,0.0926768030776167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,28911,-0.00639340107581312,0.00380340305224952,-0.0138480710582222,0.00106126890659594,0.0927798223176689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,28926,-0.00330802095596199,0.00196907391066658,-0.00716740582086849,0.0005513639089445,0.0929704131911952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,24106,0.00485758006590331,0.0029005133309544,-0.000827426062767306,0.0105425861945739,0.0939999689717729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24106,0.00448253277818524,0.00268211714537122,-0.000774416826742362,0.00973948238311284,0.0946820198931104
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,24863,0.00495335297742717,0.00296473419891547,-0.000857526052447149,0.0107642320073015,0.0947821075348029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,29688,0.00622043795402958,0.00372673877853826,-0.0010839700519054,0.0135248459599646,0.0951007611655403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24933,-0.00289093714961403,0.00173371106419452,-0.0062890108354353,0.000507136536207231,0.0954305752278431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,24440,-0.00690599954470958,0.00414240943816034,-0.0150251220435038,0.0012131229540847,0.0954982826129357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,24190,-0.00343158998485761,0.00206028820937741,-0.00746975487523733,0.000606574905522114,0.0958085880797093
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28792,-0.00925782999872261,0.00556592267274512,-0.0201670384373031,0.00165137843985783,0.0962621798224499
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,24106,0.00390818694677491,0.00235471983683508,-0.000707063933421842,0.00852343782697167,0.0969828397596573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,24106,-0.00793944183305495,0.00479086055027141,-0.0173295285115869,0.00145064484547701,0.0974908973462527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,24106,-0.00353649055216919,0.00213960472959937,-0.00773011582218396,0.00065713471784558,0.0983701556488944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,29720,-0.00343497089876768,0.00208379022211333,-0.00751919973410981,0.000649257936574452,0.099276162516335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,24961,-0.00244394072673533,0.0014845166389459,-0.0053535933390693,0.000465711885598644,0.0997172418204329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,24190,-0.00741175429888208,0.0045046927156773,-0.0162409520216096,0.00141744342384542,0.0999125694630744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,24224,0.00829286561196829,0.00504183228119906,-0.00158912565918188,0.0181748568831185,0.100021595031245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,24863,-0.00424687083226032,0.00258222049894302,-0.00930802301018865,0.000814281345667998,0.100052909467173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,29486,0.00696781591429292,0.00423743307488737,-0.00133755291248633,0.0152731847410722,0.100114941214854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,29281,-0.00494153648447178,0.00301250368089435,-0.0108460436990247,0.000962970730081148,0.100944812072407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28911,0.00616344849798119,0.00376001532484505,-0.00120618153871511,0.0135330785346775,0.101180762205937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,24011,-0.0044905591662694,0.00274069777188994,-0.00986232679917368,0.000881208466634871,0.101336181955125
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,24011,0.00281756935035721,0.00172231838129882,-0.000558174676988477,0.0061933133777029,0.101870143156677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,29429,-0.00721394876866249,0.0044236113665807,-0.0158842270471607,0.00145632950983569,0.102946890842923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,28862,-0.00637828096899427,0.00392016320496405,-0.0140618008507238,0.00130523891273526,0.103738515028557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,29561,-0.0087980490468802,0.00542845020221982,-0.019437811443231,0.00184171334947064,0.105086348145408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,24933,0.0064525629544806,0.00401874735710241,-0.00142418186544013,0.0143293077744013,0.10837109413561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29213,-0.00642121418978602,0.00400080651855493,-0.0142627949661537,0.00142036658658165,0.108509034852852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,29438,-0.00585273711272702,0.00364812114427072,-0.0130030545554976,0.00129758033004359,0.108655269868411
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,29473,-0.0122836608890073,0.00767233703388752,-0.0273214414754269,0.00275411969741224,0.109380445108481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,24096,-0.00804727955749329,0.00502636504805907,-0.0178989550516891,0.00180439593670248,0.109386990291975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,29429,-0.0099637713384642,0.00623098307823265,-0.0221764981718002,0.0022489554948718,0.109816031382966
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28911,-0.0092596348260363,0.00579493080201386,-0.0206176991979835,0.00209842954591086,0.110079436675659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,28717,-0.00379469208237014,0.00237548099762426,-0.00845063483771369,0.000861250672973415,0.110178321472946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,24552,-0.00249074677925497,0.00156352600603918,-0.00555525775109176,0.000573764192581818,0.111165918772684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,24106,-0.00565420653991804,0.00355377103718117,-0.0126195977727931,0.00131118469295706,0.111612765514342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,24011,-0.00582563543384214,0.00366255462753503,-0.0130042425038108,0.00135297163612652,0.111714270134451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,28926,-0.00650848396998461,0.00410225815738372,-0.0145489099584567,0.00153194201848749,0.112622977713422
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,24011,-0.00385772531510354,0.00243229915753379,-0.00862503166386977,0.000909581033662696,0.112743266705257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,29815,0.00631710520865391,0.00398598293209503,-0.00149542133825235,0.0141296317555602,0.113015581803971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24106,-0.00633028492538831,0.00400992572068118,-0.0141897393379234,0.0015291694871468,0.114428590205337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,24224,-0.00893668432880176,0.00566512476241095,-0.0200403288631272,0.0021669602055237,0.114695615979607
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,29306,0.0036070094354809,0.00228954139739312,-0.000880491703409618,0.00809451057437142,0.115168302523236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,29363,-0.00708561842606554,0.00449901045684068,-0.0159036789214733,0.00173244206934218,0.115283797933453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23965,-0.0054098309679237,0.00344522976143601,-0.0121624813003383,0.00134281936449089,0.116372943106957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,29344,0.00335858493154416,0.00214202579895213,-0.000839785634402011,0.00755695549749033,0.116904070995424
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",24106,-0.00408402805891824,0.00260818196763841,-0.00919606471548953,0.00102800859765305,0.11739630355521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,24106,0.00347205144735752,0.00222154835243258,-0.000882183323410347,0.00782628621812538,0.118089937576323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24840,-0.00378818484352358,0.00242439735769491,-0.0085400036646056,0.000963633977558446,0.1181767809227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,24190,0.00297201167471859,0.00190661462036202,-0.000764952981190963,0.00670897633062814,0.119059197356416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,28926,-0.00514812959440966,0.00331451983156909,-0.0116445884642851,0.00134832927546576,0.120385053719435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,24190,-0.00786585784305547,0.00506564267145954,-0.0177945174791162,0.00206280179300523,0.120487413763203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,28792,-0.00623109980805043,0.00401912740644044,-0.0141085895246737,0.00164638990857282,0.121065805230484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,28769,-0.00304670734224241,0.00196587827770526,-0.00689982876654472,0.000806414082059901,0.121201852765597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,29339,-0.00892040589323134,0.00575628141456418,-0.0202027174657771,0.00236190567931446,0.121228643536434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,24011,-0.00616072341955643,0.00398150881115012,-0.0139644806894107,0.00164303385029781,0.121795946495453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,28926,-0.00573394211248586,0.00370776597844834,-0.0130011634302446,0.00153327920527288,0.12200248370578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,24172,-0.00592938674217728,0.00383607674065327,-0.0134480971538577,0.00158932366950312,0.122192471349153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,29429,0.00868118877017304,0.00562539042692979,-0.00234457646660934,0.0197069540069554,0.122789295259097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,28790,-0.00502506051339358,0.00326157166701057,-0.0114177409807343,0.00136761995394713,0.123404019308166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24096,-0.00584946350811774,0.00379918752828585,-0.013295871063558,0.00159694404732253,0.123655977218562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,24106,-0.00494605004961004,0.00321438634569773,-0.0112462472871776,0.0013541471879575,0.123885079261792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24224,0.00354569561465537,0.00230627074512181,-0.000974595045783375,0.00806598627509412,0.124204743898245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCLN,Nicalin,28926,-0.00528322904834556,0.00343859908319387,-0.0120228832514055,0.00145642515471443,0.124439458866401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,29449,0.00362632225495375,0.00236025036246897,-0.000999768455485437,0.00825241296539294,0.124447566089873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,24190,-0.0036649358303154,0.00238821428300098,-0.00834583582499733,0.00101596416436653,0.124897031206905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,24863,-0.0088933134521563,0.00579589598540418,-0.0202532695835485,0.0024666426792359,0.124940163458698
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24106,-0.00516886311768106,0.00337235899015637,-0.0117786867383876,0.00144096050302543,0.125359375119869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,29344,0.00345411550723657,0.00225874607903967,-0.000973026807681182,0.00788125782215432,0.126221155987123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,24224,-0.00614801490599734,0.00402898678431602,-0.0140448290032567,0.00174879919126206,0.127036460499266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,24106,0.00594075472438965,0.00389329037245037,-0.00169009440561307,0.0135716038543924,0.127048988734527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,28769,-0.00475075089686359,0.00311408309929596,-0.0108543537714837,0.00135285197775649,0.127128054788538
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",24840,-0.00597390334301919,0.00393158580760126,-0.0136798115259177,0.00173200483987928,0.128658461868764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,24863,0.00254489450629138,0.00167552047719308,-0.000739125629007057,0.00582891464158981,0.128808437016689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,28769,-0.00636859898035033,0.00419461749216645,-0.0145900492649966,0.0018528513042959,0.128955113451235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,28926,0.0059167865878268,0.00390883927671357,-0.0017445383945318,0.0135781115701854,0.130114396575581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,24440,-0.00714481450709024,0.00472231047303227,-0.0164005430342335,0.00211091402005302,0.130294814940781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,29815,0.00583166654438099,0.00387008953978833,-0.00175370895360413,0.0134170420423661,0.131858244182836
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29512,-0.00484755732475815,0.00322264802747005,-0.0111639474585994,0.00146883280908315,0.132536577392492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,24840,-0.00385561104027018,0.00256559234088049,-0.00888417202839593,0.00117294994785558,0.132899437399496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAG,S-arrestin,24096,0.00520561188096691,0.00346983894500532,-0.00159527245124352,0.0120064962131773,0.133563809883098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,24416,-0.00970023460996214,0.00648268932034964,-0.0224063056778474,0.00300583645792316,0.134580931397823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29213,0.00322079329797724,0.00215360853209971,-0.00100027942493819,0.00744186602089267,0.134786120522609
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,24324,0.00367027876401488,0.00246770423115661,-0.00116642152905208,0.00850697905708184,0.136941903713844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,24863,-0.00909929748466866,0.0061211229838247,-0.0210966985329651,0.00289810356362775,0.137148888564618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,29429,0.0088819827026196,0.00600284185128301,-0.0028835873258951,0.0206475527311343,0.138982822226363
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,24840,-0.00611557346846627,0.00413376116011788,-0.0142177453422973,0.00198659840536478,0.139040493545249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,29815,-0.0024262571719517,0.00164097473341653,-0.00564256764944809,0.000790053305544695,0.139272174603188
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,24224,-0.00528314417878391,0.00357540667669184,-0.0122909412650999,0.0017246529075321,0.139518648978731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,29385,0.00486738624824991,0.00329470178332613,-0.00159022924706931,0.0113250017435691,0.13959593285228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24011,-0.00494838924401095,0.00335852527222565,-0.0115310987775732,0.00163432028955133,0.140661292944921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,24800,-0.00473281572378919,0.00321257160551795,-0.0110294560706044,0.00156382462302599,0.140705179104356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,24235,0.00580948834163087,0.00394357039054994,-0.00191990962384702,0.0135388863071088,0.140722383952303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,24096,-0.00331431011660716,0.00225439677633638,-0.00773292779822646,0.00110430756501214,0.141533152927203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24440,-0.00623910843408999,0.00424462996611993,-0.014558583167685,0.00208036629950507,0.141606387862304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,24106,-0.00497672689188324,0.00340435393481296,-0.0116492606041166,0.00169580682035016,0.143789557869651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,24106,-0.00448545109724051,0.00306983854021303,-0.010502334636058,0.00153143244157702,0.143991209326505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,28769,-0.00507767345677461,0.00347816950765642,-0.0118948856917812,0.00173953877823198,0.144336877333443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,28926,-0.00626192671909437,0.00429125437006893,-0.0146727852844295,0.00214893184624074,0.144512703829682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,24190,-0.00501541952113172,0.00344066918085834,-0.0117591311156141,0.00172829207335063,0.144939763050446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,24190,-0.00454912857265913,0.00312491964160469,-0.0106739710702043,0.00157571392488607,0.145472355321896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,24190,-0.00480991057196182,0.00330579493123044,-0.0112892686371735,0.00166944749324985,0.145684007981913
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28911,0.00292325935129719,0.00202563990608146,-0.00104699486462247,0.00689351356721684,0.148995022418182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,24235,-0.00697236331081779,0.00483140452475964,-0.0164419161793467,0.0024971895577111,0.148995707643063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,29671,-0.00410251306633301,0.00284835342516792,-0.00968528577966214,0.00148025964699611,0.149790156056793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,24440,-0.00632468770030909,0.00440761507946754,-0.0149636132560655,0.0023142378554473,0.151315414157244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,24011,-0.00509527879273976,0.00355524719772792,-0.0120635633002865,0.00187300571480696,0.151821873278605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24106,-0.00559994784259499,0.00391067256162952,-0.0132648660633888,0.00206497037819887,0.15216669362259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,29429,-0.00326065834704486,0.00227763370895379,-0.0077248204165943,0.00120350372250457,0.152269214677302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,24190,-0.0033089496522374,0.00232325976423592,-0.00786253879013981,0.001244639485665,0.154381177015289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,29317,-0.00785726050749614,0.00552063055741387,-0.0186776964000273,0.00296317538503504,0.154673131354066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,24106,-0.00411089164326918,0.00289564245606475,-0.00978635085715609,0.00156456757061774,0.155713202429554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,24011,-0.00326721125591689,0.00230564007532933,-0.00778626580356237,0.0012518432917286,0.156480786134537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,24440,-0.00560045903833014,0.00395324241128646,-0.0133488141644516,0.00214789608779132,0.156590771055625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,24106,-0.00441683725103962,0.00312787340286198,-0.0105474691206491,0.00171379461856986,0.157936520164284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,24560,-0.0101342154491655,0.00718233994880171,-0.0242116017488169,0.00394317085048581,0.158260006240236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,24746,-0.00373722097534437,0.00264882739791164,-0.00892892267525117,0.00145448072456244,0.158287749116247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",24863,-0.00337993760068565,0.00239676732706383,-0.00807760156173075,0.00131772636035945,0.158491143081626
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28911,0.00773299504179264,0.0054892306048432,-0.00302589694370003,0.0184918870272853,0.158917631748657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24106,-0.00611384533243458,0.00434901962530942,-0.0146379237980411,0.00241023313317189,0.159796859101105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,24863,0.00573812285712322,0.00408543929523599,-0.00226933816153933,0.0137455838757858,0.160173525389339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,28911,-0.00347270292697752,0.00247473712236425,-0.00832318768681146,0.00137778183285641,0.160549667279973
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,29473,0.0058468227374598,0.00416680706064027,-0.00232011910139513,0.0140137645763147,0.160570675629445
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,24788,0.00473604824614532,0.00337548263553609,-0.00187989771950542,0.0113519942117961,0.160607630633001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,29720,-0.00367333220836051,0.00263003917938242,-0.00882820899995005,0.00148154458322903,0.162519215931015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,24917,0.00360848751762748,0.00258487759883434,-0.00145787257608783,0.00867484761134279,0.162727127244714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29429,-0.00396829825511632,0.00284374500671697,-0.00954203846828158,0.00160544195804894,0.162891322209699
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLGN,Calmegin,24190,-0.00411349785097661,0.0029567832249355,-0.00990879297185018,0.00168179726989696,0.164175433299922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,24933,-0.00833828911334616,0.00599583221666563,-0.0200901202580108,0.00341354203131848,0.164334642177182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,29428,0.00678654625970359,0.00489169834507573,-0.00280118249664484,0.016374275016052,0.165342548968281
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,29492,0.00452520058947579,0.00326231813405911,-0.00186894295328006,0.0109193441322316,0.165418104822703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,24106,-0.00430557249752913,0.00311585640148215,-0.0104126510444342,0.00180150604937589,0.167037836942213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24788,-0.00565488902548493,0.00409371089224172,-0.0136785623742787,0.00236878432330883,0.167180715372687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24224,-0.00397897293899763,0.00288596110412916,-0.00963545670309078,0.00167751082509553,0.167989495123463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,24788,0.00341812735040715,0.00249114457388801,-0.00146451601441335,0.00830077071522765,0.170041249465771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,24011,-0.0042240312708991,0.00307855464897838,-0.0102579983828967,0.00180993584109853,0.170050550817551
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,29395,0.00759290567666825,0.00553654328684036,-0.00325871916553886,0.0184445305188754,0.170255694205346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,24106,-0.00401113326738691,0.00292868517555553,-0.00975135621147575,0.00172908967670193,0.170823919592396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,24011,-0.00481106007539874,0.00352009307397389,-0.0117104425003876,0.00208832234959008,0.171718900968809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24106,-0.00622992347617983,0.00456066910696616,-0.0151688349258335,0.00270898797347385,0.171948309191021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,24440,-0.00700950746827319,0.00513837221047412,-0.0170807170008025,0.00306170206425607,0.172533112544875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,24788,-0.00353354378005165,0.00259563680749997,-0.00862099192275159,0.00155390436264829,0.173418701308768
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,29815,-0.00284330143287066,0.00208969441786716,-0.00693910249189029,0.00125249962614898,0.173640857996802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,28769,-0.00733765324915361,0.005395272508259,-0.0179123873653413,0.00323708086703404,0.173835739308512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,24096,-0.00754790540006673,0.00556273180570398,-0.0184508597392465,0.00335504893911308,0.174835153188277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,24104,-0.00367016247586637,0.00270881448914967,-0.00897943887459972,0.00163911392286698,0.175463333716037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,24946,0.00429864954741574,0.00317284841735778,-0.00192013335060551,0.010517432445437,0.175486078480028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,29599,-0.0052983282203178,0.00391129559463293,-0.0129644675857984,0.00236781114516275,0.175548270529691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,28926,0.0025438712471863,0.00187890492097767,-0.00113878239792994,0.00622652489230253,0.175775151529599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,24106,-0.00627831770535114,0.0046478079215895,-0.0153880212316666,0.00283138582096427,0.176768143379526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,24011,-0.00703648737439329,0.00522154923306193,-0.0172707238711947,0.00319774912240809,0.177804253363054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,24011,-0.00295929409834629,0.00219921585956337,-0.0072697571830905,0.00135116898639792,0.178439975412478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,24224,-0.00322774523006206,0.00240104061608338,-0.00793378483758548,0.00147829437746137,0.178860446796368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24917,-0.00259697428488553,0.00193525010066786,-0.00639006448219453,0.00119611591242346,0.179630238444593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,24096,-0.00528998592236174,0.00394512284250188,-0.0130224266936654,0.00244245484894194,0.179967980856547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,29429,-0.00382728612379311,0.00285630727785371,-0.00942564838838638,0.00177107614080016,0.180274548473843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,28926,-0.00383176630407192,0.00286332529343426,-0.00944388387920307,0.00178035127105923,0.180834443953291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,24106,-0.00735689686698148,0.00550005908790114,-0.0181370126792677,0.00342321894530476,0.181038433795597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28792,-0.00555616654486287,0.00415438016232288,-0.0136987516630157,0.00258641857328998,0.181094938136351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,29429,0.00406041492100163,0.00303746691120154,-0.00189302022495339,0.0100138500669567,0.181305883369596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,24096,-0.00656836108272481,0.00492398787504317,-0.0162193773178094,0.0030826551523598,0.182232361974432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24224,-0.00542324817677874,0.00406636623031073,-0.0133933259881878,0.00254682963463028,0.182319939300396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCT,Secretin,24190,0.00407986358513859,0.0030866666437628,-0.00197000303663649,0.0101297302069137,0.186257234499857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,24096,-0.0043517300690733,0.00330006264484336,-0.0108198528529663,0.00211639271481969,0.187288305178048
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRTN,Neurturin,28926,-0.00428222602759392,0.00324908424043629,-0.010650431138849,0.0020859790836612,0.187520993422919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,29584,-0.00293562355785724,0.00224473965341613,-0.00733531327855286,0.00146406616283837,0.190958418918037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,24440,0.00465938329747545,0.00356411341672706,-0.00232627899930959,0.0116450455942605,0.191121451660061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,24235,-0.00365416286831825,0.0027983562806307,-0.00913894117835442,0.00183061544171793,0.191624565964505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28792,-0.00275500856770589,0.00211153841533805,-0.00689362386176846,0.00138360672635668,0.191991839673737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24440,-0.00477434292667474,0.00366568334606731,-0.0119590822849667,0.00241039643161719,0.192777335386729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,24961,-0.00259214858361679,0.00199077156817896,-0.00649406085724754,0.00130976369001396,0.192900247151988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,28926,-0.00782278973465808,0.00603399997021649,-0.0196494296762824,0.00400385020696624,0.19483024543936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,24914,0.00476266793283539,0.00367510063740205,-0.00244052931647262,0.0119658651821434,0.195012105404241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24800,-0.002900293994411,0.00224444377411471,-0.00729940379167584,0.00149881580285383,0.196296275475258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,24440,-0.00480995719578279,0.00373363994277634,-0.0121278914836244,0.00250797709205882,0.197662250558316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,24096,-0.00625544433185428,0.00486852114836736,-0.0157977457826543,0.00328685711894574,0.198848095147026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,28911,0.00450135134785006,0.00350499417877774,-0.00236843724255431,0.0113711399382544,0.199058546896078
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,24106,-0.00337078063766033,0.00263242599753296,-0.00853033559282493,0.00178877431750428,0.20038712678912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,24224,-0.00401817213758332,0.00314253451723676,-0.0101775397913674,0.00214119551620074,0.20103591208203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,24235,-0.00573854806577203,0.00449601865716523,-0.0145507446338159,0.00307364850227182,0.201839765544164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24224,-0.0037172164549997,0.00291321344157011,-0.00942711480047712,0.00199268189047772,0.201973086990573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,29576,-0.00215959491601757,0.00169332091069356,-0.00547850390097695,0.00115931406894181,0.202191629687986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENG,Endoglin,29815,-0.00143755056795203,0.00112975107814246,-0.00365186268111126,0.000776761545207196,0.203223580813648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,24235,0.00534164687905444,0.00419818123578939,-0.00288678834309275,0.0135700821012016,0.203253308596025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,24106,-0.00310581545833885,0.00245141234306511,-0.00791058365074647,0.00169895273406877,0.205185621672237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,24440,-0.00238080435379105,0.00187974280996585,-0.00606510026132411,0.00130349155374202,0.205325253994296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,29213,-0.00100764133508621,0.000798537629609783,-0.00257277508912139,0.000557492418948963,0.207009859233004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,24800,-0.00254731821985789,0.00201950758798566,-0.00650555309230978,0.00141091665259399,0.207192447708875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,29473,-0.00717674010777504,0.00570052763360374,-0.0183497742696384,0.00399629405408829,0.208054512837053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,24011,-0.00524344311872224,0.00416656688714582,-0.0134099142175281,0.00292302798008358,0.208238958462135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRL,Prolactin,29689,0.00625674779683535,0.0049717964262843,-0.00348797319868187,0.0160014687923526,0.208239644245549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24440,-0.00591393004884468,0.00470243873320745,-0.0151307099659313,0.00330284986824192,0.208537466057812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,24011,-0.00390463118261799,0.00310550839351191,-0.00999142763390133,0.00218216526866535,0.208648462744988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28911,0.00291318807949116,0.00232063331990744,-0.00163525322752742,0.00746162938650975,0.209364847210505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,24863,0.00407410695888418,0.00326260283554003,-0.00232059459877428,0.0104688085165426,0.211775953773096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,29669,0.00344728528017647,0.00276289844728602,-0.00196799567650414,0.00886256623685707,0.212148554319729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,29438,-0.00735686501342535,0.00589705451049626,-0.018915091853998,0.00420136182714732,0.212206159404055
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,28769,0.0055816823057584,0.00447569341586932,-0.00319067678934547,0.0143540414008623,0.212367300368918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,29473,-0.00347734727522532,0.00279541126829484,-0.0089563533610832,0.00200165881063256,0.213528465473141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,24788,-0.00419681482754103,0.00337929096390825,-0.0108202251168012,0.00242659546171914,0.214277204351493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,24391,-0.00410595649828061,0.00331773546976776,-0.0106087180190254,0.0023968050224642,0.215884488187228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,24096,-0.00244642957011164,0.0019768013921645,-0.00632096029875406,0.00142810115853078,0.215887709238854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,24440,-0.00356735545923939,0.00288546247897897,-0.00922286191803816,0.00208815099955939,0.21635146499058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,24235,0.00194413988407291,0.00157449793369862,-0.00114187606597639,0.0050301558341222,0.216928786441883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,29561,-0.00214245508125487,0.00174148787949802,-0.00555577132507099,0.00127086116256126,0.218615527858498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,29696,-0.00190927360494829,0.00156545158288043,-0.00497755870739393,0.00115901149749735,0.222614401372071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,29390,-0.00232578686737712,0.00191954545278518,-0.00608809595483607,0.00143652222008183,0.225662193303222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,24190,-0.00553375703889221,0.00456855722422164,-0.0144881291983666,0.00342061512058219,0.225803720904822
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,24096,-0.00515496685893412,0.00426075694688465,-0.013506050474828,0.00319611675695979,0.226340219380223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24788,-0.00352923398258299,0.00292933552426192,-0.00927073161013635,0.00221226364497037,0.228295911842114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,24946,-0.00473364304907986,0.00393234028478187,-0.0124410300072523,0.00297374390909261,0.228688954860256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,28769,-0.00325422160101212,0.00270534131791298,-0.00855669058412157,0.00204824738209733,0.229029712623225
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24800,0.0136040403283853,0.0113130559973145,-0.00856954942635119,0.0357776300831218,0.229178256197179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,24376,0.00255248010150742,0.00212316103082266,-0.00160891551890499,0.00671387572191983,0.229294831752351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24190,0.00404495280613103,0.00337854466519156,-0.00257699473764444,0.0106669003499065,0.231221995118498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,29561,-0.00194474197628337,0.00162640641310193,-0.00513249854596315,0.00124301459339641,0.231811767638791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28792,-0.00343328492446251,0.00287456790750888,-0.00906743802317991,0.0022008681742549,0.232344844482791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,24096,0.00297203756809176,0.00249096750382502,-0.00191025873940529,0.00785433387558881,0.232831867377943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,24011,-0.00541448758923652,0.00454875275394948,-0.0143300429869775,0.00350106780850446,0.233931017832412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,24863,-0.00403348890515101,0.00339451680865195,-0.0106867418501088,0.0026197640398068,0.234751588157218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,24096,-0.0054766740992727,0.00460927159817532,-0.0145108464316963,0.00355749823315091,0.234771674931047
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29473,-0.00494255288822816,0.00416039645326651,-0.0130969299366305,0.0032118241601742,0.234842807376838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,29260,-0.00179116406507088,0.00150912522904014,-0.00474904951398956,0.00116672138384779,0.235281065447649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29576,-0.00330165500260616,0.00279492947682185,-0.00877971677717698,0.00217640677196467,0.237492386888143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,24440,-0.003221136385764,0.00272876592018135,-0.00856951758931945,0.00212724481779145,0.237837929473218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,24011,-0.00411095902325742,0.00348866724031303,-0.010948746814271,0.00272682876775611,0.238658737194239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,24106,0.00613296983254619,0.00520718441503934,-0.00407311162093092,0.0163390512860233,0.238891962687685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,24190,-0.00559666242330875,0.00475362968778086,-0.0149137766113592,0.00372045176474174,0.239069399575247
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,29627,0.00373786667871967,0.00317499644760049,-0.00248512635857729,0.00996085971601662,0.239092366600335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,29815,-0.0051661016594461,0.0043903926679265,-0.013771271288582,0.00343906796968985,0.239331341011181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,24106,-0.00310051164142314,0.00263672631618161,-0.00826849522113909,0.00206747193829282,0.239648706820292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,24863,-0.00272574510118244,0.0023273487322075,-0.00728734861630913,0.00183585841394425,0.24153752253057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,29618,0.00631541850589776,0.00539288248645523,-0.00425463116755449,0.01688546817935,0.241581884687877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,29438,-0.00328144837069959,0.00280608470662726,-0.00878137439568903,0.00221847765428984,0.242250129255084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24917,-0.00573506843361432,0.00491800378467777,-0.0153743558515828,0.00390421898435411,0.2435700417655
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,24190,-0.00453258880874867,0.00389962139222809,-0.0121758467375157,0.00311066912001839,0.245118970938681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,24011,-0.00585221258526859,0.00503596633632725,-0.01572270660447,0.00401828143393282,0.245213170993294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,24190,-0.00384251466590191,0.00330932421533942,-0.0103287901279672,0.00264376079616336,0.245605533208767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,28109,0.00213562403867554,0.00184613793761477,-0.0014828063190494,0.00575405439640049,0.247361333734962
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,24400,-0.00402157888166474,0.00347717461604887,-0.0108368411291205,0.00279368336579104,0.247461408873362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,23965,-0.00602406325369115,0.00524801221272002,-0.0163101671906224,0.00426204068324009,0.251031537805328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,24909,-0.00281797705779858,0.00245614510549133,-0.00763202146456158,0.00199606734896443,0.251261652294024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,24011,-0.00478944987620825,0.004179277678468,-0.0129808341260055,0.00340193437358903,0.251806811651497
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,28769,-0.00244162396568521,0.00215237404536145,-0.00666027709459364,0.00177702916322322,0.256641934142779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,29344,-0.00267112482071398,0.0023559408149562,-0.00728876881802813,0.00194651917660016,0.256894997317023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,24096,-0.00881667171188488,0.00777979560308842,-0.0240650710939382,0.00643172767016842,0.257108782042873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,24096,-0.00471640433373112,0.00416226168786523,-0.012874437241947,0.00344162857448474,0.257168852665122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,29346,-0.00237239406435369,0.00209408600863015,-0.00647680264126877,0.0017320145125614,0.257264702917286
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,29429,-0.00601406889597035,0.00532035222401815,-0.0164419592550459,0.00441382146310521,0.258321463747989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",24440,-0.00339436279019671,0.0030095229434263,-0.00929302775931226,0.00250430217891883,0.259384198700534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,28792,-0.00526529558465868,0.00468368615969156,-0.0144453204576541,0.00391472928833677,0.260947020131176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,28769,0.00475557354713974,0.00423184260097134,-0.00353883795076408,0.0130499850450436,0.261124426230748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28769,-0.00579116021442976,0.00516002754395145,-0.0159048142005746,0.00432249377171509,0.261739227748025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,29473,0.00345782560091127,0.00308305558090518,-0.00258496333766289,0.00950061453948544,0.262059566630196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29603,0.00757283626526221,0.00675366731758099,-0.00566435167719652,0.0208100242077209,0.262172492287604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,29561,-0.00212762077788859,0.00190116634341859,-0.00585390681098903,0.00159866525521185,0.263100850870709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,24946,0.00193785625367964,0.00173577152461388,-0.00146425593456356,0.00533996844192283,0.264251625485044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28769,-0.00393813339638988,0.00354371667093433,-0.0108838180714212,0.0030075512786414,0.266448402396288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,29274,0.00437603263840474,0.00395259523416472,-0.00337105402055811,0.0121231192973676,0.268247279005796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,28769,-0.00432143208493426,0.00391851299685477,-0.0120017175587696,0.0033588533889011,0.270112621699143
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,24106,0.0033391704571992,0.00303293795748511,-0.00260538793947161,0.00928372885387,0.270921179537848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,28792,-0.00438926198548182,0.00398760769638761,-0.0122049730704015,0.00342644909943791,0.271025295557229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,24096,-0.00298131762178099,0.00271012196006333,-0.00829315666350512,0.00233052141994314,0.271313623555563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,24840,0.0020197225540759,0.00184338515858121,-0.00159331235674327,0.00563275746489508,0.273238419285217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,24933,0.003904643182189,0.00356682668410135,-0.00308633711864964,0.0108956234830277,0.273653999219202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,28792,-0.00421324486862976,0.00386087705328396,-0.0117805638930663,0.00335407415580681,0.275164875043649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24961,-0.00133638431763027,0.00122538258110755,-0.00373813417660108,0.00106536554134053,0.275465902588596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,29815,0.0040308337546714,0.0036985178470085,-0.00321826122546526,0.0112799287348081,0.275787551164644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,24840,-0.00273735303722401,0.00251534905668542,-0.00766743718832744,0.00219273111387942,0.276491035670494
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,24224,-0.00647293063526773,0.00595241371036536,-0.0181396615075838,0.00519380023704838,0.276850417154358
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,24011,0.00569781127248102,0.00524471501407743,-0.00458183015511074,0.0159774527000728,0.277316947082087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,28769,-0.00231729526441182,0.00213876219777169,-0.00650926917204434,0.00187467864322069,0.27860674870037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MB,Myoglobin,29815,-0.00370591586431386,0.00344367260211632,-0.0104555141644618,0.00304368243583413,0.28186790299235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,29314,-0.00556994752598462,0.00517867459162775,-0.015720149725575,0.00458025467360578,0.282135335961867
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24190,0.00346728799550511,0.00322662649583227,-0.00285689993632614,0.00979147592733637,0.282570800491148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,29815,-0.00367952533942214,0.00342593300698245,-0.0103943540331077,0.00303530335426347,0.282821789668297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,24224,-0.00386959445846936,0.00361464298813866,-0.0109542947152211,0.00321510579828241,0.284390153422403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,24788,-0.00338031614670132,0.00315770334683676,-0.00956941470650137,0.00280878241309874,0.28440549114222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,24096,-0.00239081245241901,0.00224234641433624,-0.00678581142451804,0.00200418651968003,0.286339354833687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,24788,-0.00148516808186497,0.00139465601864728,-0.00421869387841365,0.00124835771468371,0.286931924586636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,29429,0.00345206096532903,0.00324247525329739,-0.00290319053113384,0.00980731246179191,0.28704871178412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,28926,-0.00287666273624171,0.00270487953368997,-0.00817822662227406,0.00242490114979064,0.287560234483086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,24440,-0.00369448296034173,0.00349017689432896,-0.0105352296732265,0.00314626375254304,0.289820952931357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,29213,0.00289132514542191,0.00274370648761386,-0.00248633957030127,0.00826898986114508,0.2919820035707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,24863,-0.00233848790906575,0.00221958228322958,-0.00668886918419574,0.00201189336606423,0.292089537303244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,24440,-0.00456471788533266,0.00435616057194489,-0.0131027926063446,0.00397335683567934,0.294705922258477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,24235,0.00123602686309598,0.00118057054734456,-0.00107789140969935,0.00354994513589131,0.29512194133786
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,24840,-0.00254155616975843,0.00243179804178604,-0.00730788033165908,0.00222476799214221,0.295970960355825
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,24224,-0.00159872850040377,0.00153229054640286,-0.00460201797135338,0.00140456097054585,0.296792663822234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,29429,-0.00708598276615467,0.00679970151931985,-0.0204133977440216,0.00624143221171223,0.297372941541447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24863,-0.0016217295789006,0.00156281561917893,-0.0046848481924913,0.00144138903469011,0.29942109064664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,24946,0.00481849306288406,0.00466874604843958,-0.00433224919205751,0.0139692353178256,0.302047298036099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,24376,-0.00519518498319827,0.00503477680463262,-0.0150633475202782,0.00467297755388166,0.302147932462409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24440,-0.0033431090376071,0.00324371392611539,-0.00970078833279325,0.00301457025757906,0.302718759832523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,29531,0.00224359600153508,0.00218152069555033,-0.00203218456174356,0.00651937656481372,0.303744246613633
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",24863,-0.00280836201331146,0.00275015157882515,-0.00819865910780877,0.00258193508118584,0.307185614201181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTR,Transthyretin,24702,0.00169644300317802,0.00166247095843567,-0.00156200007535588,0.00495488608171193,0.307532357572582
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24190,-0.00211120244977514,0.00208902733338389,-0.00620569602320756,0.00198329112365728,0.312210827070354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTN,Titin,24106,0.00444645447722632,0.00441498969291814,-0.00420692532089323,0.0130998342753459,0.313883954779034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24788,-0.00572489757962002,0.00570448259994279,-0.0169056834755079,0.00545588831626785,0.315591498050505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,24800,0.00293144020732137,0.00292577739071196,-0.00280308347847407,0.00866596389311681,0.316384531036536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,24788,-0.00187687381819161,0.00187838548775982,-0.00555850937420087,0.00180476173781764,0.317709885628066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,24840,0.00173773848131182,0.00173924887012222,-0.00167118930412774,0.00514666626675138,0.317740690179532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,24011,0.00515005539167812,0.00515950339131222,-0.00496257125529383,0.0152626820386501,0.318207569833535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,28769,-0.00338555158661542,0.00339555356933748,-0.0100408365825169,0.00326973340928603,0.318746501014865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,28926,-0.00364417174998818,0.00365758390736481,-0.0108130362084232,0.00352469270844685,0.319096686366899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,24800,0.00523947318062478,0.00525951833241622,-0.00506918275091102,0.0155481291121606,0.319168152184796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,24235,0.00409229426859581,0.00411017920959219,-0.00396365698220488,0.0121482455193965,0.319430847786534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,24946,0.00411654816164833,0.00414358135758852,-0.00400487129922518,0.0122379676225218,0.320487737696423
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,24011,0.00289330249751325,0.00291666899505618,-0.00282336873279687,0.00860997372782337,0.321213071214751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,24011,-0.00522965867306217,0.00527586803226006,-0.0155703600162919,0.00511104267016755,0.321577727179009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24011,-0.00172736037994153,0.00174378863716178,-0.00514518610877861,0.00169046534889555,0.321901190793921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,24096,-0.00475590101642904,0.00481684250043499,-0.0141969123172816,0.00468511028442353,0.323481863982777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24190,-0.00268404413451442,0.00273000343049455,-0.00803485085828374,0.0026667625892549,0.325536020114753
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,29408,-0.0082097813960955,0.00840078930774775,-0.0246753284392811,0.00825576564709009,0.328446959142525
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,24840,0.00358048314504687,0.00367075911728384,-0.00361420472482945,0.0107751710149232,0.329368050963545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,24416,-0.00641813105094349,0.0066040733084733,-0.0193621147355512,0.00652585263366418,0.331137642572566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",29449,-0.00597418532669365,0.00616829623980475,-0.018064045956711,0.00611567530332367,0.332787267133736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,24946,-0.00204350519450675,0.00211042223262594,-0.0061799327704536,0.0020929223814401,0.332907897324224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,29164,0.00293559547814365,0.00303545969402728,-0.00301390552214982,0.00888509647843713,0.333501672401608
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29344,-0.00276668320098302,0.00286536462571387,-0.0083827978673822,0.00284943146541616,0.334272057332635
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,28911,-0.00492256678762142,0.00513557376070275,-0.0149882913585988,0.00514315778335596,0.33780699897762
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,24106,0.00316096476919035,0.00330980115442603,-0.00332624549348467,0.00964817503186538,0.339571287521466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,29434,0.00369981580065854,0.00387437332604266,-0.00389395591838506,0.0112935875197022,0.339613048957807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESPL1,Separin,24011,-0.00347711537422112,0.00364666767400508,-0.0106245840152711,0.00367035326682884,0.340343935806907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24106,0.00418217430497142,0.00440563606874886,-0.00445287238977634,0.0128172209997192,0.342488656854039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,24235,-0.00264943491932394,0.0027919008940239,-0.00812156067161078,0.0028226908329629,0.342644477140189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24840,0.00159699009227024,0.00168473805347678,-0.00170509649254424,0.00489907667708472,0.343181465015712
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,28911,-0.00377013488905676,0.00397750130999259,-0.0115660374566422,0.00402576767852873,0.343206033149646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,24224,-0.0018257552076072,0.00193140957247616,-0.00561131796966047,0.00195980755444607,0.344516826970845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,28759,-0.00366730815787654,0.00390134533813483,-0.0113139450206208,0.00397932870486771,0.347219735001656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,24440,-0.00430393475639325,0.00457961558984054,-0.0132799813124807,0.00467211179969421,0.3473281050672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,28792,0.00363893779306817,0.00387979204319581,-0.00396545461159561,0.011243330197732,0.348292966304214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,24096,0.00231410926503945,0.00246946145222569,-0.00252603518132289,0.0071542537114018,0.348721322186329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",24011,-0.00569643935791263,0.00608308104753441,-0.0176192782110801,0.00622639949525481,0.349056204508082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,24096,-0.00474461346658492,0.00507236242182062,-0.0146864438133533,0.00519721688018349,0.349599126678104
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,24096,-0.00384466715230109,0.0041113526990968,-0.0119029184425308,0.00421358413792863,0.349728440475329
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24106,-0.00266423347386182,0.00285031214687003,-0.00825084528172707,0.00292237833400343,0.349943847443275
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,24376,0.00229246432051759,0.00246222827858194,-0.00253350310550301,0.00711843174653819,0.351835523102159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,24933,-0.00181460869452283,0.0019532129717067,-0.00564290611906797,0.00201368873002231,0.352878492848472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,29391,0.00158117274071857,0.00170213949083726,-0.00175502066132245,0.00491736614275959,0.352931686640606
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,28926,-0.00297345771308275,0.00320350686006901,-0.009252331158818,0.0033054157326525,0.353317630575061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,24224,0.0013331613684548,0.00143786114211454,-0.0014850464700897,0.00415136920699931,0.353840423656469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,28439,-0.00218853096713029,0.00236329355006993,-0.00682058632526735,0.00244352439100677,0.354427204408833
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,24190,0.0025032973777506,0.00271211291375764,-0.00281244393321437,0.00781903868871556,0.356013119697516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28590,0.00519511173270297,0.00567491327154818,-0.00592771827953146,0.0163179417449374,0.359962020022752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,24106,-0.00216322841405988,0.00236997469201213,-0.00680837881040365,0.00248192198228389,0.361375624240969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,24440,-0.00475648391168136,0.00523285036415183,-0.015012870625419,0.00549990280205623,0.36337695604637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,24106,-0.00229535134811515,0.00252745971116274,-0.00724917238199412,0.00265846968576382,0.363799948831412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,24190,-0.00216677819223762,0.00238832538845762,-0.00684789595361457,0.00251433956913932,0.364290295543397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,23965,-0.00241119542719053,0.00268418950826731,-0.00767220686339445,0.0028498160090134,0.369037046984078
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,29429,-0.00413125982853808,0.00461146865256733,-0.01316973838757,0.00490721873049389,0.370331451463026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,24800,0.00332311167553179,0.00372165430886245,-0.00397133076983862,0.0106175541209022,0.371912698287324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,28911,-0.00417085662569128,0.00469287950375526,-0.0133689004530516,0.00502718720166904,0.374137981956914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24863,0.00172870524275919,0.00194541277872792,-0.00208430380354753,0.00554171428906591,0.3742235289804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,29322,-0.00345081633479423,0.00388881646635624,-0.0110728966088525,0.004171263939264,0.374887389611954
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,24106,0.00208880627540406,0.00235584257300378,-0.00252864516768334,0.00670625771849147,0.37527656840908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPGN,Epigen,24788,0.00279010282613053,0.00315082309284715,-0.00338551043584988,0.00896571608811094,0.375887234367667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24788,-0.00300292594400927,0.00340746079476847,-0.00968154910175547,0.00367569721373692,0.378175013517343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,24011,-0.00177818365235459,0.00202379530534814,-0.00574482245083695,0.00218845514612778,0.379606330862875
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,24961,0.00388207527796134,0.00442606723010614,-0.00479301649304669,0.0125571670489694,0.380444242090634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,24440,-0.00495613034559252,0.00568377908366208,-0.0160963373495702,0.00618407665838515,0.383228947606938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24106,-0.00290967205013882,0.00333989644601749,-0.00945586908433311,0.00363652498405547,0.383661116195237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,24863,-0.00213702844510691,0.00245406129038049,-0.00694698857425268,0.00267293168403886,0.383864684889691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,24011,0.00282889826201901,0.00324964632483713,-0.00354040853466175,0.00919820505869978,0.384022288665742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,29390,-0.0047374341398598,0.00544431922544887,-0.0154082998217396,0.00593343154201999,0.38421954805129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,24011,0.0014547531856503,0.00167202536196596,-0.00182241652380298,0.00473192289510359,0.384279325540495
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,24096,-0.00403689689773815,0.00465295372431015,-0.0131566861973861,0.00508289240190975,0.385622668588147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",24096,-0.00478069987392448,0.00551763849620971,-0.0155952713264955,0.00603387157864655,0.386257829190664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24096,-0.00180476586020283,0.00209948468217664,-0.00591975583726903,0.00231022411686338,0.390005307645612
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS2,Podocin,24224,-0.00581922591367864,0.00678476800215641,-0.0191173711979052,0.00747891937054792,0.391072296540727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24011,-0.00309793888716085,0.00361859450873552,-0.0101903841242825,0.00399450634996076,0.391941826712075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,24190,-0.00439483973085736,0.00514993124951182,-0.0144887049799005,0.00569902551818582,0.393457989260814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29627,-0.00398378984582056,0.00467081309633647,-0.01313858351464,0.00517100382299892,0.393715324678224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29429,0.00836049629504227,0.00984233166224568,-0.0109304737629593,0.0276514663530438,0.39564194227294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,29344,-0.00305490416412921,0.00359655363945904,-0.0101041492974689,0.00399434096921051,0.395667000198545
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,24376,0.00230454345014842,0.00271712657665865,-0.00302102464010255,0.00763011154039938,0.396360201018047
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24224,-0.00199475281522342,0.0023545537749767,-0.00660967821417775,0.00262017258373092,0.396897979157015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,28769,-0.00315954268199195,0.00373049342270114,-0.0104713097904862,0.00415222442650227,0.397029849168404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCIN,Adseverin,24096,-0.00407361968427375,0.00482793711110607,-0.0135363764220417,0.00538913705349416,0.398811974400418
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24011,-0.00465313214381278,0.00551819232032879,-0.0154687890916572,0.00616252480403164,0.399105508990079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,24106,-0.00216863517584395,0.00258493182055993,-0.00723510154414141,0.00289783119245351,0.401504253863108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,24011,0.00349364124458393,0.00416807142393005,-0.00467577874631897,0.0116630612354868,0.401931615597809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,24096,-0.00236203010815569,0.0028251546915803,-0.00789933330365309,0.0031752730873417,0.403123217283536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,29152,-0.00154474813546922,0.00184921917091464,-0.00516921771046191,0.00207972143952347,0.403526639324031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,23598,-0.00383700099525046,0.00460192003716599,-0.0128567642680958,0.00518276227759487,0.404411929229657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28792,-0.00536678282776069,0.00644134275434507,-0.017991814626277,0.00725824897075565,0.40475145952199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,28911,-0.00263831632588047,0.00319933179810031,-0.00890900665015708,0.00363237399839615,0.409579376679452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",24106,0.00211906599980293,0.00257552229723267,-0.0029289577027731,0.00716708970237896,0.410646165971773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,24190,-0.00445642238308003,0.00544611441478935,-0.0151308066360672,0.0062179618699071,0.413207916843273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,24190,-0.00184823133576754,0.00227752878603863,-0.00631218775640326,0.00261572508486818,0.417082366558207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24096,-0.00344643769912817,0.00427159679930656,-0.011818767425769,0.0049258920275127,0.419774389728524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,24749,-0.00272173355139154,0.00339715729210218,-0.00938016184391181,0.00393669474112874,0.423035301755042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,24440,-0.00277988681094197,0.00347237513859316,-0.00958574208258455,0.00402596846070062,0.423387168642172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24096,-0.00284887649016007,0.00356834846192751,-0.00984283947553798,0.00414508649521784,0.4246613831218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,29438,-0.00175961510777056,0.00221391961527022,-0.00609889755370018,0.00257966733815906,0.426738417118762
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,29589,-0.00278814866710991,0.00351082097957767,-0.00966935778708214,0.00409306045286233,0.427109479707527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEP,Leptin,29473,-0.00347492062260335,0.004407879788817,-0.0121143650086847,0.00516452376347797,0.430502519087634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,24224,-0.00218090134012374,0.00277339381986366,-0.00761675322705652,0.00325495054680905,0.43166106017835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,28792,-0.00164597912007697,0.00209385177877408,-0.00574992860647416,0.00245797036632023,0.431814751049441
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24106,0.00173939805238033,0.00221344808003531,-0.00259896018448888,0.00607775628924954,0.431973718986223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29213,0.00366520699519614,0.00466688905183544,-0.00548189554640132,0.0128123095367936,0.432246511069267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,24224,-0.00467377944752507,0.00595782760625337,-0.0163511215557817,0.00700356266073154,0.432767877139482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,23970,-0.00248515297587101,0.00318511394119317,-0.00872797630060962,0.0037576703488676,0.435257391027314
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,24011,-0.00367447055117401,0.00475100816596437,-0.0129864465564642,0.00563750545411615,0.439288223134104
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,28419,0.00463879187548899,0.00601442884036731,-0.00714948865163094,0.0164270724026089,0.440549055427176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24235,-0.00203476852078798,0.00263996090082411,-0.00720909188640325,0.00313955484482728,0.440858457528171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,24011,-0.00241253290916978,0.00313623197684533,-0.00855954758378664,0.00373448176544707,0.441755046677501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,24106,-0.0017833979701108,0.00232128363086413,-0.00633311388660449,0.00276631794638289,0.442327826089517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,24190,-0.0033057759529848,0.00430930987541313,-0.0117520233087945,0.00514047140282494,0.443015157486745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,24190,-0.00185031510115474,0.0024130696149847,-0.00657993154652474,0.00287930134421526,0.44321449848512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24011,0.00222012870938261,0.00290978212617541,-0.0034830442579212,0.00792330167668641,0.445478080430688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,24788,-0.00209725785593093,0.00276443967359578,-0.00751555961617865,0.0033210439043168,0.448065773900814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FURIN,Furin,29561,-0.00166552740757782,0.00219648408058083,-0.00597063620551624,0.00263958139036061,0.448295567939822
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,24961,-0.00205223227745108,0.00272470327401715,-0.0073926506945247,0.00328818613962254,0.451339984636588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,28926,0.00155961891148712,0.00207534444987889,-0.0025080562102755,0.00562729403324973,0.452358625828162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,24376,-0.00341888454180966,0.00459551092175461,-0.0124260859484487,0.00558831686482938,0.45690676553596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,24106,-0.00134362894397897,0.00181250473483298,-0.00489613822425161,0.00220888033629367,0.458512371234464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,29288,-0.00343244249994177,0.0046605614138101,-0.0125671428710096,0.00570225787112603,0.461440329274959
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSPN,Persephin,29429,-0.00451947872278034,0.00616560424130817,-0.0166040630357444,0.00756510559018368,0.46355528720391
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,24302,-0.00403561584537638,0.00551163076247896,-0.0148384121398351,0.00676718044908238,0.464053591537899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,29194,-0.00612672662068416,0.00837285725319954,-0.0225375268369553,0.0102840735955869,0.464335190902221
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,24106,-0.00151635188089769,0.00207541687467377,-0.00558416895525829,0.0025514651934629,0.465015216693738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,24011,-0.00294224048479774,0.00403227405799913,-0.010845497638476,0.00496101666888056,0.465597366204123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29815,-0.00110227964339353,0.00151892532114514,-0.00407937327283801,0.00187481398605095,0.468030201867474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,24863,-0.00359702754913719,0.00496733152274567,-0.0133329973337187,0.00613894223544433,0.468988571873817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,24224,-0.00165899028703679,0.00229521419216984,-0.00615761010368967,0.00283962952961609,0.469807214650554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",29373,0.00321495786054004,0.00444944382352685,-0.00550595203357258,0.0119358677546527,0.469960462966558
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,29781,0.00232987701092911,0.00322573813903509,-0.00399256974157968,0.00865232376343789,0.470129760827522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28296,0.0017912630980141,0.00248038963926615,-0.00307030059494755,0.00665282679097574,0.470195908396615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,28792,-0.00302473553902874,0.00419078916648474,-0.0112386823053388,0.00518921122728135,0.470449149903818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,29429,-0.0017376517507097,0.00241421602214455,-0.00646951515411303,0.00299421165269362,0.471679611055988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,24096,-0.00165779554075856,0.00230859526709559,-0.00618264226426591,0.00286705118274879,0.472704391183455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,29815,-0.00206972384650955,0.00288674397925293,-0.00772774204584529,0.0035882943528262,0.473395017272087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,24235,-0.00139328149753462,0.00195045493607867,-0.00521617317224881,0.00242961017717957,0.475025901919939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,24190,-0.0019955256888263,0.00279449110924132,-0.00747272826293929,0.00348167688528669,0.475176756461292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,24399,-0.00254069496091961,0.00357303926856345,-0.00954385192730398,0.00446246200546475,0.477045245072578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,29438,-0.00227205086241268,0.00321691597394469,-0.00857720617134428,0.00403310444651891,0.4800181811403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24840,-0.00366941999896606,0.00521739030304046,-0.0138955049929254,0.00655666499499325,0.481871895278226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,24440,0.00202205463029077,0.0028857411854951,-0.00363399809327963,0.00767810735386118,0.48349351689504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,24011,0.00165775977474225,0.00236706229688288,-0.0029816823271482,0.0062972018766327,0.483718788823506
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,24190,0.00174169951905867,0.00248915152228497,-0.00313703746461986,0.0066204365027372,0.484111321216117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,24106,0.00219072296858326,0.00314574829374116,-0.00397494368714941,0.00835638962431593,0.486180333539579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,24106,0.00232436137734213,0.00334166028816667,-0.00422529278746455,0.0088740155421488,0.486704356449921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,29473,-0.00302503580562914,0.00439179440446321,-0.011632952838377,0.00558288122711876,0.490959171763625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,28769,-0.00285887592544883,0.00415175249871034,-0.0109963108229211,0.00527855897202343,0.491083736864665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24840,0.00284034478121342,0.00412563222100629,-0.0052458943719589,0.0109265839343857,0.491167749777189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,24011,-0.00273382348646729,0.00397300004068621,-0.0105209035662123,0.00505325659327768,0.491396119604464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,29213,-0.00236336102279657,0.00347011486788271,-0.00916478616384667,0.00443806411825353,0.495838089740148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,29689,0.00571572969809775,0.00842142976108469,-0.0107902726336283,0.0222217320298237,0.497325333375344
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,24011,-0.00228649044810828,0.00336888046449992,-0.00888949615852812,0.00431651526231157,0.497328627631449
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,24440,-0.00193920027082026,0.00287418172014182,-0.00757259644229824,0.00369419590065772,0.499875011246957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29344,0.00173292865230297,0.00259860282068826,-0.00336033287624603,0.00682619018085196,0.504860816901314
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,23033,-0.00232078374017675,0.00348637922507646,-0.00915408702132661,0.00451251954097311,0.50562768117008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,24096,-0.00215043811501318,0.00324411065304083,-0.0085088949949732,0.00420801876494684,0.507417300980789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,24917,-0.00284419352405405,0.00431922253152817,-0.0113098696858493,0.00562148263774117,0.510225143128679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,24096,-0.00173478117490256,0.00263899925253298,-0.00690721970986719,0.00343765736006208,0.510953646314464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,28792,0.00271179134803589,0.00413083145629116,-0.00538463830629479,0.0108082210023666,0.511523210256528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,24917,-0.00114045358578462,0.00174335921319915,-0.00455743764365495,0.0022765304720857,0.513008221094169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,24235,-0.00179899253971324,0.00275262543308414,-0.00719413838855816,0.00359615330913167,0.513404648722372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,29438,0.00189434044464161,0.00293563805199432,-0.00385951013726726,0.00764819102655049,0.518743737018554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,28926,-0.00252015709549572,0.00391018258259157,-0.0101841149573752,0.00514380076638376,0.519249006681767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,24885,0.00197076673877013,0.00306088402565584,-0.00402856595151531,0.00797009942905557,0.519675135957294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,24321,-0.00478712314763448,0.00745988665253478,-0.0194085009866027,0.00983425469133369,0.52106412645956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24224,-0.00151762594653212,0.0023706432361468,-0.00616408668937985,0.0031288347963156,0.522065053307642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,24011,-0.00205761901610889,0.00322289261008146,-0.00837448853186855,0.00425925049965077,0.523194309491691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,24190,-0.00147568943670216,0.00234941873191176,-0.00608055015124922,0.0031291712778449,0.529938920672512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,28529,0.0031484050447466,0.00501804023479682,-0.00668695381545516,0.0129837639049484,0.530390781826509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,24917,-0.00107761179957232,0.00174228036276367,-0.00449248131058912,0.00233725771144448,0.536247144754943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,24914,0.00441506455292177,0.00717360787525724,-0.00964520688258242,0.018475335988426,0.538256984601416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,24440,-0.00214588273431479,0.00352189204599205,-0.00904879114445921,0.00475702567582963,0.542332419936597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,24917,0.00118371037118128,0.00194941113374411,-0.00263713545095718,0.00500455619331974,0.543714221184264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,29438,-0.00125958639824102,0.00207543258582929,-0.00532743426646642,0.00280826146998439,0.543919926511983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,28792,0.00302218762018087,0.00500107586261955,-0.00677992107055345,0.0128242963109152,0.545643989078414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,24917,-0.00119870564725137,0.00199171796655581,-0.00510247286170076,0.00270506156719802,0.547282747396879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24011,-0.0022442057635987,0.00377458552763636,-0.00964239339776597,0.00515398187056857,0.552145321511993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,24096,0.00171308226194276,0.00288131621257261,-0.00393429751469956,0.00736046203858508,0.552150892288049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,24011,0.00142336816742853,0.00239811198259961,-0.0032769313184667,0.00612366765332377,0.552827429808151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,28623,0.00434418246544108,0.00734646713089197,-0.0100548931111072,0.0187432580419893,0.554304363960872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,24106,0.0019437828509093,0.00331091044645426,-0.00454560162414105,0.00843316732595965,0.557152732877997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,24106,0.00193379547936547,0.00331495034025526,-0.00456350718753484,0.00843109814626577,0.559659272436993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24863,0.00120766486720987,0.00210949347143992,-0.00292694233681238,0.00534227207123212,0.566994933177937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,29406,-0.00226929374194377,0.00396872627260718,-0.0100479972362538,0.00550940975236631,0.567465937204479
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,29429,0.00274293811719359,0.00482583045233771,-0.00671568956938833,0.0122015658037755,0.569776720095034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,28926,-0.00138213349092552,0.00244714081076114,-0.00617852948001736,0.00341426249816631,0.572217424359948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,24440,-0.0010465292002142,0.00185687155568133,-0.00468599744934959,0.0025929390489212,0.573032883582836
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,29385,0.000850994160536908,0.0015100578367531,-0.00210871919949916,0.00381070752057298,0.57306424451748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIM,Vimentin,28911,-0.00428049102122388,0.00766245789402143,-0.0192989084935059,0.0107379264510581,0.576417505983266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,24235,-0.00293303584670762,0.00529077154663831,-0.0133029480781187,0.00743687638470347,0.579331957983393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,29213,-0.00131116810791127,0.00237704577823956,-0.00597017783326082,0.00334784161743827,0.581229639441822
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,23908,-0.00124050362837326,0.00227520163958181,-0.0056998988419536,0.00321889158520708,0.585601808808089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,24011,-0.00417602842895464,0.00767223134919406,-0.019213601873375,0.0108615450154657,0.586237153393559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24788,-0.00238763267577979,0.00438704520386907,-0.0109862412753632,0.0062109759238036,0.586276962526096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,29429,0.00198941432453751,0.0036835040112513,-0.00523025353751503,0.00920908218659006,0.589140807204956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,24190,-0.00133750759222576,0.00248135136122885,-0.00620095626023431,0.0035259410757828,0.589875353541043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29561,-0.00159873474274301,0.00297158260897486,-0.00742303665633373,0.00422556717084772,0.590575687909243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,24011,-0.00154546437220232,0.0028831318675371,-0.00719640283257503,0.0041054740881704,0.591938183585292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,24106,-0.002114307033104,0.00400955975414505,-0.0099730441512283,0.0057444300850203,0.597978670646042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,24440,-0.0029461424587776,0.00562961762519629,-0.0139801930041623,0.00808790808660712,0.600750034081406
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,24190,0.00176826906499496,0.00340222430916992,-0.00490009058097808,0.00843662871096801,0.603250176075206
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,28926,0.00107037115830482,0.00207814253189526,-0.00300278820420988,0.00514353052081953,0.606514000018748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,24224,-0.000919964848711433,0.00178862970477467,-0.00442567907006979,0.00258574937264692,0.607018586218471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,28792,-0.00170482156776234,0.003388531941328,-0.00834634417276523,0.00493670103724055,0.614887205262052
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,24011,0.00222714795422984,0.00444454893958023,-0.00648416796734741,0.0109384638758071,0.616307800462304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,24440,-0.00228332098614063,0.00457346326908249,-0.0112473089935423,0.00668066702126106,0.617604775408444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,24011,-0.00150014131739294,0.00305477086020151,-0.0074874922033879,0.00448720956860203,0.623373328614682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,24235,-0.00106563442162511,0.002174136580347,-0.00532694211910523,0.003195673275855,0.624038259577508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,24106,-0.00147659755361041,0.00301477265000389,-0.00738555194761805,0.00443235684039722,0.624288831838955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,24840,0.0022035546574129,0.00453551731365628,-0.00668605927735341,0.0110931685921792,0.627081940675181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,24106,0.00126941510519255,0.00261776079406195,-0.00386139605116888,0.00640022626155397,0.627734647252128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,24376,-0.000960028214195336,0.00200961381978488,-0.00489887130097371,0.00297881487258304,0.632855387342414
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,24566,-0.00175428986732236,0.00367436562723747,-0.0089560464967078,0.00544746676206308,0.63305294266133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,24190,-0.00115953087392591,0.00243124346729197,-0.00592476806981816,0.00360570632196634,0.633416886528426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24360,-0.00147505381743245,0.00310096739548665,-0.00755294991258628,0.00460284227772138,0.634309937502097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,28792,-0.0032256549278062,0.0067929584628901,-0.0165398535150708,0.0100885436594584,0.634895543313571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,24863,-0.000919429111974983,0.0019472090798573,-0.0047359589084953,0.00289710068454533,0.636803952693685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,24096,-0.00261905487061838,0.00556627498918051,-0.0135289538494122,0.00829084410817541,0.637986377546029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,24011,-0.00172622504658275,0.00368076547364792,-0.00894052537493267,0.00548807528176717,0.639084375416195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,24224,-0.000899173009696955,0.00192763908024394,-0.00467734560697507,0.00287899958758117,0.640888062571215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,29404,-0.000537976430610645,0.00115834259102311,-0.00280832790901594,0.00173237504779465,0.642338576442604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",24863,-0.00187611271716076,0.00409815535277833,-0.00990849720860629,0.00615627177428477,0.647104136585769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24235,0.00170943766575878,0.00375391187035389,-0.00564822960013485,0.0090671049316524,0.64884355047501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29689,-0.00140339326630086,0.00308482803061105,-0.00744965620629853,0.0046428696736968,0.649160023704219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,28792,-0.00136826882487664,0.00304387005351336,-0.00733425412976283,0.00459771648000955,0.653062727588151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,24011,0.00216222665621072,0.00482240788336109,-0.00728969279517701,0.0116141461075984,0.653889693590309
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,24106,-0.00121165424632152,0.00271454674513175,-0.00653216586677975,0.00410885737413672,0.655344117273471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,24011,0.00108125721968001,0.00242970542946833,-0.00368096542207792,0.00584347986143793,0.65631237537578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,24106,0.00125403565401772,0.00282629444034466,-0.00428550144905781,0.00679357275709325,0.657261225974949
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24696,0.000882250345427392,0.00199176518590347,-0.00302160941894341,0.00478611010979819,0.657806524796809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,28885,-0.00161396361797019,0.00364455495597991,-0.00875729133169081,0.00552936409575043,0.657883019694008
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,24440,-0.00116472319169079,0.00264030622382649,-0.0063397233903907,0.00401027700700912,0.659121445097958
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29213,0.00330978722493404,0.00753013630171253,-0.0114492799264225,0.0180688543762906,0.66027441275892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29429,0.00278108449607408,0.0063856141082599,-0.00973471915611533,0.0152968881482635,0.663185738818283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,29720,-0.000953361686875562,0.00221713225181265,-0.00529894090042836,0.00339221752667723,0.667200460288214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,24190,0.00169426252946901,0.00396642785628245,-0.00607993606884459,0.00946846112778262,0.669273353637681
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,24224,0.000925770252947996,0.00217257703696741,-0.00333248073950812,0.00518402124540411,0.67002697064413
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,24106,-0.00112810559660424,0.00264933336491481,-0.00632079899183726,0.00406458779862878,0.670252040748693
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24106,-0.00239360229947488,0.00562270841045271,-0.0134141107839622,0.00862690618501244,0.670328277921717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,24011,0.00173864187391991,0.00409069235863043,-0.00627911514899574,0.00975639889683555,0.67082308903508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",29473,-0.00203769211449534,0.00480623411654437,-0.0114579109829223,0.00738252675393161,0.671591844580221
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,29815,-0.00123029594313943,0.00291464854157117,-0.00694300708461892,0.00448241519834006,0.672949365010765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,28792,-0.00383262161843837,0.00909870800903167,-0.0216660893161404,0.0140008460792637,0.673592464886621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,28792,-0.00162448207594058,0.00386858835815053,-0.00920691525791562,0.00595795110603445,0.674549967572337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,24235,-0.000802223152477343,0.00191371882978759,-0.00455311205886103,0.00294866575390634,0.675076660831291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,29344,-0.00215351832701808,0.00521733652894179,-0.012379497923744,0.00807246126970784,0.679784002748129
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,24551,0.00166565343192092,0.00404460236914309,-0.00626176721159954,0.00959307407544137,0.680474000619384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,24840,-0.000605378261105989,0.00147976402442121,-0.00350571574897156,0.00229495922675959,0.682466433847807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,28664,-0.00240891215196598,0.00590742778354724,-0.0139874706077186,0.0091696463037866,0.683440575517586
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24011,-0.00170807675886067,0.00419603872999172,-0.00993231266964445,0.0065161591519231,0.683961034633194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,24011,-0.00107523847053555,0.00266151428045272,-0.00629180646022288,0.00414132951915178,0.68621999363017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28792,0.00326967996207619,0.00809801315275231,-0.0126024258173183,0.0191417857414707,0.686389836671731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,29438,-0.00079608829866557,0.00197260298954555,-0.00466239015817485,0.00307021356084371,0.686530051997544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,29657,0.00168065631834823,0.00418356547551828,-0.00651913201366759,0.00988044465036405,0.687886948619351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,24648,-0.000711871431698887,0.00178968990636271,-0.0042196636481698,0.00279592078477203,0.690808749714489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,21651,-0.00273819019783527,0.00692303471889719,-0.0163073382468738,0.0108309578512032,0.692463969200509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28792,-0.000905475346679489,0.00232642624400667,-0.00546527078493257,0.00365432009157359,0.697121464550931
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,24224,-0.000954512790592819,0.00248370609140292,-0.00582257672974254,0.00391355114855691,0.700752161208051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,29344,0.00172901497915494,0.00457798877502201,-0.0072438430198882,0.0107018729781981,0.705671030882274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,23965,0.000881688720792938,0.00233452148725622,-0.00369397339422925,0.00545735083581513,0.705675923648154
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,28926,-0.000813789477452898,0.00217537549522409,-0.00507752544809212,0.00344994649318633,0.708338987251236
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,24011,-0.00139472307692497,0.00373557757744503,-0.00871645512871722,0.00592700897486728,0.70888226365196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,24011,-0.00210746786845043,0.00568558594143056,-0.0132512163136543,0.00903628057675348,0.710887693168595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,24224,-0.00115962941507611,0.00312953125459311,-0.00729351067407861,0.0049742518439264,0.710980348567572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,29428,-0.00072712517415661,0.0019701613155819,-0.00458864135269714,0.00313439100438392,0.712079061906881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24011,-0.00139998302194971,0.00379371082047799,-0.00883565623008658,0.00603569018618716,0.712110600392178
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSND,Barttin,24011,0.000819445842538818,0.0022284530088285,-0.00354832205476505,0.00518721373984269,0.713085569541788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,24224,-0.00137923379433278,0.00376777647433534,-0.00876407568403004,0.00600560809536448,0.714323198327323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,24011,0.000757140719695235,0.00209690397332724,-0.00335279106802616,0.00486707250741663,0.718046161625563
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,24011,-0.000733262645395973,0.00204553660076524,-0.00474251438289585,0.0032759890921039,0.719995082607382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,28769,0.00105079914673821,0.00293150481248693,-0.00469495028573618,0.0067965485792126,0.720008892640006
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,24190,-0.000789320054116507,0.00220873964166636,-0.00511844975178258,0.00353980964354957,0.72082379150244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,24440,-0.00139346796691459,0.0039475598421311,-0.00913068525749155,0.00634374932366237,0.724095409665401
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,24064,0.00223398452030824,0.00644560442084001,-0.0103994001445382,0.0148673691851547,0.728902102270944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28388,0.00142948158515831,0.00420022760571586,-0.00680296452204478,0.00966192769236141,0.733607297642627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,29438,-0.00144526657708948,0.00426934251544061,-0.00981317790735308,0.00692264475317412,0.734972229451695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,24190,-0.00203080130144767,0.00604396782196167,-0.0138769782324925,0.0098153756295972,0.736870274781599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29373,-0.00143605400188783,0.00428554585091779,-0.0098357238696867,0.00696361586591104,0.737557752065269
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,24011,0.00064479460744849,0.00192816108020173,-0.00313440110974691,0.00442399032464389,0.738073797559863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,24106,-0.00216340385481572,0.00647723341981584,-0.0148587813576548,0.0105319736480233,0.738381546281533
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24190,-0.00121550931702579,0.00366376954413589,-0.00839649762353214,0.00596547898948056,0.740069835031841
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",29344,-0.001756643041328,0.00533240480534927,-0.0122081564598126,0.00869487037715658,0.741834617183267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,24011,-0.00201500145101621,0.00615023764286316,-0.014069467231028,0.0100394643289956,0.743194405839839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",24235,0.00182408030620393,0.00557354698098168,-0.00910007177652015,0.012748232388928,0.743463037290964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,24224,-0.00160071267081131,0.00494750801640686,-0.0112978283829687,0.00809640304134613,0.746289737308102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,24011,-0.00086211954029485,0.00268917819292238,-0.00613290879842271,0.00440866971783301,0.74852506286099
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24961,0.000408266427919097,0.00127549683824585,-0.00209170737504276,0.00290824023088096,0.748907157836397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,29438,-0.000408051583738055,0.00129057721706959,-0.00293758292919445,0.00212147976171834,0.751869965401341
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28769,0.00132221145869794,0.00420787667970633,-0.00692522683352647,0.00956964975092236,0.753353986457634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,29348,-0.00100731459015281,0.00323166056044307,-0.00734136928862123,0.00532674010831561,0.755269333585809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,24440,-0.000893776365169981,0.0028705509067653,-0.00652005614242997,0.00473250341209001,0.755529183250306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F3,Tissue factor,29536,-0.000550833805545059,0.00179384161723808,-0.00406676337533169,0.00296509576424157,0.758792741307663
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,24096,0.00122854146787864,0.0040506142332022,-0.00671066242919767,0.00916774536495494,0.761665715242275
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23965,0.00173552338806748,0.0057689239346171,-0.00957156752378203,0.013042614299917,0.76353907505162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,24788,-0.000875002462176471,0.00291593926384184,-0.00659024341930647,0.00484023849495353,0.764121945877053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,24106,0.00123058329584096,0.00411056704538236,-0.00682612811310846,0.00928729470479037,0.764659805081124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,24863,-0.0011306682906094,0.0037926124985736,-0.00856418878781365,0.00630285220659486,0.76561112139524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,29438,-0.000504454835752383,0.00169391629016286,-0.00382453076447158,0.00281562109296682,0.765854959152671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24224,0.000547159031343295,0.00184402648665839,-0.00306713288250715,0.00416145094519374,0.766683042194737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,24376,-0.00146817237164476,0.00496205017386856,-0.0111937907124271,0.00825744596913761,0.767324098404407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIT,Vitrin,24917,-0.00072805943676955,0.00246851207720588,-0.00556634310809307,0.00411022423455397,0.768043261275954
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,29720,-0.00242162326294984,0.008393253319635,-0.0188723997694344,0.0140291532435348,0.772950570888482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,24106,-0.00209370060592479,0.0074513556109132,-0.0166983576033147,0.0125109563914651,0.778726227206576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,24224,-0.000866473497616806,0.00309638348262668,-0.0069353851235651,0.00520243812833149,0.77960722555347
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",24011,0.000889496149913491,0.00321133882783612,-0.0054047279526453,0.00718372025247228,0.78179318127767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,24190,-0.000752037086728545,0.00274807960298626,-0.00613827310858161,0.00463419893512452,0.784348922684948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,24190,-0.00112659003786783,0.00414222258328855,-0.00924534630111339,0.00699216622537772,0.785641884542306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,28769,0.00101657180456358,0.00379640144441028,-0.00642437502648057,0.00845751863560774,0.788876380880852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24106,-0.000840300168636786,0.00314788092414996,-0.00701014677997071,0.00532954644269714,0.789516460384696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,24106,0.000731977373092005,0.00275703183217876,-0.00467180501797836,0.00613575976416237,0.790630654345475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,28746,-0.0014987912635228,0.00569931624217377,-0.0126694510981834,0.00967186857113779,0.792569898020909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24106,-0.00101077179838484,0.00385484024828342,-0.00856625868502035,0.00654471508825067,0.793162958530811
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,29815,0.000577614542695108,0.00223564383888749,-0.00380424738152437,0.00495947646691458,0.796126173877456
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,24235,-0.000660303305623073,0.00260428613536624,-0.00576470413094091,0.00444409751969476,0.799849369235133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,28792,-0.000590417667141339,0.00233232031816749,-0.00516176549074963,0.00398093015646695,0.800157165815254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",28911,0.00139750638966387,0.005537824799301,-0.00945663021696609,0.0122516429962938,0.800767272348282
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,24106,0.000818963246419312,0.00326475865800772,-0.00557996372327581,0.00721789021611444,0.801932568437981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,24011,0.000693043396844715,0.00276412019224791,-0.00472463217996118,0.00611071897365061,0.802026258629977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,28911,-0.000445319631959201,0.0018047490106778,-0.00398262769288769,0.00309198842896928,0.805104398710898
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,24190,-0.000806859990931413,0.0033352834956546,-0.00734401564241444,0.00573029566055161,0.808846944151061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,24235,0.000480832351145057,0.00199370290027899,-0.00342682533340176,0.00438849003569187,0.809421117869989
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24106,0.000635828721815585,0.0026386630644306,-0.0045359508844684,0.00580760832809957,0.809583331396593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,24788,0.000914576808133703,0.00389188821569839,-0.00671352409463514,0.00854267771090255,0.814214050267493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,24917,0.000458067443769371,0.00195236222081587,-0.00336856250902974,0.00428469739656848,0.81450393635594
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,23783,0.000659432145500562,0.00285027121000135,-0.00492709942610209,0.00624596371710321,0.817038928236224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,24440,-0.000679031766132537,0.00293861366142197,-0.0064387145425196,0.00508065101025453,0.817260688948603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,28926,-0.00120233234810889,0.00540266164919238,-0.011791549180526,0.00938688448430817,0.8238916490696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24106,0.000680725067223958,0.0030808878670426,-0.00535781515217955,0.00671926528662746,0.825132506232584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,28911,0.00048458812103159,0.00219496420373814,-0.00381754171829516,0.00478671796035834,0.825270999762238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24106,-0.000939512618933992,0.00432752179367187,-0.00942145533453085,0.00754243009666286,0.828130876978001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,29540,0.000257712038330763,0.00119211732970621,-0.00207883792789341,0.00259426200455494,0.828848861514707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,24011,0.000368934749725686,0.001711231011608,-0.00298507803302599,0.00372294753247737,0.829304420439586
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29344,-0.00136849191089465,0.00638686254294824,-0.0138867424950732,0.0111497586732839,0.830340580107053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28792,0.000832708340691144,0.00391942685628411,-0.00684936829762571,0.008514784979008,0.831752290641699
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24235,-0.00048838606314775,0.00230163057101563,-0.00499958198233839,0.00402280985604289,0.831959552143094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,24440,0.00112415116463488,0.00548433653489202,-0.00962514844375349,0.0118734507730232,0.837593467466097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,24224,-0.000660571327323254,0.00324325812978234,-0.00701735726169663,0.00569621460705013,0.838609016274505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24011,-0.000451633867641458,0.00223716291458102,-0.00483647318022026,0.00393320544493735,0.840013850125474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,24235,0.00343504509826225,0.0173097229877543,-0.0304920119577362,0.0373621021542607,0.842697804314105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24788,-0.000614317397182739,0.0031604565271144,-0.00680881219032696,0.00558017739596148,0.845882950840036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24190,-0.000601413627138276,0.003117808969727,-0.00671231920780319,0.00550949195352663,0.84704185015029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,29781,0.000424397822693153,0.00222863595800181,-0.00394372865499039,0.0047925243003767,0.848973954830579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,28926,0.000866030961692831,0.00460638166988022,-0.0081624771112724,0.00989453903465807,0.850872659709722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,28911,-0.000749342561018944,0.00406125787058928,-0.00870940798737393,0.00721072286533604,0.853614702592338
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,29222,-0.000867427495568567,0.00475444261423875,-0.0101861350194765,0.00845128002833939,0.855234249406639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24317,-0.000583579988014707,0.00320428379766607,-0.0068639762314402,0.00569681625541078,0.855486197306254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,29590,-0.000808019298254408,0.00446236321549275,-0.00955425120062021,0.00793821260411139,0.856310497044706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGN,Cingulin,24190,0.000473702344778801,0.00262844790307187,-0.00467805554524206,0.00562546023479966,0.856980333801932
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29650,-0.00036051794215892,0.0020069366937138,-0.00429411386183796,0.00357307797752012,0.857439622473365
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,28911,-0.000721256329885174,0.00401582757963715,-0.00859227838597399,0.00714976572620364,0.857465186197807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,24946,-0.000856264868655332,0.00477192554561935,-0.0102092389380693,0.0084967092007586,0.857595238807448
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,24235,0.000599520777217777,0.00335726841720582,-0.00598072532050563,0.00717976687494118,0.858273721923289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,29438,0.000376052727689524,0.00211367865750996,-0.00376675744103,0.00451886289640905,0.858791850941231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,24144,0.000788970497952206,0.00446300405974201,-0.00795851745914214,0.00953645845504655,0.859682570268488
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,24096,0.000709634751888996,0.004068562533296,-0.00726474781337117,0.00868401731714916,0.861537621825896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,29164,0.000583503520759351,0.00344134791477958,-0.00616153839220862,0.00732854543372732,0.865359971524767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,24440,0.000631888639102743,0.00382722226942288,-0.0068694670089661,0.00813324428717158,0.868863710290183
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,29448,0.000828409968720831,0.00505415843853213,-0.00907774057080215,0.0107345605082438,0.869805789989649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24190,-0.000409214880328288,0.00250475194846158,-0.00531852869931298,0.00450009893865641,0.870224227128886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNST,Consortin,29473,-0.00114702992239581,0.00710443673827676,-0.0150717259294183,0.0127776660846266,0.871738032943878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,24224,0.000453398164234695,0.00282331502467876,-0.00508029928413567,0.00598709561260506,0.872417112176836
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29589,0.000439970717657378,0.00276312626719272,-0.00497575676604035,0.00585569820135511,0.873489291513029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,24788,0.000543541176012297,0.00343742519607077,-0.00619381220828641,0.00728089456031101,0.874359975880571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,24933,-0.000909692116198725,0.00575376902959593,-0.0121870794142068,0.0103676951818093,0.874376373921805
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,24917,0.000288453506634499,0.00185807865341615,-0.00335338065406115,0.00393028766733015,0.876631092184035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,24946,0.000278893443533891,0.00180605673168942,-0.00326097775057738,0.00381876463764516,0.87727889073738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,24224,-0.000596790546300966,0.00398762164397799,-0.00841252896849783,0.0072189478758959,0.881033503093975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,24106,-0.000445627258568999,0.0030030090408175,-0.0063315249785713,0.0054402704614333,0.882033409321473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24933,-0.000243900928327247,0.0016655934030229,-0.00350846399825213,0.00302066214159764,0.883579298154124
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,24190,0.000464026970114378,0.0031826064285474,-0.00577388162983852,0.00670193557006728,0.884079759001336
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24106,0.000429799009335541,0.00301146330856524,-0.00547266907545232,0.0063322670941234,0.886511736353231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,24190,0.0002787481196111,0.00195717249329145,-0.00355730996724013,0.00411480620646233,0.886746380197976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24190,0.000458994408361448,0.00324529699237761,-0.00590178769669867,0.00681977651342157,0.887528500049816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24224,0.000311418025385535,0.0022133294014126,-0.00402670760138316,0.00464954365215423,0.888107195252926
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,24840,0.000631604241189572,0.00459891919522996,-0.00838227738146114,0.00964548586384028,0.890765113983109
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29296,-0.00067756560644205,0.00496255369087086,-0.0104041708405489,0.00904903962766484,0.891398764497128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,24788,-0.000400166788974818,0.00295308601237094,-0.00618821537322186,0.00538788179527222,0.892211337875634
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTD,Biotinidase,24961,-0.000182427493973182,0.00135705071396024,-0.00284224689333525,0.00247739190538888,0.893064130460169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,28926,0.000551155953856494,0.00414457615984504,-0.00757221331943979,0.00867452522715278,0.89420817375521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,24235,-0.000331560417839289,0.00266632786354863,-0.00555756303039461,0.00489444219471603,0.901038435505667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,24190,0.000536934108935951,0.0043341694977511,-0.0079580381066562,0.00903190632452811,0.901408177902126
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,24190,-0.000552130814809308,0.00457872278613253,-0.00952642747562906,0.00842216584601044,0.90401979621953
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,24190,-0.00052675067114841,0.00440212384085125,-0.00915491339921687,0.00810141205692004,0.904754826110201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",28769,0.000410440521177425,0.00355883407224879,-0.0065648742604302,0.00738575530278505,0.908184323960508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24096,0.000446699488071017,0.00391277484069372,-0.00722233919968867,0.0081157381758307,0.909108444818895
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,24235,-0.000235050700999137,0.00211839943369255,-0.00438711359103653,0.00391701218903826,0.911651568486435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,29531,0.000417724812386617,0.00378384217131462,-0.00699860584339004,0.00783405546816327,0.912095285261089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,29449,0.00200377539567053,0.0193833571711842,-0.0359876046598505,0.0399951554511915,0.917665203589087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,28911,0.000346962776426706,0.00345523904457642,-0.00642530575094307,0.00711923130379648,0.920014421507193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEB,Nebulin,24106,0.000240377769752624,0.00249255664209795,-0.00464503324875937,0.00512578878826461,0.923173326548369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,24224,-0.000344670747173882,0.00370239664754849,-0.00760136817636892,0.00691202668202115,0.925829690052444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,24440,0.000352888391753964,0.00390500828472402,-0.00730092784630512,0.00800670462981305,0.92799540317024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,28792,-0.000267647209025506,0.00308790730436617,-0.0063199455255832,0.00578465110753219,0.930929719793176
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,24863,0.000898460278879284,0.0103955101452777,-0.019476739605865,0.0212736601636235,0.931127105388194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,24800,0.00144594573842906,0.0170134778304203,-0.0319004708091947,0.0347923622860528,0.932271417010267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,24933,-0.000494923042662335,0.00582822714717811,-0.0119182482511314,0.0109284021658068,0.932327038689519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,29421,-0.000542285626034987,0.00639191883210553,-0.0130704465369618,0.0119858752848918,0.932389763289388
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,24933,-0.000241387743714229,0.00288226438087883,-0.00589062593023673,0.00540785044280827,0.933256398857699
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,24106,-0.000309914031457524,0.00372902174434125,-0.00761879665036637,0.00699896858745132,0.933765823802916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,29781,-0.00016532789992794,0.00198976528213169,-0.00406526785290605,0.00373461205305017,0.933781214179738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,29641,0.000120781156012973,0.00148943133608329,-0.00279850426271027,0.00304006657473622,0.935369234062217
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,29482,-0.000162023413982389,0.00207175431052362,-0.00422266186260869,0.00389861503464391,0.937664798501423
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29531,-0.000368778274379821,0.00500449783139813,-0.0101775940239202,0.00944003747516052,0.941258059488079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,24011,-0.000199646729142162,0.00277837967181577,-0.00564527088590107,0.00524597742761674,0.942716108597349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,29438,-0.000245057930434741,0.00348703538539937,-0.0070796472858175,0.00658953142494802,0.943973770101041
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24788,-0.000335553717562043,0.00503308316401525,-0.0102003967190319,0.00952928928390785,0.946845262057909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,29429,0.000461314286425084,0.00695253551095778,-0.0131656553150522,0.0140882838879023,0.947098075380243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,24788,-0.000192047600570143,0.00298264582335041,-0.00603803341433695,0.00565393821319667,0.948661537011653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,24440,0.000359725604585251,0.00559782398966112,-0.0106120094151505,0.011331460624321,0.948762386788649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,24440,-0.000214358257050917,0.00355209001434461,-0.00717645468516635,0.00674773817106452,0.95187970025511
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28769,0.000106551650362103,0.0031264810324646,-0.00602135117326852,0.00623445447399273,0.972813293315505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,24190,-8.15090327852396e-05,0.00275397124484618,-0.00547929267268375,0.00531627460711327,0.976388775823718
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,24190,0.000142988407547661,0.00511273823984418,-0.00987797854254693,0.0101639553576423,0.977688630549824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24788,8.26353217405236e-05,0.00311382673361407,-0.00602046507614305,0.00618573571962409,0.978828287810196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,24096,-8.77890700834428e-05,0.0035006577089881,-0.00694907817970012,0.00677350003953323,0.979993052500496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,29084,-0.000182933411810021,0.00764825073424161,-0.0151735048509236,0.0148076380273035,0.980917914609661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28926,0.000134060600243904,0.00775409378205355,-0.015063963212581,0.0153320844130689,0.98620617282555
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,24224,-4.58983885948532e-05,0.0029296671495331,-0.00578804600167974,0.00569624922449003,0.987500375473396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,28717,6.31549191544468e-05,0.00466861847185259,-0.00908733728567662,0.00921364712398551,0.98920700856409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,29025,2.2051993736456e-05,0.00191618230412367,-0.00373366532234593,0.00377776930981884,0.990817989868203
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,24235,3.03697700654877e-05,0.00353634650315216,-0.00690086937611276,0.00696160891624373,0.993148006661433
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,24376,-8.68372869193016e-06,0.00188567797051963,-0.00370461255091041,0.00368724509352655,0.996325715434024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28638,-7.55326105233567e-06,0.00361137617795088,-0.00708585056983605,0.00707074404773138,0.9983312252586
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24106,-1.37692308706914e-06,0.00207221869312605,-0.00406292556161414,0.00406017171544,0.999469836752691
